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Abstract 
The design, synthesis, and characterization of two novel metalloprotein motifs is 
presented. The first project involved the design and construction of a protein motif which 
was programmed to form a tetradentate metal complex upon the addition of metal cations. 
The overall structure of the motif was based on a pp super-secondary structure consisting of 
a flexible peptide sequence flanked by metal binding regions located at the carboxy and 
amino termini. The metal binding region near the amino terminus was constructed from a 
reverse turn motif with two metal ligating residues, (2R, 3R)-13-methyl-cysteine and 
histidine. Selection of the peptide sequence for this region was based on the 
conformational analysis of a series of tetrapeptides designed to form reverse turns in 
solution. 
The stereospecific syntheses of a series of novel bipyridyl- and phenanthrolyl-
substituted amino acids was carried out to provide ligands for the carboxy terminus metal 
binding region. These residues were incorporated into peptide sequences using solid phase 
peptide synthesis protocols, and metal binding studies indicated that the metal binding 
properties of these ligands was dictated by the specific regioisomer of the heteroaromatic 
ring and the peptide primary sequence. 
Finally, a peptide containing optimized components for the metal binding regions 
was prepared to test the ability of the compound to form the desired intramolecular 
peptide:metal cation complexes. Metal binding studies demonstrated that the peptide 
formed monomeric complexes with very high metal cation binding affinities and that the 
two metal binding regions act cooperatively in the metal binding process. The use of these 
systems in the design of proteins capable of regulating naturally occurring proteins is 
discussed. 
The second project involved the semisynthesis of two horse heart cytochrome c 
mutants incorporating the bipyridyl-amino acids at position 72 of the protein sequence. 
Structural studies on the proteins indicated that the bipyridyl amino acids had a neglible 
Vll 
effect on the protein structure. One of the mutants was modified with Ru(bpy)2+2 to form 
a redox-active protein, and the modified protein was found to have enhanced electron 
transfer properties between the heme and the introduced metal site. 
Vlll 
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General Methods 
All reagents were obtained from commercial sources and used without further 
purification. Where anhydrous conditions were employed, solvents were dried before 
use following the general procedures reported by Perrin and Armarego.l 
Routine 1 H and 13C Nuclear magnetic resonance spectra were recorded at 300 MHz 
and 75 MHz respectively on a General Electric QE-300 Spectrometer, or at 500 MHz and 
125 MHz respectively on a Bruker AM500 Spectrometer. All spectra were referenced 
using tetramethylsilane (TMS) or d6-dimethyl sulfoxide (d6-DMSO) as internal standards. 
Optical rotations were recorded at room temperature in a microcell, 1 dm path length at 589 
nm (Na lamp) on a Jasco DIP-181 Digital Polarimeter. Mass spectra were taken on a ZAB 
mass spectrometer in fast atom bombardment (FAB) mode. Infrared spectra were collected 
on a Perkin-Elmer 1600-Series FTIR Spectrometer. Thin layer chromatography (TLC) 
was carried out using EM reagents hard TLC plates with fluorescence indicator (Si02 60, 
F-254) or Merck (Al203 60 F-254). TLC plates were visualized with UV lamps or 
ninhydrin 0.2% solution in ethanol (followed by heat). Aash column chromatography was 
carried out according to the procedure of Still et a/.2using J. T. Baker (-40 J..Lm) flash silica 
gel. All synthetic intermediates were stored at 4°C after purification. 
Circular dichroism spectra were recorded on a Jasco 1600 Circular Dichroism 
Spectrometer. The spectra were baseline corrected and noise reduced using the Jasco 1600 
System Software on a 486-AT IBM-compatible personal computer, then transferred to a 
Macintosh llci personal computer for further analysis using Kaleidagraph Version 3.0 
(Synergy Software). UVNis spectra were recorded on a Shimadzu UV160U Spectrometer 
or an HP8451A Diode Array Spectrometer and subsequently processed on a Macintosh Ilci 
personal computer using Kaleidagraph Version 3.0. 
2 
Reversed-phase high pressure liquid chromatography was performed on a Beckman 
Series Gold HPLC, equipped with a dual wavelength UV detector. 
(I) Perrin, D.D.; Armarego, W.L.F. Purification of Laboratory Chemicals; Pergamon 
Press: New York, 1988. 
(2) Still, W.C.; Kahn, M.; Mitra, A. "Rapid Chromatographic Technique for 
Preparative Separations with Moderate Resolution," J . Org. Chern. 1978,43, 
2923. 
3 
Chapter 1: Introduction 
4 
Naturally occurring proteins possess enviable properties in that their diverse 
functions, accompanied by well defined supramolecular structures, provide almost limitless 
opportunities for the construction of new devices. In the quest for designing new proteins, 
it has become apparent that stable, well-defined, 3-dimensional structures are crucial to the 
development of functional entities. To date, attempts to assemble constructs with enhanced 
stabilities or novel, pre-programmed functions have focused largely on one of three 
methods: the modification of existing, naturally occurring protein structures, the selective 
screening of monoclonal antibodies raised to organic templates designed to model reaction 
pathways (catalytic antibodies), I-3 or the de novo synthesis of new proteins.4-7 In the first 
approach, the existing protein structure is treated as a scaffold, upon which new 
functionalities can be incorporated as long as the introduced modifications do not 
compromise the overall protein superstructure. This approach to protein design has 
benefited from the wide range of techniques now available to introduce both natural and 
unnatural elements directly into the polypeptide backbone; these techniques include site-
directed mutagenesis,8 in vitro expression of chemically acylated suppressor t-RNA,9 
direct chemical synthesis, 10 and semi-synthesis. 11 In addition, the chemical modification 
of protein side-chains with functionalized reagents has provided an alternative method to 
generate proteins with novel functions. 11 Thus the modification of existing protein 
structures has provided an array of diverse, functional entities which have been excellent 
systems to study protein structure and function. One of the main drawbacks to this 
approach, however, is that the designed systems are inherently limited to those naturally 
occurring proteins that are amenable to the techniques listed above. 
The area of de novo protein synthesis offers the most potential for the creation of 
truly novel protein structures with unprecedented functions. Simply stated, it involves the 
construction of proteinaceous products with rationally assembled structures and functions, 
all designed from first principles. The process of designing and testing new protein 
constructs provides the most rigorous test of the underlying principles of protein folding, 
5 
structure, and function. Many of the recent advances in the de novo protein design have 
focused on the construction of compact, stable, secondary structural motifs, which have 
then been assembled in a modular sense to form higher order structures that mimic native 
systems. This hierarchic condensation is based on the framework model of protein 
folding, 12 which proposes that proteins fold along a defined pathway and that the folding 
process is initiated and stabilized by small units of secondary structure (e.g., a-helix, 13-
sheet, 13-tums). The design of small structural elements has relied heavily on the results of 
studies with native proteins and with protein fragments found to adopt stable secondary 
structures, 13· 15 as well as synthetically prepared templates designed to induce a-helix 16 
and 13-sheet 17 conformations. The conclusions from these studies, in conjunction with 
those derived from surveys of crystal structures of natural proteins, 18-20 have provided a 
foundation for the selection of primary sequences designed to assume particular secondary 
structures (e.g., a-helix, 13-sheet). Protein designs based on helical motifs have received 
considerable attention, primarily due to the prevalence of helical motifs in natural 
proteins, 21 •22 and the ability to construct sequences with controlled aggregation 
properties. 23 Successful protein designs have been reported for the coiled-coil structural 
motif24 and higher order helical bundles composed of 3 or 4 helical domains.4•25•26 
In contrast, designs based on ~-sheet structures have been hampered due to 
extensive solubility problems; the limited solubilities have been attributed to the use of 
bulky, hydrophobic amino acids which have high propensities for extended 
conformations 19•20 and to the potential for 13-sheet structures to form infinite lattices.27 
This packing arrangement has been observed in the crystal structures of enkephalin peptide 
hormones28•29 and has recently been implicated in the formation of amyloid plaque proteins 
associated with Alzheimer's disease.30 However, globular 13-structures are prevalent in 
nature (e.g., immunoglobin family of proteins), and several designs modeled after these 
systems have been reported. For example, an eight-stranded antiparallel ~-barrel structure 
has been designed by Richardson 7 based on the immunoglobulin VL domain, and the 
6 
design, synthesis, and characterization of a protein containing a novel ~-sheet fold with an 
engineered metal binding site has recently been reported. 31 The latter protein, called the 
"minibody," was designed using ~-sheet strands and hypervariable loop fragments derived 
from the immunoglobin V H chain to form a 6-stranded ~-sandwich protein. It should be 
noted that solubility problems hindered the characterization of these motifs; in both cases 
the solution structure was assessed using circular dichroism spectroscopy. The results 
from these models hold promise for the future design of stable, soluble protein motifs 
based solely on the ~-sheet secondary structure. 
Despite these advances, the de novo synthesis of functional proteins has remained 
largely elusive to date. While several systems have been reported to exhibit catalytic 
activity, 32·35 the lack of detailed structural analyses in these systems has prevented 
comprehensive characterization of the reaction mechanisms. As a result, the nature of the 
observed catalytic activities for most of these systems is not well understood.6 Even in the 
most well characterized systems, which are composed of defined secondary structural 
elements (e.g., 3- and 4-helical bundles), it is very difficult to precisely predict the tertiary 
interactions between the structural motifs.5 In fact, most of the designs reported to date 
which employ natural amino acid sequences mimic the so-called "molten-globule" protein 
folding state rather than the correctly folded proteins found in nature.4 It is clear from these 
studies that more constraints on the structural framework are required for these systems to 
assume native-like protein structures. 
One approach to this problem has employed the use of synthetic templates to induce 
and direct the correct folding of polypeptide chains. Mutter, using the template-assisted 
synthetic protein (TASP) approach, has assembled a series of 4-helix bundle proteins 
covalently attached to a branched cyclic decapeptide template. 36 The resulting synthetic 
proteins were more stable than the corresponding 4-helical bundle proteins constructed 
from linear peptide sequences as determined by CD spectroscopy, NMR spectroscopy, and 
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chemical denaturation studies. Similarly, 4-helical bundle motifs have been synthesized 
using porphyrin ring templates by a number of research groups.4 
The incorporation of metal binding sites into the designed motifs has been attempted 
as another possible solution to this problem. Metal cations play central structural and 
functional roles in naturally occurring protein architectures.37 In some cases, such as the 
"zinc-finger" regulatory proteins38 and the protein hormone insulin, 39 metal cations are 
essential for correct folding and stabilization of the protein structure. In light of these 
examples, the construction of sites capable of binding metal cations selectively and in high 
affinity has received considerable attention in de novo protein design.31 ·40-46 Indeed, the 
demonstration of selective binding of metal cations has been considered to be one of the 
first steps in the construction of functional protein designs.4 However, the construction of 
sites capable of binding metal cations using the ribosomally encoded amino acids presents a 
formidable challenge, as the number of amino acids capable of ligating metal cations is 
fairly limited. 
The approach taken by this laboratory has been to utilize unnatural amino acids in 
designed motifs to direct the polypeptide conformation or introduce functional groups 
capable of emulating the reactivities found in native enzyme systems. It is surprising that 
while the ability of non-encoded amino acids to constrain peptide conformation has 
precedent in a wide variety of naturally occurring peptide hormones and synthetically 
prepared peptides,47 these moieties have not been utilized to a significant extent in de novo 
protein design .4 With the wide variety of methods now available for the synthesis of 
optically pure a-amino acids containing complex functionalities,48 it is now possible to 
prepare functionalized amino acids capable of directing the overall polypeptide 
conformation or introducing groups with enhanced reactivities. In addition, the recent 
advances in solid phase peptide synthesis49 have provided methods to prepare relatively 
long polypeptide sequences(== 100 residues) suitable for the construction of small designed 
motifs or for the assembly of larger constructs using semisynthetic methodologies. As a 
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result, unnatural amino acids can be incorporated anywhere within a peptide sequence, and 
this versatility makes them ideal building blocks for the assembly of highly functionalized 
polypeptide motifs. The work presented in this dissertation describes the application of 
these concepts towards the development of two novel metal-binding protein motifs which 
display not only effective metal-binding properties, but also utilize metal cations to perform 
designated functions. The first motif concerns to the de novo design of proteins 
programmed to regulate the activity of peptide-binding enzymes while the second project 
involves the engineering of an existing protein structure through semisynthetic techniques 
to incorporate unnatural amino acids capable of binding metal cations with high affinities. 
The first project involved the development of proteins which were designed to 
function as regulatory subunits for naturally occurring enzymes which process peptidyl 
substrates (e.g., kinases, proteases). The de novo design of these proteins was based on 
native enzyme systems where regulation of enzyme activity is often achieved through 
conformational changes in regulatory domains which are induced by chemical 
modulators .50-53 For example, the cAMP dependent protein kinase complex contains a 
regulatory subunit which responds to physiological levels of cAMP; in the absence of 
cAMP it has a high affinity for the catalytic subunit active site and thus forms a tight 
complex between the catalytic and regulatory domains.54-56 However, upon binding 
cAMP, the regulatory subunit undergoes a conformational change which results in the 
dissociation of the protein complex to release the catalytic subunit. This process is shown 
schematically in Figure 1-1 . 
The de novo designed regulatory protein is proposed to effect its action on a 
targeted enzyme in a similar fashion ; however, the required conformational changes will be 
induced by metal cations. As shown in Figure 1-2, the overall structure of the protein is 
based on a 1313 supersecondary structure (in the absence of metal cations) and it contains 
three distinct regions which are responsible for either metal cation binding or interacting 
with the catalytic pocket of the targeted enzyme. The first region of the protein, situated 
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cAMP 
\.... 2C + R2 (cAMP)2 
Figure 1-1. Mechanism of cAMP dependent protein Kinase C regulation (C =catalytic 
subunit, R = regulatory subunit) 
near the amino terminus, is designed to form a 13-Type II reverse tum secondary structure 
with two metal binding ligands. The Type II 13-tum conformation is expected to serve as a 
conformationally stable "platform" upon which the two ligands can form a bidentate metal 
binding site. The third region, situated near the carboxy terminus, is also 
+ 
Inactive Active 
L L L 
, ........ Jr--~ ........ ~,.....---±;-+-~ 
Region 1 Region 2 Region 3 
Figure 1-2. Schematic of proposed metal-dependent regulatory protein (M+2 =metal 
cations) 
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implicated in metal cation binding, as it is composed of an unnatural amino acid capable of 
bidentate metal cation coordination. Finally, the second region, located in the center of the 
peptide sequence, is designed to incorporate a consensus sequence capable of acting as a 
competitive inhibitor for the targeted enzyme (e.g., cAMP-dependent protein kinase C). In 
the absence of metal cations, this region of the peptide is expected to bind in the catalytic 
pocket of the targeted enzyme and effectively block the enzyme catalytic activity. 
The regulatory action of the proposed motif is based on the fact that many enzymes 
that process peptidyl substrates (e.g., kinases, proteases) have binding domains which 
require the substrates to adopt an extended conformation. For example, analyses of the X-
ray crystal structure of the cAMP dependent protein kinase containing a bound 
inhibitor57•58 have shown that a five residue consensus sequence common to all known 
substrates and inhibitors of this enzyme adopt an extended conformation when bound in the 
catalytic pocket. It is believed that the region of the regulator motif containing the 
inhibitory consensus sequence targeted to the enzyme (e.g., cAMP dependent protein 
kinase) will have a high affinity for the catalytic pocket in the absence of divalent metal 
cations, since the peptide will be expected to be relatively conformationally free under these 
conditions. However, upon the addition of a divalent metal cation, the designed protein is 
proposed to form a tetradentate metal complex utilizing the metal binding ligands located in 
the first and third regions of the protein sequence. In this case the metal cation serves as a 
template, and monomeric complex formation involving these ligands would induce a 
conformational change in the central region of the protein motif causing it to change from 
an extended conformation to one which contains a constrained bulge or loop (See Figure 1-
2). This restriction on the conformational flexibility of the central region is proposed to 
reduce the binding affinity of the regulatory motif for the catalytic pocket of the enzyme and 
therefore promote the dissociation of the regulatory motif from the enzyme active site. 
Since the regulatory protein motif design contains three distinct regions, it was 
envisioned that overall design could be assembled via a modular approach utilizing 
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optimized peptide sequences and amino acids as determined by model studies performed 
for each region of the design. As a result, initial studies focused on the design of the first 
metal binding region which was proposed to contain a reverse turn motif capable of binding 
metal cations in aqueous solution. In order to determine the sequence requirements for 
stable reverse turn motifs in solution, a systematic study was carried out on a series of 
tetrapeptides as described in Chapter 2. These studies provided a series of guidelines for 
the selection of primary sequences which contain significant amounts of turn character in 
solution. The guidelines provided a basis for the work described in Chapter 3, which 
investigated the effects of incorporating functional groups at the first and fourth positions 
(positions i and i+3 respectively) of the reverse turn motif. These studies indicated that a 
tetrapeptide incorporating the unnatural amino acid, (2R, 3R)-p-methyl cysteine, at the first 
position with a histidine residue at the fourth position adopted a significant amount of 
reverse turn character and was capable of binding metal cations in aqueous solution. 
The third region of the designed motif, proposed to contain an unnatural amino acid 
capable of bidentate metal cation coordination, was investigated in Chapter 4 through the 
stereospecific syntheses of a series of novel bipyridyl- and phenanthrolyl-substituted amino 
acids. These amino acids were synthesized using a variety of routes to afford the optically 
pure enantiomers with N<l-FMOC protection to allow peptide incorporation using solid 
phase peptide synthesis protocols. The metal binding properties of peptides incorporating 
these amino acids was studied in Chapter 5, and the results from these investigations 
indicated that these amino acids were capable of selectively binding a variety of metal 
cations with affinities ranging over five orders of magnitude in some cases. The metal 
binding affinities and the stoichiometries of the metal complexes was found to be dependent 
both on the specific regioisomer of the bipyridyl/phenanthrolyl-amino acid employed as 
well as on the particular primary sequence of the peptide in which the amino acid was 
incorporated. 
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The studies described in Chapter 6 highlight the potential applications of the 
bipyridyl-substituted amino acids in larger systems through the semisynthesis of two 
cytochrome c mutants incorporating the residues at position 72 of the protein sequence. 
This project was undertaken as a collaborative effort with Professor Harry B. Gray and 
Deborah Wuttke, and it was proposed that the bipyridyl amino acids, when incorporated 
into the polypeptide backbone of the protein structure, could serve as effective anchors for 
redox-active metal centers. These redox-active centers could then be used in the study of 
intraprotein electron transfer processes between the introduced metal centers and the 
covalently bound heme group. The construction and structural characterization of these 
novel proteins was carried out and the results from these studies indicated that 
incorporation of the bipyridyl amino acids at position 72 of the protein sequence using 
semi-synthetic methodologies had a negligible effect on the overall protein structure. 
Further, one of the proteins was found to undergo modification of with Ru(bpy)2+2 to 
form the desired redox-active Ru(bpy)3+2 center on the protein surface. Enhanced electron 
transfer properties were observed with the modified protein, and these properties were 
applied towards the study of protein folding processes. 
Finally, the work described in Chapter 7 represents a continuation of the regulatory 
protein design as it involves the construction of a prototype of the regulatory motif. The 
prototype was based on optimized components determined from the studies in Chapters 2-
5, and it was prepared in an effort to test the ability to form intramolecular monomeric 
complexes with the proposed metal binding regions. The results from metal binding 
studies demonstrated that the peptide forms monomeric complexes with very high metal 
cation binding affinities. These results show the potential for the future design of 
functional, regulatory motifs targeted to naturally occurring enzymes. 
The work described in this dissertation demonstrates the utility of unnatural amino 
acids in the development and construction of novel metal-binding protein motifs. In 
general, the results from these studies indicate that the metal complex coordination 
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environment can be influenced both by the choice of the metal binding ligands and the 
three-dimensional structure of the polypeptide framework. These attributes will prove 
useful in the future design of metalloprotein motifs containing metal coordination sites 
capable of complex reactivities. 
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Reverse turns play an important structural role in the compact globular architecture 
of native folded proteins. 1•3 However, although the reverse tum has been the subject of 
numerous experimental4-9 and theoretical 10-12 investigations, the explicit role of the tum 
motif in the protein folding process in nature remains an open issue.2·13-15 In fact it is 
probable that this small motif is simply a versatile element in the hierarchy of protein 
structure, and the specific responsibility in folding, be it active or passive, is dependent 
upon the local amino acid sequence. 16 A current predicament in the de novo design and 
synthesis of proteins concerns the ability to precisely predict and control the three-
dimensional architecture of a protein-like biopolymer.17 In this context, we reasoned that it 
would be advantageous to delegate a specific function to the reverse tum in the protein 
infrastructure. Therefore, our objective in this work has been to identify and construct a 
conformationally well-characterized turn motif, which could be used to actively nucleate18 
and stabilize folded protein structures. Progress in this area would complement the recent 
developments in a-helix and ~-sheet stabilization and the utilization of those structural 
motifs in de novo protein design. 17 
At the present time there are 11 classes of reverse turns known; 19 however, only 3 
of these classes are commonly found in protein structures. 1•19 We have chosen specifically 
to focus on the type II rather than type I turn. While the latter type of ~-turn is most 
common in naturally occurring proteins which are composed of L-amino acids, 1 the former 
appears to represent a more useful target for optimization for use as a structural nucleation 
element for a number of reasons. First, the type II turn motif is compatible with a 
heterochiral sequence, which would render it "position specific" within a longer 
polypeptide chain since such a sequence cannot be integrated as part of either a regular a-
helix or ~-sheet structure. 16 This preference, first realized by Venkatachalam,2° has been 
attributed to the elimination of steric interactions between the amide carbonyl oxygen and 
the side-chain of the D residue. The type I turn, however, is more compatible with an L-L 
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sequence based on similar arguments and the fact that the central amide bond adopts the 
opposite orientation. Second, the peptide backbone of the type II turn has been found to 
form a more planar conformation than a type 1. 19 Such a conformation maximizes the 
interactions within the peptide backbone and minimizes those between the side-chain and 
backbone. This planar arrangement fixes the side-chains of the residues at positions i and 
i+3 to lie in the same plane with the distance between the two ca. carbons of these residues 
approximately 7 A apart. These attributes could be exploited in de novo design motifs, as 
the type II reverse turn can be viewed as a structural platform with the potential for 
programming functionality at the i and i+3 positions. In contrast, the type I turn has been 
found to adopt a more twisted conformation in protein structures and interactions between 
the side-chain of the residue at position i and the main chain atoms of position i+3 are 
common. 19 Third, the dihedral angles for the residues involved in a type Ilj3-turn allow 
for a very favorable hydrogen-bonding alignment between the carbonyl oxygen and the 
amide NH of the i and i+3 residues which may be more inherently stable.4 
Finally, the wide range of studies using cyclic peptides4•7 and immunogenic peptide 
fragments6 provide a basis for the investigation of reverse turn formation in aqueous 
solution. Despite this wealth of information, however, the linear peptide sequence 
requirements for the type II turn conformation have not been well defined. Many of the 
experimental studies reported to date have been performed under widely different 
conditions and characterized by a variety of techniques3 thereby making direct comparisons 
of the results difficult to interpret. In addition, since the type II tum prefers a heterochiral 
sequence, probabilistic studies1•19•21 based on amino acid occurrences in protein structures 
are of limited value for the determination of the primary sequence requirements for this 
motif. Indeed, the results of these studies have shown that there are very few statistically 
significant positional preferences in the type II tum beyond proline at the i+ 1 position and 
glycine at the i+2 position. 19 In order to determine the specific sequence requirements for 
the type II tum motif, a systematic study of a series of tetrapeptides was undertaken in both 
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dimethyl sulfoxide (DMSO) and aqueous environments. The goal of this work was to 
formulate general guidelines for the construction of reverse turn motifs under these 
conditions, similar to those published for a-helices22 and f3-sheets.23 The systematic study 
was based on the general sequence Ac-L-Xaa-Pro-D-Xaa-L-Xaa-NH2, with the following 
constraints: a proline or proline derivative was invariant at the i+ 1 position, a D-amino acid 
residue was always incorporated at the i+2 position, and blocking groups on the amino and 
carboxyl termini were employed to better mimic a long peptide chain (see Figure 2-1). 
Conformational analysis of the tetrapeptides in solution in dimethyl sulfoxide 
(DMSO) and water was based on several experimental criteria. These include an 
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Figure 2-1. Diagram of the tetrapeptide sequence used for systematic studies 
evaluation of nuclear Overhauser effects (NOEs), amide temperature coefficients and 
qualitative interpretation of circular dichroism (CD) spectra. NOE effects were observed 
. d . . 1 . f 1 0 h ff t t 9·24-26 usmg two- 1mens10na rotating- rame nuc ear ver auser e ec spec roscopy 
(ROESY) and results were compared with those predicted for protein secondary structure 
by Wuthrich.27 NOE studies provide unequivocal evidence for through-space interactions 
between protons, which would be unique to a folded structure. Variable temperature (VT) 
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studies allow for an assessment of whether or not exchangeable protons are solvent 
shielded and hence potentially involved in hydrogen-bonding interactions.3·6 Temperature 
coefficients can be influenced by many factors beyond backbone hydrogen-bonding; 
however, comparisons made between closely related peptides, such as those in the studies 
discussed herein, are very useful for providing auxiliary information pertaining to 
substitution trends in solution conformations. Finally, the CD spectra of certain reverse 
turn structures have been predicted28·29 and observed30·31 to be distinct from those of 
other secondary structural motifs and random chain conformers; therefore, the CD studies 
in water provide a further, independent, indicator of solution state conformations. 
In general, the main limitation of these data is that they cannot provide a quantitative 
measure of the absolute population of a specific conformation in linear peptide models; 
however, the evidence under evaluation can afford an indication of the existence of a 
population of structures with a defined conformation. Furthermore, a comparison of 
relative populations within the series of peptides can be used to indicate which features of 
the sequence are important for the structural integrity of the motif. 
Through the course of these studies, several tetrapeptides, Ac-Val-Pro-D-Ser-His-
NH2 in particular, were found to adopt a significant amount of reverse turn (J3-type II) 
character in both water and dimethyl sulfoxide (DMSO). The positive results from these 
peptides, in conjunction with the results from the other peptides of the systematic study, 
provide a basis for understanding the interactions that govern the reverse tum formation in 
linear peptide sequences. The conclusions from these studies can now be applied to design 
of viable, pre-programmed structural nucleation elements for incorporation into larger 
polypeptides. The key attributes of the motif are two-fold: firstly, the capped tetrapeptides 
emulate short, internal sequences of long, linear polypeptides. Secondly, the motif appears 
to owe its stability only to a complementary combination of local steric and hydrogen 
bonding effects and not to dominant interactions between oppositely charged groups or 
specific effects due to strong side chain-main chain interactions. These effects have been 
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shown to "lock" small peptides into local secondary structures and 13-turn 
conformations. 32·33 
Results 
Conformational Study of Ac-Val-Pro-D-Ser-His-NH2 and Ac-Vai-Pro-D-Ala-His-NH2. 
NOE studies on Ac-Val-Pro-D-Ser-His-NH2 and Ac-Val-Pro-D-Ala-His-NH2 in 
water and DMSO provide the strongest evidence to indicate the presence of a turn 
population. Figure 2-2 illustrates the through space connectivities which might be 
observed in a typical type II 13-turn structure. Interactions 1, 2, and 3 are classified as 
"sequential" connectivities.6 
( o , H; C) , C; ~, 0; Q, N; e , R) 
Figure 2-2. NOE interactions expected for a [3-type II reverse turn motif: 1, ProCa-
(i+2)NH; 2 , (i+2)Ca-(i+J)NH; 3 and 3', (i)Ca-ProC8, 4, (i+2)NH-
(i+J)NH; 5, ProCa-(i+J)NH, 6, (i) sidechain-(i+J) sidechain. 
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Figure 2-3. Sections of the 500-MHz ROESY spectra of Ac-Val-Pro-D-Ser-His-NH2 in 
(A) DMSO (298 K) and (B) 90/10 H20/D20 (278 K). The regions 
encompassing crosspeaks from the amide and alpha carbon protons are 
shown. Labeled peaks represent those important for conformational 
analyses and can be assigned to the following interactions: dNN[His, Ser], 
daN [Pro, Ser], daN [Pro, His], daN [Ser, His], dao [Val, Pro], 
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Figure 2-4. Sections of the 500-MHz ROESY spectra of Ac-Val-Pro-D-Ser-Ile-NH2 in 
(A) DMSO (298 K) and (B) 90% H20 /10% D20 (278 K). The regions 
encompassing crosspeaks from the amide and alpha carbon protons are 
shown. Labeled peaks represent those important for conformational 
analyses and can be assigned to the following interactions: dNN [Ser, Ile], 
daN [Pro, Ser], daN [Ser, lie], dao [Ile, Pro], doN [Ile,Val] (DMSO 
only), and dNy [Amide Cap, lie] . 
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Although interactions 1, 2 and 3 would be present, in varying intensity, in the 
spectra of many peptides, 4, 5 and 6, would be observed in a type II reverse turn folded 
structure.27 The diagnostic regions of the ROESY spectra of Ac-Val-Pro-D-Ser-His-NH2 
in DMSO and water are shown in Figure 2-3. In DMSO, the sequential NOEs (1, 2 and 
3, Figure 2-2) are strong. In addition, the long range connectivities dNN (His, Ser), daN 
(Pro, His) and dyo2 (Val, His) interactions (4, 5 and 6, Figure 2-2) are observed. In 
water the sequential NOEs and the dNN(His,Ser) are present; however, the remaining long 
range interactions are not seen. The ROESY spectra of Ac-Val-Pro-D-Ala-His-NH2 in 
both DMSO and water show the interactions 1, 2, 3 and 4, with the long range interaction 
(4) being weak in water. The ROESY data for these and related peptides are summarized 
in Table 2-1. A small amount of a second, ordered conformation (<10% in all peptides) is 
evident in the 1D NMR spectra. This minor component could be due to the cis amide 
conformer of the proline residue; however, this conformation was not analyzed in detail. 
Table 2-1. Observed ROESY Connectivitiesa in DMSO and Water 
Peptide DMSO Water 
Ac-Val-Pro-o-Ser-His-NH2 1,2 ,3,4,5 and 6 1,2,3 and 4 
Ac-Val-Pro-D-Ser-Phe-NH2 1,2,3,4 and 6 1,2,3 and 4b 
Ac-Val-Pro-D-Ser-Ile-NH2 1,2,3,4 and 6 1,2,3 and 4 
Ac-Val-NapPro-D-Ser-His-NH2c ND 1,2,3 and 4 
Ac-Val-Pro-D-Ala-His-NH2 1 ,2,3 and 4 1,2,3 and 4b 
Ac-Val-Pro-D-Ala-Phe-NH2 1,2 and 3 1,2 and 3 
a See Figure 2-2 for definition of interactions; b Crosspeak relatively weak; c NapPro = 
cis -(2S,4S)-4-(naphth-2-yl)-amido-proline 
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VT studies on these two peptides provide data which is consistent with the NOE 
observations. In an ideal ~-turn [i+3 to i hydrogen bond] in the absence of interactions 
between the side chain functionality and the peptide backbone, the temperature coefficients 
would be predicted to show maximum solvent shielding of the i+3 residue NH and 
minimum shielding of the i+2 residue NH.3 In a structure containing a y-turn, [i+2 to i 
hydrogen bond] involving the proline and D-amino acid residue, the converse would 
apply.3 It should be noted that the absolute magnitudes of the temperature coefficients are 
influenced strongly by solvent effects; in DMSO values range from 0 to -8 ppb/K, and in 
water the values can range from -2 to -11 ppb/K. It is generally accepted that temperature 
coefficients > -4 ppb/K in H20 (> -3 ppb/K in DMSO) is indicative of strong solvent 
shielding and coefficients from -4 to -6 ppb/K in H20 (-3 to -4.5 ppb/K in DMSO) indicate 
moderate solvent shielding of the exchangeable proton. Protons with temperature 
coefficients < -6 ppb/K in H20 ( < -4.5 ppb/K in DMSO) are considered to be exposed to 
the solvent milieu. The amide proton temperature coefficients of the tetrapeptides examined 
are summarized in Tables 2-2 and 2-3. In both DMSO and water, the VT data for Ac-Val-
Pro-D-Ser-His-NH2 and the D-alanine-containing analog indicate some ~-turn population: 
temperature coefficients for the i+3 NH show of strong solvent shielding in DMSO and 
moderate shielding in water. 
The CD spectra of Ac-Val-Pro-D-Ser-His-NH2 and Ac-Val-Pro-D-Ala-His-NH2 in 
water are shown in Figures 2-Sa and 2-Sb. CD spectra of reverse turns are distinct from 
those of other secondary structural motifs.28-31 The spectral type associated with a type II 
~-turn, classified as a class B spectrum, is characterized by negative ellipticities >220 nm 
and <190 nm and a positive ellipticity in the 200-210 nm range. All spectra in Figures 2-5a 
and 2-Sb show maxima and minima in the appropriate wavelength range for a type II ~­
turn; however, the absolute value for 8 is weaker for Ac-Val-Pro-D-Ala-His-NH2 than 
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Table 2-2. Temperature Coefficients for Amide Proton Chemical Shifts in DMSO 
(!1o/!1T)a 
Peptide i i + 2 i + 3 
Ac-Val-Pro-D-Ser-His-NH2 -7.3 -7.8 -2.9 
Ac-V al-Pro-o-Ala-His-NH2 -5.5 -5.0 -2.7 
Ac-Val-Pro-o-Ser-Phe-NH2 -5.0 -5.1 -2.9 
Ac-Val-Pro-o-Ser-Ile-NH2 -6.2 -4.6 -3.5 
Ac-Val-Pro-o-Ala-Phe-NH2 -5.8 -4.2 -4.5 
Ac-Ala-Pro-D-Val-His-NH2 -4.6 -3.8 -4.4 
Ac-Ala-Pro-o-Ala-Phe-NH2 -5.2 -3.8 -4.5 
Ac-tert-Leu-Pro-o-Ala-His-NH2 -6.0 -4.8 -4.2 
Ac-Ala-Pro-Gly-Phe-NH2 -5.5 -3.9 -3.9 
Ac-Ala-Pro-D-Leu-Phe-NH2 -5.3 -3.2 -5.4 
Ac-Ala-Pro-D-V al-Phe-NH2 -5.3 -3.9 -5.4 
a In parts per billion per degree Kelvin. 
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Table 2-3. Temperature Coefficients for Amide Proton Chemical Shifts in Water 
(68/6T)a 
Peptide i i + 2 i + 3 
Ac-Val-Pro-D-Ser-His-NH2 -8.7 -9.4 -5.0 
Ac-Val-Pro-D-Ala-His-NH2 -7.9 -8.1 -4.9 
Ac-Val-Pro-D-Ser-Phe-NH2 -8.7 -8.8 -5.8 
Ac-Val-Pro-D-Ser-Ile-NH2 -8.1 -9.3 -6.2 
bAc-Val-NapPro-D-Ser-His-NH2 -8.9 -7.0 -4.8 
Ac-Val-Pro-D-Ala-Phe-NH2 -8.4 -9.1 -6.2 
Ac-Ala-Pro-D-Val-His-NH2 -7.6 -8.8 -7.8 
Ac-Ala-Pro-D-Ala-Phe-NH2 -9.3 -8.5 -6.8 
Ac-tert-Leu-Pro-D-Ala-His-NH2 -7.6 -9.0 -6.5 
Ac-Ala-Pro-Gly-Phe-NH2 -6.1 -7.3 -7.5 
CAc-Ala-Pro-D-Leu-Phe-NH2 -8.2 -9.1 -8.9 
Ac-Ala-Pro-D-Val-Phe-NH2 -9.9 -9.9 -8.7 
a In parts per billion per degree Kelvin; b NapPro = cis-(25,45)-4-(naphth-2-yl)amido-
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Figure 2-5. CD spectra in H20 at 25° C of (A) Ac-Val-Pro-o-Ser-Xaa-NH2 (Xaa =His, 
Phe and Ile); (B) Ac-Val-Pro-o--Ala-Xaa-NH2 (Xaa =His and Phe) 
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Ac-Val-Pro-D-Ser-His-NH2. The relative spectral intensities lend support to the NOE 
observations which suggested that the latter peptide was a stronger tum. The intensity of 
the positive ellipticity for the D-serine-containing peptide approaches a value for 9 of 2300 
deg.cm2 dmoJ-1 . (It should be noted that it is not possible to directly compare the CD 
spectra of peptides in this study with those calculated or in model systems, since the latter 
are based on only a core triamide unit.) 
The CD spectrum of Ac-Val-Pro-D-Ser-His-NH2 is invariant over the concentration 
range from 51lM-5mM; therefore, it is assumed that intermolecular interactions are not 
affecting the measurements. Also, the upper concentration limit for the CD studies 
approaches that used in the NMR experiments, so the observations made in the two 
experiments can be correlated. 
Collectively, these spectroscopic observations indicate the presence of a population 
of an ordered conformation in Ac-Val-Pro-D-Ser-His-NH2. Ac-Val-Pro-D-Ala-His-NH2 
also shows evidence of a similar structure, but to a lesser degree. In order to more fully 
understand the interactions that stabilize these particular sequences, a series of related 
peptides were studied based on the general structure Ac-L-Xaa-Pro-D-Xaa-L-Xaa-NH2. 
Since tum formation is a complex process involving many interdependent effects, it is not 
feasible to carry out an exhaustive survey. However, these studies demonstrate that in this 
closely related series of peptides, the opportunity exists for a significant amount of 
conformational variability. 
Conformational Consequences of Residue Substitution 
Influence of Modifications at position Ci+J) 
In order to address the importance of histidine as the i+3 residue, related peptides 
with single residue replacements were examined. All spectroscopic data in water was 
collected < pH 4.5, thus the histidine side chain would be ionized. Ac-Val-Pro-D-Ser-
Phe-NH2 and Ac-Val-Pro-D-Ser-lle-NH2 can be compared with Ac-Val-Pro-D-Ser-His-
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NH2, and Ac-Vai-Pro-o-Aia-Phe-NH2 can be compared with Ac-Val-Pro-o-Ala-His-
NH2. 
NOE studies of these peptides in DMSO and water essentially indicate that a 
diminution of the tum population accompanies replacement of either 0-serine at i+2 or 
histidine at i+3. For example, ROESY spectra of Ac-Val-Pro-o-Ser-Ile-NH2 in DMSO 
lack the daN [i+ 1, i+3] and long range connectivities observed in the corresponding 
histidine-containing peptide (See Figure 2-4). Also, the dNN [i+2, i+3] interaction in Ac-
Val-Pro-o-Ala-His-NH2 is absent in Ac-Val-Pro-o-Ala-Phe-NH2 in water. However, 
observation of the daN [i+ 1, i+3] connectivity may not be possible, even in a viable tum, 
as the predicted distance27 for this interaction in a perfect type II tum is 3.3A--a value 
which is close to the limits of detection in the ROESY experiment. 34 The VT data, 
presented in Tables 2-2 and 2-3, show similar trends, indicating that histidine at i+3 has a 
positive, but not unique, effect on the conformation. In the unordered peptide, Ac-Ala-
Pro-0- Val-His-NH2 (also documented in Tables 2-2 and 2-3), the histidine NH 
temperature coefficient is typical of a solvent exposed proton. This latter observation rules 
out the possibility that the low coefficients are due only to a side chain specific effect. 
CD studies for the o-serine and o-alanine containing peptides illustrated in Figures 
2-5a and 2-5b, respectively, support the conclusions reached in NMR experiments. 
Essentially, the peptides which show NMR evidence of being better turns are characterized 
by a CD spectra with more Class B character. 
Influence of Modification at position (i) 
The side chain substituent of the amino acid residue at the i position experiences 
steric crowding from the S-methylene of the proline ring in a f3-turn. 35 Therefore, the 
influence of the steric effects of residues was probed through a series of systematic 
variations of steric bulk in this position. Specifically, Ac-Vai-Pro-O-Ala-Phe-NH2 was 
compared with Ac-Aia-Pro-O-Ala-Phe-NH2, and Ac-tert-Leu-Pro-O-Ala-His-NH2 was 
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compared with Ac-Vai-Pro-D-Ala-His-NH2. The ROESY spectrum of Ac-Val-Pro-D-Ala-
Phe-NH2 does not show any long range interactions indicative of a folded structure; 
therefore, it is likely that the population of folded structure(s) is low. However, the VT 
data for these two pairs of peptides in water and DMSO (Tables 2-2 and 2-3) and the CD 
spectra in water collectively provide an idea of the influence of the i residue substitutions. 
The CD spectra for each pair of peptides are illustrated in Figures 2-6a and 2-6b. In 
contrast to the spectra observed with the previous five peptides (in which CD spectra 
showed a distinct positive ellipticity maximum between 200 and 210 nm), Ac-Ala-Pro-D-
Ala-Phe-NH2 shows a very broad positive ellipticity ranging from 205-225 nm, and the 
ten-leucine-containing peptide exhibits no positive ellipticity. Thus it appears that either 
increasing or decreasing the steric bulk beyond valine perturbs the tum conformation in a 
negative way. 
Effects of Proline Functionalization 
Proline serves a key role in protein folding and structural stabilization due to the 
constrained cj> dihedral angle imposed by the pyrrolidine ring.3 In an effort to expand the 
utility of the proline residue to assume both structural and functional roles, a functionalized 
proline derivative was synthesized which contains a naphthyl group attached to the y-
carbon through an amide linker (See Appendix 1). This residue, cis-(25,45)-4-(naphth-2-
yl)-amido-proline (NapPro, see below) was designed to act primarily as a fluorescent probe 
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Figure 2-6. CD spectra in H20 at 25° C of (A) Ac-Xaa-Pro-D-Ala-Phe-NH2 (Xaa =Ala 
and Val); (B) Ac-Xaa-Pro-D-Ala-His-NH2 (Xaa = t-Leu and Val) 
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The tetrapeptide Ac-Val-NapPro-D-Ser-His-NH2 incorporating this unnatural residue was 
prepared and conformationally analyzed in water to test the effect of proline modification on 
the tum population. 
Incorporation of the functionalized proline derivative does not substantially affect 
the tum integrity when compared to the parent sequence Ac-Val-Pro-D-Ser-His-NH2. In 
water, the observed NOE connectivities are consistent with a significant population of type 
II 13-tum structure and all of the sequential NOEs are present (1, 2, and 3) in addition to the 
long range connectivity dNN (Ser, His) (4). In addition to these NOE connectivities, 
several long range connectivities were observed between the naphthyl ring protons and the 
side chain groups of positions i and i+2 .36 These connectivities suggest that the naphthyl 
group resides above the proline ring, between the side chains of the i and i+2 residues. 
The variable temperature coefficients for Ac-Val-NapPro-D-Ser-His-NH2 support the 
results from the ROESY experiment as the i+3 NH (see Table 2-3) shows moderate solvent 
shielding as compared to the other amide protons within the peptide. However, the CD 
spectra for this peptide does not show the class B structure that would be expected from the 
nuclear magnetic resonance studies (See Figure 2-7). This marked difference can be 
attributed to the presence of the naphthyl group chromophore in the peptide; aromatic 
chromophores have been shown to affect circular dichroism spectra, especially when the 
group resides within a reverse tum. 3.37 
Influence of (i+2) Residue. 
The effect of varying the steric bulk of the i+2 residue was also investigated. For 
this purpose, a homologous series of four peptides, of general structure Ac-Ala-Pro-D-
Xaa-Phe-NH2 (Xaa = Gly, D-Ala, D-Val and D-Leu), were studied to see if a change in 
the i+2 residue might alter the tum population. The temperature coefficients for the amide 
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Figure 2-7. CD spectra in H20 at 25° C of Ac-Val-NapPro-D-Ser-His-NH2 and Ac-Yal-
Pro-D-Ser-His-NH2 
respectively. In DMSO there appears to be no type II ~-turn population and, in fact, in 
some cases, the i+2 NH coefficients show some solvent shielding (e.g., for Ac-Ala-Pro-D-
Leu-Phe-NH2; (-)3.2 ppb/K). This observation suggests the presence of an alternate 
folded structure such as a y-tum or a reverse tum in which the amide NH of the D-leucine is 
hydrogen bonded to the carbonyl group of the acetyl cap. In water, changes in the steric 
demand of the i+2 residues to the small, flexible residue glycine, or more sterically 
demanding residues D-valine or D-leucine, weaken the turn; the D-alanine-containing 
peptide has the lowest coefficient for the i+3 NH. In water there is no indication of an 
alternate folded structure. 
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Figure 2-8 shows the CD spectra for this series of peptides in water. Following a 
similar trend to the water VT data in which Ac-Ala-Pro-D-Ala-Phe-NH2 demonstrates a 
slight turn population, the CD spectrum shows a negative ellipticity at 197 nm and a broad 
positive ellipticity from 208 nm to 220 nm. The spectra of the glycine, D-valine and D-
leucine analogs are quite varied and lack any positive ellipticity in the region characteristic 



















- • • • • Ac-AI•Pro-Giy-Phe-NH, 
/ 
- - • • • Ac-AI•Pro-0-Leu-Phe-NH, 
- - • Ac-Aia-Pro-0-Vai-Phe-NH, 
195 205 215 225 235 245 255 265 
A./nm 
Figure 2-8. CD spectra in H20 at 25° C of Ac-Ala-Pro-Xaa-Phe-NH2 (Xaa = Gly, D-
Ala, D-Val and D-Leu) 
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Discussion 
The short linear peptides examined in this study could potentially adopt many 
conformations. However, the prolyl-D-amino acid dipeptide core of the sequence prevents 
adoption of either ordered a-helical or ~-sheet structures; thus, it is reasonable to limit 
discussion to the three predominant types of interconverting conformers.38 These would 
be represented by: (i) "open" (unfolded) structures with no hydrogen-bonding interactions; 
(ii) a y-tum structure [i+2 to i hydrogen bond]; and (iii) f3-tum structures [i+3 to i hydrogen 
bond]. The ~-tum could be either a Type I or II structure; however, the latter is expected in 
the heterochiral sequence studied, since this conformation results in reduced steric 
interactions between the carbonyl oxygen of the central amide and the side chain of the i+2 
residue.20 
The combined spectroscopic data for the peptide Ac-Val-Pro·D-Ser-His-NH2 show 
evidence of a significant population of a folded conformation and allow identification of the 
likely conformation. The NOE experiments indicate the presence of a Type II ~-turn 
structure. In both solvents, the observed NOE daN (Pro, Ser) (1, Figure 2) is very 
strong, indicating that these two protons are on the same face of the molecule as is 
characteristic of a type II turn (typical proton-proton distances in turns; type II 2.2A, type I 
3.4A). In addition, the interaction between the 0-protons on the proline ring with the a-CH 
of the (i) residue is characteristic of a trans Xaa(i)-Pro(i+2) amide (in the trans isomer the 
da8(Yal, Pro) distance is 2.0-3.9A, whereas in the cis isomer it is 4.3-5.0A27). A small 
amount of a second conformer, assigned as the cis amide rotomer to proline (based on 
chemical shift data) was noted in the 1 D I H NMR spectra. It is surprising that the 
contribution of the cis rotomer is as low as it is, particularly with a bulky residue such as 
valine in the i position. The cis amide rotamer often arises in those situations where steric 
congestion becomes an issue and the backbone cannot unfold to relieve the added strain. 
For example, the distribution of conformers for the peptide cyc/o-(L-Val-L-Pro-Gly)2 is 
biased very strongly in favor (>80% in D20 or DMSO) of the two-cis amide isomer.4 
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Also, studies on linear, uncapped pentapeptides of general structure Tyr-Pro-L-Xaa-L-Yaa-
L-Zaa (uncapped terminii) also show high proportions of the cis amide rotomer.6 It 
appears that the balance of steric bulk at the i, i+2 and i+3 positions around the turn, 
coupled with the turn type, may be responsible for the shift in equilibrium between the two 
rotomers. 
In the peptides examined, the side chain of the D i+2 residue would be removed 
from the crowded face of the molecule in the Type II conformation. Both VT and CD 
studies are in agreement with the turn identification. In the VT experiments, the i+3 amide 
NH is solvent shielded in both solvents. Furthermore, with regards to the CD studies, 
while either an open conformation or a Type I turn would be characterized by negative 
ellipticities in the 200-210 nm range, and they-turn would show a maximum at longer 
wavelengths2 (approximately 230 nm), the Type II turn would be expected to show a CD 
pattern similar to that illustrated in Figure 2-5a. The intensity of the positive ellipticity for 
the D-serine-containing peptide approaches a value for 8 of 2300 deg.cm2dmol-l which is 
not strong. However, the absolute intensity of the CD spectra for reverse turns is always 
much lower than that observed for the regular a-helix and ~-sheet, since it is composed of a 
"non-recurring" arrangement of chromophores. In addition, low band intensities can be 
attributed to equilibrium between the tum conformation and unordered structures which 
show an intense negative band around 200 nm39 and can therefore cancel out the intensity 
of the positive maximum. 
The role of 0-serine in stabilizing the type II ~-turn motif is unclear. Although 
many reports have discussed Type I turn stabilization by L-serine,40.4 1 there is only one 
discussion of the Pro-o-Ser dipeptide influence on conformation. Studies of Boc-Pro-0-
Ser-NHMe in solution in carbon tetrachloride and in the solid state have suggested that the 
serine hydroxyl group may provide additional stabilization to the turn conformation through 
a hydrogen bonding interaction from the y-0 (Ser) to the amide NH;38 however, the VT 
data for the blocked tetrapeptides in these studies do not indicate that this is the case in 
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water or DMSO. In homochiral sequences, residues such as serine and cysteine exhibit 
unique conformational properties which have been correlated with advantageous side chain 
interactions.42 While the prolyl-D-serine dipeptide core of the sequence does seem to be a 
strong turn determinant, it is noteworthy that even in the absence of the extra hydroxyl 
functionality, the turn is present, albeit to a lesser degree. 
The results from the peptide containing the functionalized proline derivative, 
NapPro, stand as a testament to the turn nucleation properties of the tetrapeptide sequence 
Ac-Val-Pro-D-Ser-His-NH2. Incorporation of the bulky naphthyl group on the proline ring 
had significant ~-turn character based on the observed variable temperature coefficients and 
the observed NOE connectivities; in fact, the results of these studies are comparable to 
those observed for Ac-Val-Pro-D-Ala-His-NH2. While the effects of incorporation of more 
reactive functionalities on the proline ring will need to be examined, the results from this 
model system hold promise for the generation of designed motifs where proline derivatives 
can play active roles in both structural stabilization and pre-programmed functions. 
The observed steric effects at the i + 2 position are consistent with the predicted 
dihedral angles for each residue, as derived from Ramachandran plots.43 The ideal 
dihedral angles for the i+2 residue in the type II turn are cp = 80° and 'I'= 0°;3 P-branching, 
or incorporation of sterically demanding groups at the i+2 amino acid residue, would be 
expected to restrict the conformational space open to that residue, and hence prohibit 
assumption of the ideal torsional angles. The spectroscopic data (both CD and VT studies) 
indicate that the tetrapeptides with either D-leucine or D-valine at the i+2 position exist 
largely in an open conformation in water. In contrast, VT studies in DMSO suggest some 
population of an alternate folded structure (Ac-Ala-Pro-D-Leu-Phe-NH2 [~3/~T = -3.2 
ppb/K for i+2 NH]). In the latter solvent, however, the ROESY studies did not provide 
further insight on the conformation of these peptides as no diagnostic NOEs were 
observed. Conformational analysis of simple dipeptides, of general structure tert-BuCO-
Pro-D-Xaa-NHMe,5 have indicated that the heterochiral dipeptides showed a high P-turn 
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ratio in aprotic solvents, regardless of the steric bulk of the i+2 residue. The results of 
these studies suggest that the full effect of steric bulk at the i+2 position in the type II tum 
may not be felt in the absence of complete amino acids at the i and i+3 location around the 
motif. 
The optimum residue at the i position, in the folded motif, should be one which 
favors an extended f3-sheet conformation. In these investigations, we have focused 
principally on the influence of steric effects. It appears, from the limited study carried out 
thus far, that valine at the i position results in the highest tum population based on both CD 
and VT data. Increasing the steric demand of this residue to tert-leucine, or decreasing it to 
alanine, weakens the integrity of the turn. These steric effects are rather pronounced as 
would be anticipated with residues preceding proline. Schimmel and Flory35 have noted 
that although the (<)>,'If) dihedral angles of residue i are independent of the neighboring 
residues (i -1 and i + 1), this is not true for residues adjacent to proline. In this case, 
interactions with the oCHz of proline affects the (<)>,'If) conformational space accessible to 
the preceeding residue significantly. 
With regards to the influence of amino acid replacements at the i+3 position, three 
amino acids have been considered. In this case, in contrast to the i residue effect, ~­
branching, (e.g ., in the peptide, Ac-Val-Pro-D-Ser-Ile-NHz) does not stabilize tum 
formation relative to the two unbranched i+3 amino acid-containing peptides. While the 
spectroscopic data shows that histidine at the i + 3 position stabilizes the turn motif, the 
origin of this enhanced stability is still unknown. It is possible that the histidine imidazole 
ring forms a weak hydrogen bond with the central amide carbonyl oxygen atom; both the 
protonated No and NE atoms are within hydrogen bonding distance (depending on the 
value of x2 =± 90°) when the histidine resides in the trans XI rotamer. In support of this 
hypothesis, analyses of peptide crystal structures44 have shown that the aromatic amino 
acids often adopt the trans rotamer for X 1 and generally assume a planar orientation with 
respect to the peptide main chain (X2 = ±90°). Further investigation will be necessary to 
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clarify the actual mechanism for the enhanced stability of the tum motif when histidine is 
incorporated at position i+3. 
Conclusions 
In general short linear peptides, in which both amino and carboxyl terminii are 
derivatized, are considered to be conformationally unstructured in solution in polar aprotic 
and protic media. This instability is attributed to the fact that competition for intermolecular 
hydrogen-bonding interactions by solvent tends to diminish any advantageous stabilization 
which might be gained from intramolecular hydrogen bond formation which accompanies a 
folded structure. This study has presented spectroscopic evidence to indicate that the short 
linear peptide Ac-Val-Pro-D-Ser-His-NHz shows an observable population of a folded 
conformation in both DMSO and water. From the NMR and CD studies, this conformation 
has been identified as a type II ~-turn. In this peptide, we suggest that an adventitious 
combination of steric effects influences the conformational space accessible to the peptide 
backbone in such a way as to promote intramolecular hydrogen-bonding and folding of the 
turn motif. The specific contribution of the hydroxyl and imidazole side chains in 
stabilizing this reverse tum structure have yet to be elucidated. 
The demonstration that a short peptide, which is terminal capped to emulate an 
internal sequence within a long polypeptide, can adopt a sufficiently stable folded structure 
to be observed in aqueous solution now sets the stage for utilizing this short peptide as an 
engineered structural nucleation site for de novo protein design and synthesis. The 
heterochiral sequence provides an additional advantage in this regard, since the prolyl-D-
arnino acid dipeptide pair cannot adopt any other ordered secondary structure such as the a-
helix or ~-sheet. In addition, the demonstration that the turn stability is observed with polar 
residues such as D-serine and histidine and to some degree with less polar residues such as 
D-alanine and phenylalanine also means that the turn motif could be used as an exposed 
turn on the surface of a globular, folded structure or as an internal turn element. Finally, 
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the fact a peptide containing a functionalized proline derivative still retains significant ~-turn 
character in aqueous solution is particularly interesting, as it provides direct evidence that 
the derived turn sequences are amenable to functionalization without loss of structural 
integrity. The ability to incorporate reactive groups into the tum sequence is crucial to the 
design of functional motifs. The research described in Chapter 3 provides an extension to 
the work outlined herein, as it involves an examination of the effects of incorporation of 
functionality at position i of the tum sequence. 
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Experimental 
Peptide Synthesis and Characterization 
Commercially available starting materials and reagents for the synthesis of all 
tetrapeptides described were purchased from Milligen Biosearch or Sigma Chemical Co. 
The unnatural amino acid, NapPro, was synthesized as described in Appendix I. Peptides 
were synthesized on a 0.1-0.2 mmol scale by solid phase methods using N<C9-
fluorenylmethyloxycarbonyl (FMOC) protected amino acids45•46 and benzotriazol-1-yloxy-
tris(dimethylamino)phosphonium hexafluorophosphate/1-hydroxybenzotriazole 
(BOP/HOBt)47 mediated amide coupling chemistry on a Milligen 9050 automated peptide 
synthesizer. PAL resin48 (Milligen GEN077483 substituted at ca. 0.30 meq/g) was used 
to afford amides at the carboxyl terminus. In most cases, 2.5 amino acid equivalents were 
used per coupling; however, in cases where low coupling efficiency was expected (as in 
the incorporation of the unnatural amino acid, NapPro), 4.0 equivalents were employed. 
Activated esters were formed in situ using BOP, HOBt and 0.451 M N-methyl-morpholine 
in dimethylformamide (DMF). Coupling times varied from 0.5-2.0 hr depending upon 
coupling efficiency of the particular amino acid. Deprotection of FMOC-protected amine 
groups was performed using a 7 min. 20% piperidine/DMF wash. Peptides were N-
acetylated on the resin using 20 equivalents of acetic anhydride and 5 equivalents of 
triethylamine in 3 mL DMF. After shaking for 2 hr, the resin was washed with 
dichloromethane and air dried. 
Peptides were deprotected and cleaved from the resin by treatment with 
trifluoroacetic acid (TFA)/thioanisole/ethanedithiol/anisole (90:5:3:2) for 2 hr. After 
filtration of the resin, the combined filtrates were concentrated to ca. 2 mL volume and 
precipitated with ether/hexane 2:1. The supernatant was decanted and the pep tides were 
washed with ether/hexane 2:1 (3x20 mL). The peptides were repeatedly lyophilyzed until 
no traces of the cleavage mixture remained. Purification of the peptides was accomplished 
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using reverse phase HPLC (Cts) Gradient elution with 0.08% TFA in acetonitrile added to 
0 .1% TF A in water when necessary. 
The purity of each peptide was assessed to be >95% by thin layer chromatography 
(TLC) and High Pressure Liquid Chromatography (HPLC). TLC was carried out using 
the following eluent systems: A. n-butanol: acetic acid: water (4: 1: 1) and B: n-butanol: 
acetic acid: water: ethyl acetate (1 :1:1:1). TLC plates were visualized with I2 vapors, UV 
lamps, or by exposure to Ch vapors followed by treatment with a solution of o-toluidine in 
acetic acid with KI.49 In some peptides, the presence of a small quantity (<10%) of an 
alternate conformational isomer was apparent by l H NMR. 
Chemical shifts of NMR spectra are reported as o units ppm relative to DMSO-d6 
(2.49 ppm) for lH and (39.5 ppm) for l3C in DMSO-d6 as solvent and DMSO (2.73 ppm) 
as an internal standard in 10% Dz0/90% H20 solutions at 5 °C, pH= 3.6 ± 0.6. 
Spectroscopic Studies 
CD Studies 
Peptide solutions were prepared in double-distilled HzO (4 mM concentration) and 
degassed using four freeze-pump-thaw cycles and stored under argon. Standard peptide 
spectral samples were prepared by serial dilution with degassed double-distilled HzO 
(degassed by argon sparging for 1 hr) to 50 mM and analyzed in a 1.0 em path length 
quartz cell. For aggregation studies, CD spectra were collected at concentrations ranging 
from 5 11M to 5 mM in quartz cells varying in path length from 0.01 -1.0 em. Both the 
optics and sample chamber were flushed continuously with dry N2 throughout each 
experiment. All spectra were obtained from 280 nm to 195 nm at a scan speed of 50 
nrn/min, a time constant of 0.5 sec, and a bandwidth of 1 nm. In all cases a minimum of 8 
scans were taken. Data was processed on a Macintosh Ilci computer with KaleidaGraph 
software, version 2.1.1. Values of e were calculated in ellipticity per mole of peptide 
residue with the blocked tetrapeptides treated as pseudohexapeptides. 
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NMR Studies 
lH resonance peak assignments were made either in one-dimension (1-D) by 
homonuclear single frequency decoupling experiments or by the use of two-dimensional 
correlation spectroscopy (2D COSY) experiment. NOEs were detected using the 2D spin-
locked ROESY experiment, which is necessary for the detection of NOE effects in 
relatively small systems (MW 400-1500).24-26.49 It should be noted that the ROESY cross 
peaks, while useful in obtaining qualitative proximity information ( <3 A) cannot be easily 
used to derive quantitative distance information in the same way as 2D nuclear Overhauser 
effect spectroscopy (NOESY) data. 34 
20 COSY experiments were run in either magnitude mode or phase sensitive mode 
and the FID's were multiplied by a phase shifted sine bell apodization function prior to 
Fourier transformation. 20 ROESY experiments were run in phase sensitive mode using 
TPPI (Time Proportional Phase Increments). For the ROESY experiments the spinlock 
power setting was calculated by determining the power of a 125 microsecond 90 degree 
pulse. The experimental parameters, such as mixing time, water suppression parameters, 
spin-lock power and offset frequency were varied to optimize amide cross peak intensity 
and to minimize HOHAHA artifacts50 using the model peptide Tyr-Pro-Gly-Asp-Yal which 
had previously been shown to exhibit the NOEs of interest in this study.6 In ROESY 
experiments on the AM500 spectrometer the spinlock was applied through the decoupler 
channel using normal mode with 01/02 coherence. The FIDs were multiplied by a phase 
shifted squared sine bell apodization function prior to Fourier transformation. In a typical 
COSY or ROESY experiment the relaxation delay was 1.3 s and the transmitter offset was 
positioned in the center of the spectrum or on the water resonance and the data matrix 
consisted of 512 t1 increments containing 2K complex points. All COSY and ROESY 
experiments run in 90/10 H20:D20, solvent suppression were obtained using presaturation 
at 278K. (Note: the reported 90/10 H20:D20 proton chemical shifts were also recorded at 
this temperature.) 
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The temperature dependence of the assigned amide proton shifts was determined 
between 300 K and 325 K in DMSO and 278 K and 310 K in H20. In all cases the 
chemical shifts were found to vary linearly with temperature. A minimum of six 
temperature steps were recorded in each experiment. Temperature calibration of the actual 
probe temperature was performed using either an ethylene glycol or methanol standard. 
Ac-Yal-Pro-D-Ser-Hjs-NHz 
1H NMR (DMSO-d6) o: 8.95 His-t: (s, 1H), 8.53 Ser-NH (d, 1H), 8.05 Val-NH (d, 1H), 
8.01 His-NH (d, 1H), 7.35 Cap-NH (s, 1H), 7.27 His-o & Cap-NH (m, 2H), 4.42 His-
a (m, 1H), 4.34 Pro-a (m, lH), 4.20 Val-a (m, 1H), 4.17 Ser-a (m, 1H), 3.86 Pro-o (m, 
1H), 3.71 Ser-~ (m. 1H), 3.65 Ser-~ (m, 1H), 3.60 Pro-o (m, 1H), 3.22 His-~ (m,1H), 
3.00 His-~ (m, 1H), 2.05 Pro-p (m, lH), 1.98 Pro-y (m,lH), 1.82 Pro-y (m, lH), 1.82 
Ac-cap (s, 3H), 1.80 Pro-~ (m, 1H), 1.75 Val-~ (m, 1H), 0.90 Val-y (m, 6H). 
lH NMR (10% D20/ 90% H20) o: 8.70 Ser-NH (d, 1H), 8.50 His-NH & His-t: (m, 2H), 
8.25 Val-NH (d, lH), 7.52 Cap-NH (s, 1H), 7.21 Cap-NH (s, 1H), 7.15 His-o (s, 1H), 
4 .60 His-a (m, lH), 4.38 Ser-a (m, 1H), 4.32 Pro-a (m, 1H), 4.23 Val-a (m, 1H), 
3.85 Pro-o (m, 1H), 3.75 Ser-~ (m, 1H), 3.67 Ser-~ (m, 1H), 3.55 Pro-o (m, 1H), 3.22 
His-P (m,lH), 3.00 His-~ (m, lH), 2.21 Pro-~, (m, 1H), 2.00 Pro-y (m, 1H), 1.90 Pro-y 
(m, 1H), 1.88 Ac-cap (s, 3H), 1.85 Pro-~ (m, 1H), 1.82 Val-~ (m, 1H), 0 .83 Val-y (d, 
3H), 0.80 Val-y (d, 3H). 
13C NMR (DMS0-d6) o: 172.2, 171.8, 171.5, 170.7, 169.1 , 133.0 , 129.9, 116.6, 61.1, 
60.0, 56.1, 55.3, 51.8, 47.5 , 30.0, 29.1, 26.3 , 24.5, 22.1, 18.7. 
HRMS: Calcd. for [MH]+ C21H34N706 [480.2570]; Obsd. [480.2586] . 
TLC (B) Rf 0.44. 
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Ac-Yal-Pro-D-Ala-His-NHz 
IH NMR (DMSO-d6) o: 8.95 His-£ (s, 1H), 8.37 Ala-NH (d, 1H), 7.95 His-NH (d, 
1H), 7.90 Val-NH (d, 1H), 7.29 Cap-NH (s, 1H), 7.27 His-o (s, 1H), 7.23 Cap-NH (s, 
lH), 4.44 His-a (m, lH), 4.22 Val-a (m, 1H), 4.20 Pro-a (m, 1H), 4.17 Ala-a (m, 1H), 
3.84 Pro-o (m, lH), 3.56 Pro-o (m, 1H), 3.21 His-13 (m, lH), 2.96 His-13 (m, lH), 2.08 
Pro-13 (m, 1H), 1.95 Pro-r (m,1H), 1.84 Pro-r (m, 1H), 1.82 Ac-cap (s, 3H), 1.78 Pro-13 
& Val-13 (m, 2H), 1.16 Ala-!3 (d, 3H), 0.82 Val-y (d, 6H). 
IH NMR (10% D20/ 90% H20) o: 8.71 Ala-NH (d, lH), 8.62 His-£ (s, lH), 8.56 His-
NH (d, lH), 8.36 Val-NH (d, lH), 7.71 Cap-NH (s, lH), 7.33 Cap-NH (s, 1H), 7.30 
His-o (s, lH), 4.67 His-a (m, 1H), 4.38 Pro-a (m, 1H), 4.36 Val-a (m, 1H),4.27 Ala-a 
(m, 1 H), 3.96 Pro-o (m, 1H), 3.69 Pro-o (m, 1 H), 3.35 His-13 (m, 1 H), 3.13 His-13 (m, 
1H), 2.31 Pro-13 (m, 1H), 2.09 Pro-r (m, 1H), 2.00 Pro-y, Val-13, & Ac-cap (m, 5H), 
1.90 Pro-13 (m, 1H), 1.30 Ala-13 (d, 3H), 0.97 Val-y (d, 3H), 0.93 Val-y (d, 3H). 
13C NMR (DMSO-d6) o: 171.86, 171.66, 171.64, 170.68, 169.22, 133.48, 129.87, 
116.63, 60.09, 56.05, 51.65, 48.25, 47.41, 29.65, 29.07, 26.60, 24.62, 22.12, 18.75, 
18.64, 17.25. 
MS: Calcd. for [MH]+ (Low Res.) C21H34N705 [464]; Obsd. [464] . 
TLC (B) Rf 0.35. 
Ac-Yal-Pro-D-Ser-Phe-NHz 
IH NMR (DMSO-d6) o: 8.24 Ser-NH (d, 1H, J = 8.1 Hz), 8.07 Val-NH (d, 1H, J = 8.3 
Hz), 7.90 Phe-NH (d, 1 H, J = 8.8 Hz), 7.28 Cap-NH (s, 1H), 7.18 Phe-ring & Cap-NH 
(m, 6H), 4.33 Phe-a & Pro-a (m, 2H), 4.23 Val-a (m, 1H), Ser-a 4.17 (m, 1H), 3.85 
Pro-o (m, 1H), 3.52 Pro-o & Ser-13 (m, 3H), 3.07 Phe-13 (m, 1H), 2.85 Phe-13 (m, 1H), 
2.04 Pro-13 (m, 1H), 1.95 Pro-y (m, 1H), 1.86 Pro-13, Pro-y & Val-13 (m, 3H), 1.83 Ac-
cap (s, 3H), 0.86 Val-y (d, 3H), 0.82 Val-y (d, 3H). 
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lH NMR (10% 020/90% H20) o: 8.46 Ser-NH (d, IH, J = 8.1 Hz), 8.28 Phe-NH (d, 
IH, J = 7.3 Hz), 8.14 Val-NH (d, IH, 7.8), 7.59 Cap-NH (s, 1H), 7.33 Phe-ring (m, 
5H), 7 .09 Cap-NH (s, 1H), 4.58 Phe-a (m, 1H), 4.45 Pro-a (m, 1H), 4.39 Val-a & Ser-
a (m, 2H), 3.94 Pro-o (m, 1H), 3.71 Pro-o & Ser-13 (m, 3H), 3.23 Phe-13 (m, IH), 3.01 
Phe-13 (m, 1H), 2.30 Pro-13 (m, 1H), 2.05 Pro-y & Val-13 (m, 3H), 2.02 Ac-cap (s, 3H), 
1.95 Pro-13 (m, 1H), 1.00 Val-y (d, 3H), 0.94 Val-y (d, 3H). 
13C NMR (DMSO-d6) o: 172.7, 171.8, 170.6, 169.5, 169.2, 138.3, 129.1, 127.9, 
126.0, 61.2, 59.8, 56.0, 54.9, 54.3, 47.3, 37.2, 29.8, 29.0, 24.6, 22.1, 18.9, 18.7. 
HRMS : Calcd. for [MH]+ C24H36Ns06 [490.2666]; Obsd. [490.2674]. 
TLC (B) Rf 0.50. 
Ac-Yal-Pro-D-Ser-Ile-NH2 
1H NMR (DMSO-d6) o: 8.01 Ser-NH (d, IH, J = 7.7 Hz), 7.99 Val-NH (d, 1H, J = 7.3 
Hz), 7.24 Ile-NH (d, 1H) 7.16 Cap-NH (s, 1H), 7.00 Cap-NH (s, 1H), 4.18 Pro-a (m, 
1H) 4.16 Ser-a (m, 1H), 4.15 Val-a (m, 1H), 4.04 Ile-a (m, 1H), 3.4 Pro-o (m, 1H) 
3.30 Pro-o & Ser-13 (m, 3H), 2.03 Pro-13 (m, 1H), 1.95 Pro-y (m, 2H), 1.92 Ac-cap (s, 
3H), 1.90 Val-13 & Pro-13 (m, 2H) 1.87 lle-13 (m, 1H), 1.18 Ile-yl (m, 1H), 1.03 Ile-y1 
(m, 1H), 0.94-90 Val-y, lle-y2, & lle-o (m, 12H). 
lH NMR (10% 020/90% H20) o: 8.20 Ile-NH (d, 1H), 7.85 Cap-NH (s, 1H), 7.65 
Ser-NH (d, 1H), 7.35 Val-NH (d, 1H), 7.27 Cap-NH (s, 1H), 4.49 Pro-a (m, 1H), 4.47 
Ser-a (m, 1H) 4.38 Val-a (m, 1H), 4.22 Ile-a (m, lH), 3.99 Pro-8 (m, 1H), 3.90 Ser-13 
(m, 2H), 3.70 Pro-o (m, 1H), 2.32 Pro-13 (m, 1H), 2.05 Pro-y (m, 2H), 2.02 Ac-cap (s, 
3H), 1.95 Pro-13, Val-13, & Ile-13 (m, 3H), 1.42 Ile-y1 (m, 1H), 1.21 Ile-y1 (m, 1H), 1.00 
Val-y (d, 3H), 0 .98 Val-y & Ile-y2 (m, 6H), 0.88 Ile-o (m, 3H). 
Be NMR (DMSO-d6 ) 8: 172.7, 171.7, 170.4, 169.5, 169.2, 61.5, 59.6, 57.0, 56.0, 
54.9, 47.2, 36.3, 29.8, 29.1, 24.5, 24.0, 22.1, 19.0, 18.6, 15.4, 10.9. 
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HRMS: Calcd. for [MH]+ C21H3sNs06 [456.2822]; Obsd. [456.2820]. 
TLC (A) Rf = 0.65. 
Ac-Val-Pro-D-Ala-Phe-NH2 
IH NMR (DMSO-d6) o: 8.11 Ala-NH (d, lH, J = 7.8 Hz), 8.08 Val-NH (d, lH, J = 8.4 
Hz), 8.03 Phe-NH (d, lH, J = 8.6 Hz), 7.37 Cap-NH (s, lH), 7.26 Phe-ring (m, 5H), 
7.16 Cap-NH (s, 1H), 4.35 Phe-a (m, 1H), 4 .27 Val-a (m, 1H), 3.84 Pro-a (m, 1H), 
3.11 Ala-a (m, 1H), 3.12 Pro-o {m, IH), 2.83 Pro-o (m, IH), 2.12 Phe-~ (m, IH), 1.98 
Phe-~ (m, 1H), 1.87 Ac-cap, Pro-~. Pro-y, & Val-~ (m, 8H), 1.05 Ala-~ (d, 3H, J = 7.0 
Hz), 0.91 Val-y (d, 3H, J = 6 .5 Hz), 0.87 Val-y (d, 3H, J = 6.6 Hz). 
IH NMR (10% D20/90% H20) o: 8.54 Ala-NH (d, IH, J = 6.5 Hz), 8.37 Phe-NH (d, 
1H, J = 7.3 Hz), 8.30 Val-NH (d, IH, J = 7.3 Hz), 7.65 Cap-NH (s, 1H), 7.40 Phe-ring 
(m, 2H), 7.30 Phe-ring (m, 3H), 7.20 Cap-NH (s, IH), 4.57 Phe-a (m, 1H), 4.38 Val-a 
(m, IH), 4.36 Pro-a {m, 1H), 4.22 Ala-a (m, 1H), 3.96 Pro-o (m, 1H), 3.71 Pro-o (m, 
1H), 3.25 Phe-~ (m, IH), 3.00 Phe-~ (m, IH), 2 .29 Pro-~ (m, 1H), 2.1-1.95 Pro-y & 
Val-~(m, 3H), 2.0 Ac-cap (s, 3H), 1.91 Pro-~ (m, IH) 1.17 Ala-~ (d, 3H), 0 .99 Val-y (d, 
3H), 0.91 Val-y (d, 3H). 
13C NMR (DMSO-d6) o: 172.9, 171.5, 171.2, 170.6, 169.2, 138.3, 129.1, 127.9, 
126.1, 59.9, 55.9, 54.1, 47.9, 47.32, 37.3, 29.8, 29.1, 24.6, 22.2, 19.0, 18.7, 17.8; 
HRMS: Calcd. for [MH]+ C24H36NsOs [474.2716]; Obsd. [474.2706] . 
TLC (A) Rf = 0.57. 
Ac-Ala-Pro-D-Val-His-NH2 
lH NMR (DMSO-d6) o: 8.95 His-~: (s, 1H), 8.22 Ala-NH (d, 1H, J = 7.3 Hz), 8.09 His-
NH (d, IH, J = 7.0 Hz), 8.0 Val-NH (d, 1H J = 7.3 Hz), 7.28 Cap-NH (s, 1H), 7.25 
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His-o (s, lH), 7.22 Cap-NH (s, lH), 4.50 Ala-a (m, lH), 4.49 His-a (m, lH), 4.35 Pro-
a (m, lH), 3.78 Val-a (m, 1H), 3.65 Pro-o (m, 1H), 3.52 Pro-o (m, 1H), 3.20 His-~ (m, 
1H), 2.95 His-13 (m, 1H), 2.05 Pro-~ (m, lH), 1.92 Val-~ & Pro-y (m, 2H), 1.85 Pro-y 
(m, 1H), 1.80 Ac-cap (s, 3H), 1.75 Pro-~ (m, 1H), 1.11 Ala-~ (d, 3H), 0.7 Val-y (d, 
3H), 0.62 Val-y (d, 3H). 
lH NMR (10% 020/ 90% H20) o: 8.85 His-NH (d, 1H, J = 8.1 Hz), 8.54 His-E (s, 1H), 
8.46 Val-NH (d, 1H, J = 7.4 Hz), 8.39 Ala-NH (d, 1H, J = 5.3 Hz), 7.67 Cap-NH (s, 
1H), 7.36 Cap-NH (s, 1H), 7.33 His-o (s, 1H), 4.76 His-a (m, 1H), 4.53 Ala-a (m, 
1 H), 4.49 Pro-a (m, 1 H), 4.08 Val-a (m, 1 H), 3.85 Pro-o (m, 1 H) 3.68 Pro-o (m, 1 H), 
3.40 His-13 (m, 1H), 3.17 His-~ (m, 1H), 2.32 Pro-~ (m, 1H), 2.07 Pro-y (m, 2H) 1.99 
Ac-cap (s, 3H), 1.90 Val-~ & Pro-13 (m, 2H), 1.32 Ala-~ (d, 3H) 0.8 Val-y (d, 3H), 0.71 
Val-y (d, 3H). 
13C NMR (OMSO-d6) o: 172.2, 171.9, 171.2, 170.8, 168.7, 133.7, 130.1, 117.1, 59.7, 
58.2, 51.7, 46.8, 46.0, 29.3, 29.1, 27.0, 24.6, 22.2, 18.9, 17.6, 16.8. 
HRMS: Calcd. for [MH]+ C21H34N705 [464.2621]; Obsd. [464.2598]. 
TLC (A) Rf = 0.30. 
Ac-tert-Leu-Pro-D-Ala-His-NH? 
lH NMR (OMSO-d6) o: 8.07 Ala-NH (d, 1H, J = 7.0 Hz), 7.98 His-NH (d, 1H, J = 8.2 
Hz), 7.92 t-Leu-NH (d, 1H, J = 8.9 Hz), 7.53 His-E (s, 1H), 7 .25 Cap-NH (s, 1H), 7.07 
Cap-NH (s, 1 H), 6.76 His-o (s, 1H), 4.53 r-Leu-a (d, 1H, J = 8.9 Hz), 4.36 Pro-a & 
His-a (m, 2H), 4.26 Ala-a (m, 1H), 3.76 Pro-o (m, 1H), 3.65 Pro-o (m, 1H), 3.00 His-~ 
(m, 1H), 2.83 His-13 (m, 1H), 2.06 Pro-13 (m, 1H), 1.87 Pro-13, Pro-y & Ac-cap (m, 6H), 
1.14 Ala-13 (d, 3H, J = 7.0 Hz), 0.97 t-Leu-y (s, 9H). 
lH NMR (10% 0 20190% H20) o: 8.63 His-E (s, 1H), 8.59 Ala-NH (d, lH), 8.56 His-
NH (d, 1H), 8.16 t-Leu-NH (d, lH), 7.70 Cap-NH (s, lH), 7.36 His-o (s, lH), 7.31 
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eap-NH (s, lH), 4.61 His-a (m, 1H), 4.50 t-Leu-a (d, lH), 4.40 Pro-a (m, lH), 4.25 
Ala-a (m, 1H), 3.95 Pro-& (m, 1H), 3.66 Pro-& (m, lH), 3.37 His-~ (m, lH), 3.17 His-~ 
(m, 1H), 2.10 Pro-~ (m, lH), 2.08 Pro-y (m, 1H), 2.06 Ac-cap (s, 3H), 1.98 Pro-y (m, 
1H), 1.92 Pro-~ (m, 1H), 1.29 Ala-~ (d, 3H), 1.01 t-Leu-y (s, 9H). 
Be NMR (DMSO-d6) &: 171.9, 171.4, 168.9, 168.6, 168.1, 129.5, 116.2, 57.3, 51.3, 
50.4, 47.9, 47.3, 46.1, 33.8, 28.8, 25.9, 25.1, 24.1, 21.8, 17.2, 16.2. 
MS: ealcd. for [MHJ+ (Low Res.) C22H36N705 [478]; Obsd. [478]. 
TLe (A) Rf = 0.36. 
Ac-Ala-Pro-o-Ala-Pbe-NH2 
1H NMR (DMSO-d6) &: 8.15 L-Ala-NH (d, 1H, J = 7.3 Hz), 8.09 D-Ala-NH (d, IH, J = 
7.6 Hz), 8.04 Phe-NH (d, lH, J = 8.7 Hz), 7.36 eap-NH (s, 1H), 7.25 Phe-ring (m, 
5H), 7.12 eap-NH (s, 1H), 4.53 L-Ala-a (m, 1H), 4.38 Phe-a (m, 1H), 4.27 Pro-a (m, 
1H), 4.18 D-Ala-a (m, 1H), 3.69 Pro-& (m, lH), 3.58 Pro-& (m, 1H), 3.11 Phe-~ (m, 
1H), 2.84 Phe-~ (m, 1H), 2.08 Pro-~ (m, 1H), 1.96 Pro-y (m, 1H), 1.84 Ac-eap & Pro 
~.y (m, 5H), 1.18 L-Ala-~ (d, 3H, J = 6.9 Hz), 1.05 D-Ala-~ (d, 3H, J = 7.8 Hz). 
lH NMR (10% D20/ 90% H20) &: 8.57 D-Ala-NH (d, 1H), 8.40 L-Ala-NH (d, 1H), 
8.39 Phe-NH (d, 1H) 7.66 eap-NH (s, 1H), 7.37 Phe-ring (m, 2H), 7.31 Phe-ring (m, 
1H), 7.27 Phe-ring (m, 2H), 7.23 eap-NH (s, 1H), 4.56 Phe-a (m, 1H), 4.54 L-Ala-a 
(m, 1H), 4.40 Pro-a (m, 1H), 4.22 D-Ala-a (m, 1H), 3.85 Pro-& (m, 1H), 3.65 Pro-& (m, 
1H), 3.25 Phe-~ (m, 1H), 3.00 Phe-~ (m, 1H), 2.30 Pro-~ (m, 1H), 2.08 Pro-y (m, 2H), 
1.98 Ac-cap (s, 3H), 1.90 Pro-~ (m, 1 H) 1.34 D-Ala-~ (d, 3H), 1.18 L-Ala-~ (d, 3H). 
Be NMR (DMSO-d6) &: 172.9, 171.6, 171.5, 171.2, 168.8, 138.3, 129.2, 127.9, 126.1, 
59.9, 54.1, 48.2, 46.8, 46.1, 37.3, 28.9, 24.6, 22.3, 17.6, 16.8. 
HRMS: ealcd. for [MH]+ e22H32N505 [446.2403]; Obsd. [446.2408]. 
TLe (A) Rf= 0.51 . 
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Ac-Ala-Pro-Gly-Phe-NH2. 
IH NMR (DMSO-d6) S: 8.21 Gly-NH (t, IH, J = 5.6 Hz), 8.16 Phe-NH (d, IH, J = 7.4 
Hz), 7.90 Ala-NH (d, IH, J = 8.5 Hz), 7.36 Cap-NH (s, IH), 7.25 Phe-ring (m, 5H), 
7.18 Cap-NH (s, 1H), 4.55 Phe-a (m, lH), 4.41 Ala-a (m, 1H), 4.28 Pro-a (m, lH), 
3.75-3.42 Pro-S & Gly-a (m, 4H), 3.09 Phe-13 (m, IH), 2.85 Phe-13 (m, 1H), 2.07 Pro-13 
(m, IH), 1.95 Pro-y (m, lH), 1.84 Ac-cap & Pro-y, 13 (m, 5H), 1.18 Ala-13 (d, 3H, J = 
6.87 Hz). 
1H NMR (10% 020/90% H20) S: 8.60 Ala-NH (d, IH), 8.40 Gly-NH (dd, 1H, J = 5.5 
Hz), 8.22 Phe-NH (d, IH, J = 7.3 Hz), 7.70 Cap-NH (s, lH), 7.40 Phe-ring (m, 2H), 
7.32 Phe-ring (m, IH), 7.22 Phe-ring (m, 2H), 7.18 Cap-NH (s, lH), 4.59 Ala-a (m, 
1H), 4 .57 Phe-a (m, I H), 4.40 Pro-a (m, 1H), 3.90 Gly-a (dd, lH), 3.86 Pro-S (m, 
lH), 3.84 Gly-a (dd, lH), 3.68 Pro-o (m, lH), 3.20 Phe-13 (m, 1H), 3.05 Phe-13 (m, 
1H), 2.30 Pro-13 (m, lH), 2.06 Pro-y (m, 2H), 2.01 Ac-cap (s, 3H), 1.85 Pro-13 (m, 1H), 
1.33 Ala-13 (d, 3H). 
13C NMR (DMSO-d6) S: 172.7, 172.0, 171.0, 168.7, 168.4, 138.0, 129.0, 127.9, 
126.1, 59.9, 53.9, 46.7, 45.9, 42.0, 37.3, 28.9, 24.4, 22.1, 16.5. 
HRMS: Calcd. for [MH]+ C21H3oNsOs [432.2247]; Obsd. [432.2250]. 
TLC (A) Rf = 0.70. 
Ac-Ala-Pro-D-Val-Phe-NH2 
lH NMR (DMSO-d6) S: 8.24 Phe-NH (d, 1H, J = 8.7 Hz), 8.14 Ala-NH (d, 1H, J = 7.5 
Hz), 7.72 Val-NH (d, 1H, J = 8.6 Hz), 7.36 Cap-NH (s, lH), 7.26 Phe-ring (m, 4H), 
7.18 Phe-ring (m, 1H), 7.14 Cap-NH (s, IH), 4 .55 Ala-a (m, 1H), 4.46 Phe-a (m, lH), 
4.40 Pro-a (m, IH), 4.09 Val-a (m, IH), 3.68 Pro-S (m, IH), 3.59 Pro-S (m, 1H), 3.14 
Phe-13 (m, 1H), 2.78 Phe-13 (m, IH), 2.04 Pro-13 (m, lH), 1.84 Ac-cap, Pro-13, Pro-y & 
Val-13 (m, 7H), 1.20 Ala-13 (d, 3H, J = 6.9 Hz), 0.58 Val-y (dd, 6H). 
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lH NMR (10% D20/90% H20) S: 8.68 Phe-NH (d, 1H, J = 7.9 Hz), 8.41 A1a-NH (d, 
1H, J = 5.4 Hz), 8.30 Val-NH (d, 1H, J = 7.9 Hz), 7.68 Cap-NH (s, 1H), 7.33 Phe-ring 
(m, 2H), 7.30 Phe-ring (m, 3H), 7.26 Cap-NH (s, 1H), 4 .65 Phe-o. (m, 1H), 4.54 Ala-o. 
(m,1H), 4.46 Pro-o. (m, 1H), 4.08 Val-o. (m, 1H), 3.83 Pro-S (m, 1H), 3.66 Pro-S (m, 
1H), 3.30 Phe-~ (m, 1H), 2.94 Phe-~ (m, 1H), 2.32 Pro-~ (m, 1H), 2.02 Pro-y (m, 2H), 
1.99 Ac-cap (s, 3H), 1.92 Pro-~ (m, 1H), 1.88 Val-~ (m, 1H), 1.35 Ala-~ (d, 3H), 0.69 
Val-y (d, 3H), 0.60 Val-y (d, 3H). 
Be NMR (DMSO-d6) S: 173.0, 171.5, 171.0, 170.5, 168.7, 138.2, 129.0, 127.9, 
126.0, 59.5, 57.6, 54.0, 46.6, 45.9, 37.2, 29.9, 29.0, 24.4, 22.1, 19.0, 17.3, 17.0. 
HRMS: Calcd. for [MH]+ C24H36NsOs [474.2716]; Obsd. [474.2716]. 
TLC (A) Rr = 0.75. 
Ac-Ala-Pro-D-Leu-Phe-NHz 
lH NMR (DMSO-d6) S: 8.15 Ala-NH (d, 1H, J = 7.6 Hz), 8. 12 Phe-NH (d, 1H, J = 8.8 
Hz), 7 .95 Leu-NH (d, 1H, J = 8.0 Hz), 7.34 Cap-NH (s, 1H), 7.24 Phe-ring (m, 5H), 
7.16 Cap-NH (s, 1 H), 4.55 A la-o. (m, 1 H), 4 .39 Ph e-o. (m, 1 H), 4.27 Pro-o. (m, 1 H), 
4.17 Leu-o. (m, 1H), 3.63 Pro-S (m, 2H), 3.12 Phe-~ (m, 1H), 2.81 Phe-~ (m, lH), 
2.04 Pro-~ (m, IH), 1.94 Pro-y (m, 1H), 1.88 Pro-y (m, 1H), 1.83 Ac-cap (s, 3H), 1.75 
Pro-~ (m, 1H), 1.30 Leu-~ (m, 2H), 1.20 Ala-~ (d, 3H, J = 7.0 Hz), 0.85 Leu-y (m, lH), 
0.78 Leu-S (d, 3H, J = 5.7 Hz), 0.74 Leu-S (d, 3H, J = 5.6 Hz). 
lH NMR (10% D20/90% H20) S: 8.63 Phe-NH (d, 1H, J = 8.3 Hz), 8.44 Leu-NH (d, 
1H), 8.42 Ala-NH (d, 1H), 7 .73 Cap-NH (s, 1H), 7.41 Phe-ring (m, 2H), 7.36 Phe-ring 
(m, lH), 7.32 Phe-ring & Cap-NH (m, 3H) 4.68 Phe-o. (m, 1H), 4.60 Ala-o. (m, lH), 
4 .43 Pro-o. (m, 1H), 4.25 Leu-o. (m, 1H), 3.85 Pro-S (m, 1H), 3.70 Pro-S (m, 1H), 3.40 
Phe-~ (m, 1H), 2.95 Phe-~ (m, 1H), 2.30 Pro-~ (m, 1H) 2.05, Pro-y (m, 2H), 2.02 Ac-
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cap (s, 3H), 1.90 Pro-13 (m, 1H), 1.38 Ala-13 (d, 3H), 1.32 Leu-13 (m, 2H), 1.25 Leu-y (m, 
1H), 0 .82 Leu-S (d, 3H), 0.79 Leu-S (d, 3H). 
13C NMR (DMSO-d6) S: 173.0, 171.7, 171.5, 171.1, 168.7, 138.2, 129.1, 127.9, 
126.0, 59.8, 54.1, 51.0, 46.8, 46.0, 37.2, 29.0, 24.5, 23.9, 22.8, 22.2, 21.6, 16.9. 
HRMS: Calcd. for [MNa]+ C2sH37NaNsOs [510.2692]; Obsd. [510.2690]. 
TLC (A) Rf = 0.60. 
Ac-Val-NapPro-D-Ser-His-NH2 
lH NMR (10% 020/90% H20) S: 8.52 Ser-NH (d, 1H), 8.29 His-E (s, lH), 8.08 His-
NH & Val-NH (d, 2H), 8.03 Nap-NH (d, 1H), 7.66 Nap-Ring (m, 3H), 7.54 Nap-Ring 
(s, lH), 7.42 Cap-NH (s, lH), 7.30 Nap-Ring (m, 2H), 7.16 Nap-Ring (d, lH), 7.00 
Cap-NH (s, 1H), 6.98 His-o (s, 1H), 4.41 His-a (m, 1H),4.30 Pro-y (m, 1H), 4.24 Pro-
a (m, lH), 3.95 Val-a (m, 1 H), 3.88 Ser-a (m, 1H), 3.83 Pro-S (m, 1H), 3.55 Ser-13 (m, 
lH), 3.50 Nap-13 (s, 2H), 3.42 Ser-13 (m, 1H), 3.35 Pro-S (m, 1H), 3.06 His-13 (m, lH), 
2.82 His-13 (m, lH), 2.33 Pro-13 (m, 1H), 1.73 Acetyl-Cap & Pro-13 (m, 4H), 1.57 Val-13 
(m, lH), 0.61 Val-y (d, 3H), 0 .55 Val-y (d, 3H). 
13C NMR (DMSO-d6) S: 180.0, 171.2, 171.1, 170.4, 169.4, 168.8, 133.2, 133.0, 
132.4, 131.2, 127.1, 126.8, 125.5, 125.0, 60.4, 58.3, 55.7, 54.8, 52.3, 51.5, 47.8, 
29.1, 25.9, 21.7, 18.2. 
Calcd. for [MH]+ C33H43Ng07 [663.3254]; Obsd. [663.3228]; RP-HPLC (Eluents, A: 
0.1% TFA in H20; B: 0.08% TFA in CH3CN: 5 mins- 100% A, 25 mins- Linear 
Gradient 0-60% B, 5 mins- 60% B, 2 mins- Linear Gradient, 60-0% B; UV Detection 
228, 280 nm) RT: 30.1 mins. 
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Chapter 3: Investigations of Functional Group Incorporation at Position i 
of 13-Type II Reverse Turns 
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Introduction 
Reverse turns have been implicated in a number of essential protein functions, from 
acting as glycosylation or phosphorylation sites for effective post-translational protein 
processing to providing a template in the construction of enzyme active sites. 1 Reverse 
turns sequences in native proteins are known to have a strong bias toward polar residues 
and these amino acids often act to stabilize and direct the overall folding of the turn 
structure through specific side-chain interactions with the polypeptide backbone. For 
example, most Type I turns are stabilized by hydrogen bonds between polar groups at 
position i (Ser, Asp, Asn) and the main chain atoms of the residue at position i+2. In 
fact, over 48% of all Type I turns contain one of these residues at position i, of which over 
57% participate in a long range hydrogen bond with the i+2 peptide bond.2 The Type I 
turn has been shown to have a fairly twisted, non-planar topography due to the relative 
orientation of the central amide bond, and it has been postulated that non-backbone 
hydrogen bonding networks are often required to stabilize the overall motif. 
In contrast, such interactions are rare for Type II turns in protein structures, as the 
more planar arrangement of the peptide backbone discourages side-chain - main chain 
interactions. Therefore, the stability of the Type II tum is not expected to be as dependent 
on interactions at long range which involve side chain groups. These predictions were 
borne out by the results of the studies in Chapter 2, which found that peptides could adopt 
the reverse turn motif in the absence of any side-chain based electrostatic or hydrogen 
bonding interactions. As a result, the Type II turn is particularly well-suited for protein 
design, since the addition or removal of functional groups on the turn structure would not 
be expected to have deleterious effects on the overall structural stability. In addition, the 
relatively flat topography of the Type II tum provides a structural "platform" where the 
side-chains at positions i and i+3 are brought into close proximity [Ca(i )-Ca<i+J) ""7A] 
with the same relative orientation with respect to the polypeptide backbone (See Figure 3-
1 ). These characteristics provide an excellent template for the design of pre-programmed, 
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Figure 3-1. Stereodiagram of a Type II reverse tum 
functional protein motifs through the selective incorporation of reactive groups at the i and 
i+3 positions of the reverse turn sequence. 
The results of the studies presented in Chapter 2 provided a set of guidelines for 
selecting primary sequences which adopt stable Type II reverse turn structures in aqueous 
solution. While the primary focus of that work was to evaluate the effects of steric 
interactions on Type II reverse turn formation, a strong preference was observed for 
histidine at position i + 3. This observation is particularly useful for designing functional 
motifs, as histidine plays a central role in many aspects of native protein function and 
structure. The imidazole side-chain is a powerful functional group capable of acting as 
both a hydrogen bond acceptor and donor through the two nitrogen atoms in the 
heteroaromatic ring. The ability to serve a dual role in hydrogen bonding interactions has 
been exploited in the construction of "relay" systems, where the imidazole ring serves as a 
bridging group between two distal hydrogen bonding groups. These indirect hydrogen 
bonding arrangements have been implicated in the catalytic function of a number of 
enzymes, including members of the serine protease family and more recently, a family of 
lipases.3-8 In these enzymes, the histidine is involved in a hydrogen bonding network with 
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a nucleophilic serine hydroxyl group (or water). This interaction provides a mechanism to 
funher activate the serine hydroxyl group by facilitating the removal of the hydroxyl 
proton. Histidine has also been implicated in other functional roles of catalysis, as the 
imidazole ring can act either as a nucleophile or as an efficient base under physiological 
conditions; in fact, it is one of the strongest bases known at neutral pH.9 Finally, 
imidazole can also serve as an excellent ligand for a wide variety of metal cations 10 and 
histidine is frequently employed as a ligand in metal binding sites of metalloproteins; in 
fact, histidine is the most common ligand for Zn+2 metalloenzymes.11 
It is envisioned that the diverse functional propenies of histidine could be exploited 
in the design of novel protein motifs based on the Type II reverse turn. In an effon to 
realize this goal, two functional protein motifs were designed using the structural guidelines 
presented in Chapter 2 to provide a basis for the incorporation of reactive groups at position 
i capable of interacting with a histidine at position i+3 . In the first motif, the potential for a 
hydrogen bonding network between the histidine side chain and hydroxy amino acids 
incorporated at postion i was investigated in an attempt to mimic pan of the active site 
machinery present in native serine proteases. In the second design, the Type II reverse tum 
was studied as a potential bidentate metal binding site through the incorporation of groups 
capable of binding metal cations at position i. 
Serine Protease Mimic 
The serine protease family of enzymes has been the subject of intense investigation 
for over 50 years, and is probably the most well studied class known to date.12 The key 
step in the catalytic mechanism of these enzymes is believed to involve a nucleophilic attack 
by the serine hydroxyl group on the substrate amide carbonyl carbon to produce a 
tetrahedral intermediate, which then collapses to form an acyl-enzyme intermediate.12 
Subsequent hydrolysis of the acyl-enzyme intermediate releases the cleaved substrate and 
regenerates the active site (See Figure 3-2). Activation of the serine hydroxyl group is 
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accomplished through the so-called "catalytic triad," a hydrogen bonding relay system 
composed of an aspartatic acid, histidine, and the nucleophilic serine residues.3-8 A large 
number of model systems have been assembled to mimic the hydrogen bonding network, 
many of which are based on a cyclic peptide backbone. 13-18 The cyclic peptide backbone 
provides a rigid constraint on the overall topography of the peptide, and therefore allows 
the coordination of long range interactions between various functional groups and the 
imidazole side chain of histidine. Attempts to model the hydrogen bonding network with 
linear peptides have presented largely ambiguous results, 15•16•18 due to the lack of 
structural rigidity peptide backbone. 
Figure 3-2. Mechanism of esterase hydrolysis proposed for the serine protease family of 
enzymes 
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In contrast, the reverse tum motif studied in Chapter 2 was structurally well-
characterized and found to be stable in aqueous solution. In order to test whether the 
reverse turn motif could be used to construct part of the long range hydrogen bonding 
interactions similar to that found in native serine proteases, a series of peptides was 
synthesized with the general sequence Ac-Xaa-Pro-D-Ser-His-NH2, where Xaa = Ser, 
Thr, (allo )Thr. The three pep tides were designed to test various aspects of the tum motif; 
the serine peptide provides a sensitive test of the requirement of 13-branched amino acids at 
the first position of the tum when the potential for long range interactions exists. In the 
absence of any side-chain interactions, the peptide would not be expected to assume the 
reverse turn structure. In contrast, the threonine analogs are more conformationally 
restrained and would be expected to nucleate and stabilize the reverse turn motif based on 
the conclusions obtained from the earlier studies. The pair of diastereomers differ only in 
the stereochemistry at the 13-center, and therefore provide a means to probe the effect of the 
orientation of the side-chain hydroxyl group on the overall structure. All three of the 
peptides were structurally characterized in aqueous solution using nuclear magnetic 
resonance techniques and circular dichroism spectroscopy as discussed in Chapter 2. 
These peptides were further analyzed for long range hydrogen bonding interactions through 
the measurement of the histidine imidazole side chain pK3 values and subsequent 
comparison to known values. Finally these peptides were tested for esterase activity to 
evaluate the potential function of the overall designs. 
Metal-Binding Site Motif 
Metal binding sites centered on reverse turns are well-precedented in native 
proteins; for example, both superoxide dismutase and carboxypeptidase contain Zn+2 
metal-binding sites constructed on a Type I 13-tum. In both of these proteins, the metal 
ligands are two histidine residues located at the i and i+3 positions of the reverse turn 
motif. The metal-binding motifs studied in this chapter were based on this overall design, 
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with thiolate ligands placed at postion i. The choice of a thiolate ligand, rather than an 
imidazole ligand, was based on several criteria. First, thiolate groups (cysteine) are often 
used as metal ligands in native protein structures for the construction of both structural and 
functional metal binding sites. In fact, "structural" Zn+2 binding sites found in many 
proteins (e.g., alcohol dehydrogenase and aspartate transcarbamylase) are constructed 
almost exclusively from thiolate ligands (4 cysteines).11 In addition, while non-ligating 
cysteine residues are often found in regular secondary structures (a-helix, 13-sheet), metal-
binding cysteine residues are most often located in turn and loop regions of protein 
structures. 19 Second, based on the guidelines presented in Chapter 2, it is known that tum 
formation is highly dependent on the steric bulk of the residue placed at position i . Beta-
branched amino acids (e.g., valine) were found to be essential for efficient turn formation. 
Incorporation of a neutral thiol group, either with cysteine or the unnatural amino acid 
(2R,3R)-J3-methyl-cysteine (Bmc), was believed to be a fairly conservative substitution of a 
13-branched amino acid such as valine. 
Figure 3-3. (2R ,3R)-13-Methyl-cysteine (1) 
In order to test whether a metal-binding site could be assembled using the Type II 
reverse turn motif as a structural template, two peptides were prepared containing thiolate 
ligands at position i and histidine at position i+3; Ac-Cys-Pro-D-Ser-His-NH2 and Ac-
Bmc-Pro-D-Ser-His-NH2. The sequences were chosen based on the guidelines obtained 
from Chapter 2 using a Pro-D-Ser dipeptide core, as well as acyl and amide capping groups 
to eliminate electrostatic interactions between the main chain terminii. In both cases, the 
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structural conformation of each peptide was determined using 2D-NMR and circular 
dichroism spectroscopy. In addition, the metal-binding characteristics and the peptides 
were analyzed by circular dichroism spectroscopy for both Zn+2 and Co+2 cations. 
Results and Discussion 
Serine-Protease Mimic 
Confonnational Analysis of Ac-Ser-Pro-D-Ser-His-NH2 and Ac-Ser-Pro-o-Ser-Phe-NH2 
The observed NOE connectivities for the two peptides which incorporate serine at 
position i indicate that Ac-Ser-Pro-D-Ser-His-NH2 and Ac-Ser-Pro-D-Ser-Phe-NH2 have 
very different turn propensities (See Table 3-1 ). All of the sequential NOEs (1, 2, 3) 
and two of the long range NOEs (4 and 5) expected for type II reverse turns are observed 
for Ac-Ser-Pro-D-Ser-His-NH2, indicating that this peptide has a significant population 
of Type II reverse turn conformation in solution. In contrast, the Ac-Ser-Pro-D-Ser-Phe-
NH2 peptide has very little reverse turn character as indicated by the fact that only the 
sequential NOEs (1, 2, 3) are observed. These generalizations are borne out by the 
variable temperature coefficients for the peptides (See Table 3-2); Ac-Ser-Pro-D-Ser-His-
NH2 has a low coefficient for the i+2 proton (-6.1 ppb/K) and a high coefficient for the 
i+3 proton (-8.6 ppb/K), both of which are consistent with Type II turn fonnation. 
However, Ac-Ser-Pro-D-Ser-Phe-NH2 shows almost no difference between the three 
amide proton coefficients, indicating that the peptide is essentially disordered in solution. 
Finally, the circular dichroism spectra for the two peptides is consistent with the NMR 
studies; the CD spectrum for Ac-Ser-Pro-D-Ser-His-NH2 is a typical Class B spectra 
(See Figure 3-4), with a maximum ellipticity at 200 nm near 2000 deg·cm2·dmol·l. The 
corresponding spectra for Ac-Ser-Pro-D-Ser-Phe-NH2 does not contain any features 
characteristic of Type II turns. 
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Table 3-1. Observed ROESY Connectivitiesa of Peptides Containing Functionalized 
Residues at Position i in Water 
Peptide Observed NOE 
Connectivities 
Ac-Cys-Pro-D-Ser-His-NH2 1,2b, and 3 
Ac-Bmc-Pro-D-Ser-His-NH2c 1,2,3,4 and 5 
Ac-Ser-Pro-D-Ser-His-NH2 1,2,3,4b, Sb and 6d 
Ac-Ser-Pro-D-Ser-Phe-NH2 1,2, and 3 
Ac-(al/o)Thr-Pro-D-Ser-His-NH2 1,2,3, and 4 
Ac-Thr-Pro-D-Ser-His-NH2 1,2,3, and 4 
a See Figure 2-2. for definition of interactions; b Crosspeak is relatively weak; c Bmc : 
(2R,3R)-~-Methyl-cysteine; d Connectivites observed between His o ring proton and 
Ser(i+2) a, His o ring proton and His a proton. 
Table 3-2. Temperature Coefficients for Amide Proton Chemical Shifts of Peptides 
Containing Functionalized Residues at Position i in Water (68/6T)a 
Peptide i i + 2 i + 3 
Ac-Cys-Pro-D-Ser-His-NH2 -8.4 -9.3 -6.6 
Ac-Bmc-Pro-D-Ser-His-NH2b -7.7 -9.0 -6.1 
Ac-Thr-Pro-D-Ser-His-NH2 -7.8 -8.7 -5 .3 
Ac-(allo )Thr-Pro-D-Ser-His-NH2 -8.2 -6.5 -6.7 
Ac-Ser-Pro-D-Ser-His-NH2 -8.0 -8.6 -6. 1 
Ac-Ser-Pro-D-Ser-Phe-NH2 -7.7 -8.3 -7 .6 
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Figure 3-4. Circular dichroism spectra for Ac-Ser-Pro-D-Ser-His-NH2 and Ac-Ser-Pro-
D-Ser-Phe-NH2 at pH=4-0, 25° C. 
Ac-Thr-Pro-D-Ser-His-NHz and Ac-(a//o)Thr-Pro-D-Ser-His-NHz 
The NOE data for Ac-Thr-Pro-D-Ser-His-NH2 suggests that this peptide has some 
tum character in solution, as the long range amide-amide NOE, 4, is observed in addition 
to strong NOEs for the sequential connectivities (1,2, and 3)_ This is further supported by 
the variable temperature data, as the i+J amide has the lowest coefficient of the three amide 
protons. Finally, the CD spectra shows a weak but definite amount of Class B character 
(See Figure 3-5)_ These results are all consistent with the conclusions derived from the 
studies in Chapter 2 which found that ~-branched amino acids help stabilize turn formation 
at when placed at position i_ 
The alia-threonine peptide has spectroscopic signatures which suggest the presence 
of a type II ~-.turn conformation. The observed NOE connectivities are all consistent with 
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type II turn formation as the long range dNN[Ser-NH, His-NH] (4) connectivity is 
observed in addition to all of the expected sequential NOEs (1,2,3). The variable 
temperature data show that the i+3 amide proton is shielded from solvent as expected, but 
the data also shows a similar effect for the residue at position i+2. As discussed in Chapter 
2, the amide proton at the i+2 position would be expected to show a large temperature 
coefficient in an ideal type II turn; it is possible that the increased solvent shielding of the 
i+2 amide proton is due to another turn population, such as a -y-tum.20 However, the CD 
spectrum for this peptide, while it does not contain elements of the traditional Class B 
spectra, is not consistent with the experimentally derived spectrum for a y-turn (maximum 






















215 225 235 245 255 265 
A./nm 
Figure 3-5. Circular dichroism spectra for Ac-Thr-Pro-D-Ser-His-NH2 and Ac-(allo)Thr-
Pro-D-Ser-Phe-NH2 at pH=4.0, 25° C. 
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position could be attributed to a hydrogen bonding interaction between the alia-threonine 
side-chain and the amide proton. This hypothesis would be consistent with the observed 
NOE connectivities, as the peptide could still assume a type II reverse turn conformation 
with the central amide bond slightly rotated to accomodate the hydrogen bonding interaction 
with the threonine side-chain. 
Measurement of Histidine pKa Values 
The fact that Ac-Ser-Pro-D-Ser-His-NH2 shows a signficant amount of turn 
character in solution is surprising in light of the earlier studies outlined in Chapter 2, which 
demonstrated that P-branched amino acids were strongly preferred over non-branched 
amino acids in the i position of the turn sequence. Since Ac-Ser-Pro-D-Ser-Phe-NH2 
demonstrated very little turn character in solution, this suggests that the serine at position i 
and the histidine at position i+3 act cooperatively to stabilize the reverse turn conformation. 
It was postulated that this enhanced turn stability could arise from an intramolecular 
hydrogen bond between the serine hydroxyl side chain and one of the histidine imidazole 
ring nitrogen atoms. Hydrogen bonding interactions between serine side-chains and a wide 
number of functional groups are well precedented in protein and peptide structures; in fact it 
is estimated that over 80% of all serine or threonine residues are involved in some form of 
side-chain hydrogen bonding interactions in protein structures.21 ·22 Similarly, histidine is 
often involved in hydrogen-bonding relay systems between hydroxyl and carboxylate 
groups in nature;5·9 these interactions have been known to influence the relative basicity of 
the ring system over a wide range of pKa values.9 
In order to test whether hydrogen bonding interactions were present in the peptides, 
incorporating serine, and the threonine diastereomers at position i, the histidine imidazole 
pKa were determined using lH NMR monitored pH titrations.23 The pKa value was also 
determined for Ac-Val-Pro-D-Ser-His-NH2, since this peptide has been found to have a 
significant amount of Type II reverse tum character. (See Chapter 2 .) 
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As can be seen in Table 3-3, all of the peptides and the control compound, Ac-His-
NHMe, have Hill coefficients near unity so it can be assumed that the histidine ring is the 
only ionizing species in the titration over the pH range studied (pH= 2.5-1 0). The pKa 
values for Ac-Yal-Pro-D-Ser-His-NH2 and Ac-Thr-Pro-D-Ser-His-NH2 are identical and 
are within experimental error(± 0.02 pKa units) to the pKa found for Ac-His-NHMe, 
Table 3-3. Histidine Imidazole pKa Values for Selected Tetrapeptides 
Peptide Hill Coefficient (n) oK~ 
Ac-His-NHMe 0.95 6.53 
Ac-Yal-Pro-o-Ser-His-NH2 1.00 6.52 
Ac-Thr-Pro-o-Ser-His-NH2 1.00 6.52 
Ac-Ser-Pro-D-Ser-His-NH2 0.96 6.65 
Ac-(allo )Thr-Pro-D-Ser-His-NH2 1.09 6.70 
thereby implying that the histidine ring protons are relatively free in solution. However, 
Ac-Ser-Pro-D-Ser-His-NH2 shows an elevated pKa value, which supports the hypothesis 
that the histidine ring protons are involved in a hydrogen bonding interaction. In addition, 
Ac-(a/lo)Thr-Pro-o-Ser-His-NH2 exhibits an even larger pKa shift from the control 
compound (Ac-His-NHMe) in contrast to the results obtained for Ac-Thr-Pro-o-Ser-His-
NH2. The elevated pKa value for the (allo)Thr containing compound could be explained 
through a hydrogen bonding interaction similar to that proposed for Ac-Ser-Pro-D-Ser-His-
NH2. The observed changes in pKa are relatively small in magnitude; however, similar 
shifts have been observed in mutants of bovine pancreatic ribonuclease when specific 
hydrogen bonding interactions were altered through site-specific mutagenesis.24 It has 
been noted that the stereochemistry of ~-branched amino acids can drastically affect the 
orientation of the side-chains in both solution and the solid state.25·26 In light of this, it is 
possible that the (2S,3S) stereochemistry of alia-threonine allows the hydroxyl group to 
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assume the correct orientation to undergo hydrogen bond formation with the histidine ring 
protons across the turn, whereas the (2S,3R) stereochemistry of threonine directs the 
hydroxyl away from the histidine ring protons. (For a stereodiagram of the peptide in this 
conformation, see Figure 3-7 .) This arrangement could also account for the discrepancy 
between the two threonine-containing peptides in terms of the amide variable temperature 
coefficients (see above). It is possible that the hydroxyl group of the a//o-threonine could 
form an additional hydrogen bond to the i+2 amide bond, thereby shielding the proton from 
solvent. Further support for this hypothesis can be obtained through analysis of the XI 
rotamer distributions of these residues. 
Side-chain XI Rotamer Conformer Analysis 
Side-chain XI distributions of amino acids in peptides and proteins have been found 
to exist almost exclusively in one of three staggered rotamer populations in both the 
solution27 and solid states.2 I·22 The strong preference of residues to adopt these 
conformations has been attributed to the reduction of unfavorable steric interactions 
between the ~-substituents and the main atoms in the eclipsed conformations. The three 
conformations have been classified as gauche- (g-, X1= -60°), gauche+ (g+, X1= 60°), and 
trans (t, XI= 180°) based on the relative position of the largest ~-substituent and the a-
carbon NH group (see Figure 3-6). Information regarding the relative populations of these 
rotamer conformations in solution can be obtained through analysis of the lH NMR 3Ja~ 
vicinal coupling constants. (See Experimental Section.) These calculations were 
performed for those residues in the tetrapeptides at positions i and i+3 where spectral 
overlap did not pose a problem in determining the coupling constants. The full results from 
these calculations are presented in Table 3-4. 
The rotamer population calculations indicate that the aromatic amino acids at 
position i+3 have a strong preference for the g- rotamer conformation (>55% of the time on 
average) in all the peptides studied. This rotamer population places the aromatic side-chain 











































over the i+2 residue, and in support of these calculations, several weak, but significant, 
long-range NOEs have been observed between the aromatic ring protons (either Phe-ring or 
the histidine imidazole-Co protons) and the i+2 serine a- and 13-protons. The strong 
preference for the g- rotamer population is well precedented for aromatic amino acids in 
peptides, as a survey of oligopeptide crystal structures found that ==45% of the aromatic 
amino acids assumed this rotamer conformation.2I 
Unfortunately, detailed studies of the rotamer conformations of the residues at 
position i were not possible, as the coupling constants for the 13-protons could not be 
obtained for many of the residues due to extensive peak overlap in the I H NMR lD 
spectra. However, the coupling constants were determined for the two peptides containing 
the threonine analogs. While one rotamer population can be determined for threonine (it is 
not possible to calculate more than one rotamer population for 13-branched amino acids 
based on the 3] al3 I H coupling constant alone; see Experimental Section), several 
interesting conclusions can be drawn from the data about the effects of the threonine 
residues on the overall turn conformation. The rotamer population calculated for Ac-
(a/la)Thr-Pro-D-Ser-His-NH2 indicates that the threonine exists primarily in the trans 
conformer (48% of the time on average).28 This conformation places the methyl group in 
the g- conformation and orients the hydroxyl group towards the central amide bond thereby 
bringing it in close contact with the histidine ring Ne or No (depending on the value of X2 
for the histidine residue). This conformation would be expected to be energetically favored 
overall, as neither 13-substituent would experience unfavorable gauche steric interactions 
with the main chain atoms. A stereodiagram of the peptide, with alia-threonine in the 
preferred trans conformation and the histidine side-chain in the gauche- rotamer, is shown 
in Figure 3-7. Numerous hydrogen-bonding interactions are possible when the alia-
threonine side-chain resides in this conformation; the hydroxyl group of the side-chain is 
within ==2.6 A of the histidine ring Ne or No protons, and it has the correct orientation for 
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Table 3-4. 31 af3 1 H Vicinal Coupling Constants and Calculated Side-Chain X 1 








31 af3 = 5.5 Hz 
f(g-) = 0.27 
Position i+Ja 
31af3t= 9.60 Hz; 31af32= 4.40 Hz 
f(g-) = 0.59 
f(g+) = 0.10 
f(t) = 0.31 
31a131= 9.70 Hz; 31a132= 5.56 Hz 
f(g-) = 0.60 
f(g+) = 0.21 
f(t) = 0.19 
31aj3t= 9.54 Hz; 31a132= 4.40Hz 
f(g-) = 0.58 
f(g+) = 0.08 
f(t) = 0.34 
Ac-(a//o)Thr-Pro-D-Ser-His-NH2 31af3= 7.7 Hz 31a131= 9.84 Hz; 31a132= 4.35 Hz 
Ac-Bmc-Pro-D-Ser-His-NH2 
Ac-Cys-Pro-D-Ser-His-NH2 
f(g-) = 0.48 f(g-) = 0.58 
f(g+) = 0.08 
f(t) = 0.34 
31a131= 9.73 Hz; 31a132= 4.72 Hz 
f(g-) = 0.60 
f(g+) = 0.29 
f(t) = 0.11 
31aj3t= 9.41 Hz; 31a132= 4.77 Hz 
f(g-) = 0.57 
f(g+) = 0.31 
f(t) = 0.12 
a 31 al31 and 31 al32 refer to the vicinal coupling constants for Hl3l and H132 respectively 
as defined in Figure 3-6a; b Coupling constants could not be determined due to 
extensive overlapping peaks in the 1 H 1 D NMR spectra. 
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Figure 3-7. Stereodiagram of Ac-(a//o)Thr-Pro-D-Ser-His-NH2 with sidechains in the 
preferred X 1 rota mer conformations [ (a/lo )Thr X 1 = t, His X 1 = g-; dashed 
line represents proposed hydrogen bond]. 
favorable hydrogen bonding interactions. In addition, while the central amide bond proton 
is too distant (==4.8 A) to interact with the side-chain hydroxyl group when the peptide has 
ideal J3-turn dihedral angles, it is possible that these two groups could be involved in a 
hydrogen bonding interaction if some distortion of the turn dihedrals occurred.29 These 
interactions, while not rigorously proven, are consistent with both the anomalous variable 
temperature coefficient data and the elevated pKa values for the histidine imidazole protons 
observed for this peptide. By analogy, it is possible that similar hydrogen bonding 
interactions are involved in Ac-Ser-Pro-D-Ser-His-NH2, as this peptide also shows an 
elevated histidine pKa. While the rotamer populations for the serine at position i could not 
be calculated in this case, it has been noted that serine is capable of assuming any one of the 
rotamer populations with equal propensity in protein structures.22 As a result, it is likely 
that the serine hydroxyl could reside in the trans conformer (as was found for (a//o)Thr) 
and participate in a hydrogen bond with the histidine imidazole. 
In contrast to the peptide containing (allo )Thr, the preferred rotameric state for 
threonine in Ac-Thr-Pro-D-Ser-His-NH2 is more difficult to determine, as the calculated 
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population of g- is too low for reasonable analysis (only 27% on average). However, 
surveys of oligopeptide crystal structures have shown that threonine residues frequently 
adopt the g+ or g- conformations but not the t rotamer; 28 indeed, no structures have been 
found with the hydroxyl group in the t conformation.21 This selectivity has been attributed 
to unfavorable steric interactions experienced by the threonine-methyl group when the 
residue assumes the t conformation (hydroxyl group in trans, methyl-grouping+). In the t 
rotamer, the methyl group of threonine would experience two gauche steric interactions 
between the main chain amide groups. (See Figure 3-6b.) Based on the low percentage of 
the g- conformer, the predominant rotamer conformation would be expected to be g+ (g+ 
hydroxyl, g- for methyl). In support of this conformer, a strong NOE is observed between 
the threonine ~-proton and the proline S-protons. While it is possible that this NOE would 
be observed in any case due to conformational averaging, only the g+ rotamer places the ~­
proton close enough in space to the praline-S protons to give rise to a significant NOE in 
the ROESY experiments30 (d~0[Thr,Pro] in g+, 2.60 A; in g-· 4.23 A; in t, 4.31 A).29 A 
stereodiagram of the peptide, Ac-Thr-Pro-D-Ser-His-NH2, is shown in Figure 3-8, with 
the threonine in the predicted g+ conformation and the histidine in the preferred g-
conformation. Unlike the (a/lo)-threonine-containing peptide, the hydroxyl group is not in 
the correct orientation for efficient hydrogen bonding with the histidine side-chain when the 
residue assumes the predicted conformation. The fact that the peptide did not show an 
elevated histidine imidazole pKa is also consistent with the proposed conformation. As a 
result, while the preferred conformation of the threonine residue cannot be determined 
rigorously, the g+ conformation is most consistent with all of the data collected on the 
peptide. 
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Figure 3-8. Stereodiagram of Ac-Thr-Pro-D-Ser-His-NH2 with the sidechains in the 
preferred XI rotamer populations (Thr Xl=g+, His Xl= g-) 
Esterase Actvity of Serine and Threonine Containing Peptides 
The data for Ac-Ser-Pro-D-Ser-His-NH2 and Ac-(al/o)Thr-Pro-D-Ser-His-NH2 
suggests that a hydrogen bonding relay system is in operation between the Ser-Oy-
His(lm)-NH hydrogen bond. In order to test whether these interactions are sufficient to 
promote catalytic activity, the rates of esterase hydrolysis were measured for the series of 
peptides using p-nitrophenyl-acetate (p-NPA) as the ester substrate. 
Rates of p-NPA hydrolysis have been used to measure the catalytic efficiencies for 
a number of model enzyme systems, 14-16•18 primarily because it is relatively simple to 
assay and the results can be directly correlated to native proteolytic enzymes which show 
esterase activity (e.g., chymotrypsin).31 The p-NPA esterase activity of the peptides was 
measured under pseudo-first order conditions, and the observed rate constants (kJ) were 
then converted to second order rates (kcat) to correct for the background hydrolysis rate and 
differences in peptide concentrations. (See Experimental section of this chapter for methods 
of calculation.) These conversions allow a direct comparison of the esterase activity both 
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Table 3-5. p-Nitrophenol-acetate Hydrolysis Rates for Peptides in H20 at pH=7.6oa 
Peptide pKa a.b kcat (M-1. min-I )C 
Imidazole 7.20 (H20) 0.71 32.1 ± 0.3 
Ac-Ser-Pro-D-Ser-Phe-NH2 - - 0 
Ac-Thr-Pro-D-Ser-His-NH2 6.52 0 .92 2.92 ± 0.2 
Ac-Val-Pro-D-Ser-His-NH2 6.52 0.92 3.58 ± 0 .1 
Ac-Ser-Pro-D-Ser-His-NH2 6.65 0.90 5.42 ± 0.3 
Ac-(allo )Thr-Pro-D-Ser-His-NH2 6.70 0.89 4.96 ± 0.1 
a Rates were measured in 0.07 M NaPi with 5% v/v I ,4-dioxane; hThe apparent degree of 
dissociation; see Experimental Section for calculations; csecond order hydrolysis rates 
were calculated using a background hydrolysis rate of kw = 1.1 x IQ-2 min-I . (See 
Experimental Section.) 
among the peptides within the current study and also to the results of the existing protease 
models and native enzymes. The results of these studies are presented in Table 3-5. 
It is well established that imidazole is capable of efficient p-NPA hydrolysis32 and 
the second order rate of hydrolysis for imidazole obtained in these studies is identical with 
the reported value. 33 In general, the peptides show reduced catalytic activities when 
compared to the imidazole rate. This phenomenon has been noted with derivatives of 
histidinei 6 and other peptide models; I3-IS ,l7 the reduced activity has been attributed to 
unfavorable steric interactions arising from the substitution of the imidazole ring. Even 
with the reduced rates, however, several trends emerge from the kinetic data. First, both 
peptides with the elevated histidine imidazole pKa values, Ac-Ser-Pro-D-Ser-His-NH2 and 
Ac-(a/lo)Thr-Pro-D-Ser-His- NH2, show higher rates of esterase activity than the other 
peptides. This effect cannot be attributed to a higher concentration of neutral imidazole 
resulting from the elevated pKa values, since calculation of the second order rate constant 
(kcaJ is based on the effective imidazole concentration determined from the pKa value for 
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each peptide (see Experimental Section). Further, the fact that Ac-Thr-Pro-D-Ser-His-NH2 
does not exhibit an enhanced rate demonstrates that the elevated esterase activities present in 
the Ser(i) and (allo)Thr(i) peptides are not simply due to the presence of a hydroxyl group 
at position i, but are more dependent upon the presence of the hydrogen-bonding 
interaction between the hydroxyl side-chain at position i and the histidine ring imidazole. 
Similar effects have been noted with highly constrained cyclic peptides, where the extent of 
hydrogen bonding interactions can be rigidly controlled. 14 In these studies, the peptides 
which were capable of side-chain interactions demonstrated higher catalytic efficiencies 
when compared to those where these interactions were disfavored. 
There are two mechanisms proposed for the imidazole-catalyzed hydrolysis of p-
NPA; either general-base catalyzed or nucleophilic attack by the imidazole ring nitrogen 
atoms. The mechanism proposed for the native proteolytic enzymes essentially follows the 
general-base mechanism, where the histidine ring nitrogens activate a serine hydroxyl (or 
water molecule) which can then attack the ester bond. (See Figure 3-2.) In contrast, in the 
nucleophilic attack mechanism, the imidazole molecule attacks the ester carbonyl directly to 
form an acyl-imidazole intermediate which then hydrolyzes to regenerate the free imidazole 
molecule. (See Figure 3-9.) It is now generally accepted that the imidazole catalyzed 
hydrolysis of p-NPA follows the direct nucleophilic attack mechanism.33 
Figure 3-9. Imidazole-catalyzed ester hydrolysis by the nucleophilic attack mechanism 
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One experiment which can be used to distinguish the mechanistic pathways is 
through measurement of a solvent isotope effect on the hydrolysis rate when the reactions 
are run in deuterium oxide rather than in water. A large solvent isotope effect (/qf/ko > 2) 
would be expected for the general base mechanism, as this pathway requires that a 
hydrogen bond be broken during the rate limiting step of the nucleophilic attack on the acyl 
substrate. 34 In contrast, the direct nucleophilic attack mechanism (see Figure 3-9) does not 
require any hydrogen bonds to be broken in the rate limiting step, and therefore a negligible 
solvent isotope effect would be expected (kHiko = 1).34 In order to distinguish which 
mechanism was favored for the peptides in the present study, the rates of hydrolysis were 
measured for the peptides in 99.9% 020 and compared to the rates obtained in water. 
These rates are presented in Table 3-6, along with the pKa values for the peptides in 99.9% 
Both peptides, Ac-Ser-Pro-D-Ser-His-NH2 and Ac-(allo)Thr-Pro-D-Ser-His-NH2, 
do not show any appreciable differences in the esterase activity between the two solvent 
systems. The negligible solvent isotope effect direct nucleophilic attack mechanism as 
Table 3-6. p-Nitrophenol-acetate Hydrolysis Rates for Peptides in 020 at p0=7.6oa 
Peptide pKa kcat (M-1. min-l)b kHiko 
Imidazole 7.20 (H20) 32.1 ± 0 .3 :::: 1.0 
7.63 (020) 33.5 ± 2.3 
Ac-Ser-Pro-D-Ser-His-NH2 6.65 (H20) 5.42 ± 0.3 1.11 
7.17 (020) 5.11 ± 0.4 
Ac-(allo)Thr-Pro-D-Ser-His-NH2 6.70 (H20) 4.96 ± 0 .1 1.22 
7.25 (020) 4.05 ± 0 .1 
a pO =pH + 0.4; 0.07 M NaPi, 5% v/v 1 ,4-dioxane; b Second order hydrolysis rates for 
020 were calculated using a background hydrolysis rate of kw = 3.2 x t0-3 min-I 
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observed for free imidazole. The enhanced rates of esterase activity for these peptides is 
likely to be due to efficient acyl transfer of the acetate group from the acylated imidazole 
intermediate to the Oy of the Ser(i) and (al/o)Thr(i) residues. These processes have been 
well-documented in other peptide models containing both hydroxyl and thiol groups.14.35 
The results from these mechanistic studies have implications for the design of future 
models targeted to emulate native proteolytic enzymes, as the observed nucleophilic 
mechanism is very different from the reaction pathway proposed for the native enzymes. 
The data suggests that the Ser-His motif, while contributing to enhanced rates of catalysis, 
is not sufficient to mimic the full enzyme activity (chymotrypsin, 
kcat=lO,OOO M-Lmin-1). 16 It is apparent that at least the third component, an aspanatic 
acid residue, is required for an accurate model of the proteolytic enzymes. The full Asp-
His-Ser triad would be expected to disfavor the nucleophilic attack mechanism, as both 
nitrogens of the central histidine ring would be occupied in hydrogen bonding interactions 
and therefore unable to play a nucleophilic role. Future protease mimics based on the 
reverse turn motif could incorporate a carboxylate group in the turn sequence, possibly 
through the use of a modified proline such as that described in Appendix I, or through a 
modified D-residue at position i+2, to provide the third component of the catalytic triad. 
Metal-Binding Motif 
Synthesis and Peptide Incorporation of N<X-(9-FluorenylmethoxycarbonyD-S-
tritylmethyl-(3-methyl-cysteine (8) 
Synthesis of (2R ,3R)-N<X-Fmoc-S-trityl-~-methyl-cysteine was accomplished along 
a stereoselective synthetic route (Scheme 3-1) following the methods described by Morell, 
Fleckenstein, and Gross. 36 The key step of the synthetic route involves a nucleophilic 
attack of a protected thiolate (thioacetate anion) on a suitably-protected activated threonine 
analog, 3. Interestingly, the nucleophilic substitution was found to be extremely sensitive 
to the configuration of the stereocenter on the ~-carbon of the threonine analog 3 . When 
the naturally-occurring threonine diastereomer (2S,3R) 3b was employed in the synthesis, 
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the reaction proceeded to yield the corresponding elimination product 4 as the predominant 
product; this was found to be the case over a wide range of solvents (DMF, THF, DMSO) 
and temperatures ( -78° C to 40° C). However, when the corresponding protected 
(allo )threonine-tosylate 3a was used in the substitution reaction, a quantitative yield of the 
substitution product 5 was obtained with complete inversion as determined by inspection of 
the 10 NMR spectra. Evidently the combination of the bulky protecting groups on the 
amino (BOC) and carboxyl terminii (methyl ester), in conjunction with the large tosyl 
group on the y-hydroxyl group, force the threonine analog 3b to assume a rotamer 
conformation that promotes o:,l3 elimination rather than substitution. Extensive hydrolysis 
of the protected 13-methyl cysteine analog 5 in 6N HCl, followed by thiol protection with 
triphenylmethanol in trifluoracetic acid as described by Photaki et ai.,37 yielded the S-trityl 
protected 13-methyl cysteine, which was subsequently protected with Fmoc-ONSu to 
provide the target 13-methyl-cysteine analog 8 ready for solid phase peptide synthesis. 
Incorporation of 1 into a tetrapeptide, Ac-Bmc-Pro-D-Ser-His-NH2, was 
accomplished using standard solid phase peptide synthesis protocols. The resulting peptide 
was found to be fairly clean, with only one other peptidyl impurity detected by RP-HPLC. 
Conforrnational Analysis of Ac-Cys-Pre=D-Ser-His-NH2 and Ac-Bmc-Pro-D-Ser-His-NH2 
The spectroscopic data collected on the 13-methyl cysteine peptide, Ac-Bmc-Pro-D-
Ser-His-NH2, shows that it adopts a significant population of reverse turn character in 
solution. As can be seen in Table 3-1, all of the sequential NOEs (1, 2, and 3; see Figure 
2-2 for assignment) and the two long range interactions that are diagnostic of Type II 
reverse turn forrnation, 4 dNN(Ser-NH, His-NH) and 5 do:N(Pro-o:, His-NH), are 
observed. The NOE connectivity 5 is particularly informative, as this long range 
interaction is only observed in those cases where the peptide conforrnation is highly 













































































































































































































































































































ROESY experiment (<3.5A) and would be expected to have a weak intensity even if the 
peptide assumed an ideal reverse turn conformation. Since the NOE connectivity observed 
for the ~-methyl-cysteine peptide has a moderate intensity, it is possible that the peptide 
assumes a slightly distorted turn conformation, as result of the steric bulk of the thiol and 
methyl groups of the ~-methyl-cysteine residue. This possibility is also supported by the 
circular dichroism data (see below). The results from the variable temperature studies (see 
Table 3-2) on the ~-methyl-cysteine peptide further support the NOE observations as low 
coefficients are observed for the i+3 amide (-6.6 ppb/K), while high coefficients are 
observed for the i+2 amide ( -9.3 ppb/K). Interestingly, the circular dichroism spectrum 
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Figure 3-10. Circular dichroism spectra for Ac-Cys-Pro-D-Ser-His-NH2 and Ac-Bmc-
Pro-D-Ser-His-NH2 at pH=4.0, 25°C. 
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and ""220 nm, along with a negative ellipticity below 190 nm, unlike the ideal type II tum 
which is characterized by a Class B spectrum (see Chapter 2). This unexpected CD 
signature could be due to a distorted reverse turn conformation, as slight distortions of 
peptide conformations have been predicted to have dramatic effects on the overall CD 
spectrum. 38 
In contrast, the spectroscopic data collected for the cysteine-containing peptide 
indicate that the peptide has a reduced population of reverse tum conformation in solution. 
Results from the ROESY experiments indicate that the peptide is not constrained in the 
reverse turn conformation, as only the sequential NOE connectivities (1, 2, and 3; see 
Table 3-1) are observed in the ROES Y spectrum. However, results from the variable 
temperature NMR experiments (see Table 3-2) show a low coefficient for the i+3 amide 
and a correspondingly high i+2 amide coefficient, which is suggestive of reverse tum 
formation in solution. Similarly, the CD spectrum of the cysteine-containing peptide 
exhibits weak Class B character characteristic of a reduced, but observable, population of 
the type II reverse tum. 
In summary, the spectroscopic data collected for the two thiol-containing peptides, 
Ac-Cys-Pro-D-Ser-His-NH2 and Ac-Bmc-Pro-D-Ser-His-NH2, is consistent with the 
general conclusions from the earlier peptide studies discussed in Chapter 2, which indicated 
that sterically hindered amino acids at the i position can serve to constrain the peptide 
conformation significantly. 
Metal-Bindine Titrations 
The metal binding properties of the two thiol-containing peptides were evaluated 
with metal cation titrations monitored with circular dichroism spectroscopy. The two 
peptides were titrated with ZnCh and CoCl2, and the spectra from typical titrations are 
shown in Figure 3-11 and Figure 3-12. For both peptides dramatic changes in the spectra 
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Figure 3-11. (A) Circular dichroism spectra of the titration of Ac-Cys-Pro-D-Ser-His-
NH2 (50 11M) with ZnCl2 (pH=7.4, 100 mM PIPES, 25° C; ZnCl2 added in 
20 11M aliquots). (B) Circular dichroism spectra of the titration of Ac-Bmc-
Pro-D-Ser-His-NH2 (50 11M) with ZnCl2 (pH=7.4, 100 mM PIPES, 25° 
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Figure 3-12. (A) Circular dichroism spectra of the titration of Ac-Cys-Pro-D-Ser-His-
NH2 (50 ~M) with CoCh (pH=7.4, 100 mM PIPES, 25° C; CoCh added 
in 40 ~M aliquots). (B) Circular dichroism spectra of the titration of Ac-
Bmc-Pro-D-Ser-His-NH2 (25 ~M) with CoCh (pH=7.4, 100 mM PIPES, 
25° C; CoCl2 added in 10 ~M aliquots). 
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cations and that a conformational change occurs upon metal coordination. Unfortunately, 
while the spectral changes follow a consistent pattern upon increasing metal cation 
concentration for both peptides, well-defined isodichroic points were not observed in any 
of the titrations. The lack of isodichroic points suggests that the peptides undergo multiple 
equilibrium processes upon addition of metal cations. 39 Attempts were made to discourage 
intermolecular complex formation by variation of the peptide concentration; however, these 
effects were observed over the full range of concentrations employed (5 ~M- 100 ~M). 
Since the peptides contain two metal ligating groups (thiol, imidazole), the peptide could 
potentially form a wide range of intermolecular complexes. The number and identity of the 
various metal complexes could not be ascertained directly from the spectra and, as a result, 
it was not possible to determine the dissociation constants for the monomeric peptide:metal 
complexes. 
Conclusions 
The type II reverse turn provides an ideal template for de novo design of functional 
protein constructs. As discussed in Chapter 2, the propensity for linear tetrapeptides to 
form stable reverse turn conformations is highly dependent upon the primary sequence, and 
the overall conformational stability arises from a series of cooperative interactions between 
neighboring residues. Since the studies in the previous chapter focused primarily upon the 
effects of steric interactions on turn formation, incorporation of functional groups at 
position i capable of long range intramolecular interactions could have dramatic effects on 
the overall peptide conformation. The results described in this chapter demonstrate that 
tetrapeptides incorporating either hydroxyl or thiol groups at position i in the consensus 
sequence Ac-Xaa-Pro-D-Ser-His-NH2 can adopt stable reverse turn conformations in 
aqueous solution. While the studies in Chapter 2 indicated that steric bulk at position i was 
essential for effective reverse turn formation, the results from the current studies suggest 
that several additional long range interactions may contribute to the overall turn stability 
97 
when hydroxyl-containing amino acids are incorporated at position i. For example, the 
peptide containing serine at position i exhibited a significant amount of reverse tum 
character in solution, as detected by NMR and CD spectroscopy, despite the fact that this 
residue has limited steric bulk. Further, pH titrations on the peptide revealed that the 
imidazole side chain of the histidine residue has an elevated pKa value. The elevated pKa 
value was attributed to a long range hydrogen bonding interaction between the hydroxyl 
side-chain and the imidazole ring. Similar observations were noted with a peptide 
containing (25,35)-L-threonine, but not with the peptide containing the (25,3R)-L-
threonine diastereomer. The contrast in reactivities of the two threonine diastereomers was 
ascribed to differences in the XI rotamer preferences; in the (25,35)-L-threonine-containing 
peptide, the hydroxyl group is preferentially directed towards the imidazole ring, whereas 
in the (25,3R)-L-threonine diastereomer the hydroxyl group is directed towards the solvent 
milieu. 
Since similar serine-histidine hydrogen lx>nd interactions are an integral component 
of the active site catalytic machinery of the serine protease family, the peptides were tested 
for esterase activity. While the peptides displayed reduced reactivities relative to imidazole, 
enhanced reactivities were observed for the serine and (25,35)-L-threonine containing 
peptides relative to the peptide containing the (25,3R)-L-threonine residue. The mechanism 
of the observed catalytic activities, determined by deuterium isotope effects, was found to 
be the result of an imidazole-based nucleophilic attack mechanism. In contrast, the native 
enzymes carry out esterase activity through a general base mechanism. These findings 
suggest that the peptide model systems, while they contain elements of native protease 
active site machinery, do not contain the full complement of the native enzyme active site 
topographies. It is possible that through additional functional group incorporation that 
more accurate representations of the protease mimics could be achieved with these model 
systems. 
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The results from peptides incorporating thiol-containing amino acids at position i 
were found to be consistent with the guidelines derived in Chapter 2 for reverse turn 
formation. The peptide containing a ~-branched, thiol-containing amino acid, (2R, 3R)-~­
methyl-cysteine, constrained the peptide conformation to adopt a conformation consistent 
with a distorted type II reverse-turn character in solution. In contrast, the corresponding 
peptide containing a cysteine residue exhibited a small amount of reverse tum population in 
solution as observed by CD and NMR spectroscopy. It was believed that a thiol group at 
position i and a histidine residue at position i+3 would assemble to form a bidentate metal 
binding site when the compound adopted a reverse turn conformation. Metal cation 
titrations performed on the peptides using circular dichrosim spectroscopy indicated that 
both peptides were capable of effective metal binding activity. However, a critical analysis 
of the metal binding properties of the two peptides was complicated by the formation of 
multiple metal cation:peptide complexes. It is envisioned that a more quantitative analysis 
of these motifs could be accomplished through studies of larger peptide systems which are 
designed favor the formation of stable intramolecular, monomeric metal complexes. An 
example of such a system is described in Chapter 7, where a peptide containing the Bmc-
Pro-D-Ser-His sequence was incorporated in a dodecapeptide containing 4-bipyridyl-
alanine (4Bpa, see Chapter 4). This peptide formed well-defined monomeric complexes 
for all of the metal cations studied (See Chapter 7). 
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Experimental Section 
Preparation of Na-(9-F luorenylmethoxycarbonyl )-S -tritylmethyl-{3-methyl-cysteine 
Preparation of (2R,3R)-~-Methyl-cysteine (1, See Figure 3-3) was carried out 
using the method of Gross36 using a protected derivative of L-alla-threonine. The (allo )-
threonine was prepared from N-Benzoyl-L-threonine (Aldrich Chemical Co.) as 
described by Elliot.40 Tritylation of the cysteine analog was performed as reported by 
Photaki, et a/.31 
Na-(9-Fluorenylmethoxycarbonyn-S-tritylmethyl-B-methyl-cysteine (1) A solution of 
(2R ,3R)S-tritylmethyl-~-methyl cysteine (0.9939 g, 2.52 mmol) in 24 mL 1:1 (v:v) 
dioxane: 10% Na2C03 was stirred at room temperature and a solution of FMOC-ONSu 
(0.8568 g, 2.54 mmol) in 10 mL dioxane was added drop wise. After 1.5 h, the mixture 
was extracted with ethyl ether (3 x 50 mL). The ether fractions were dried over Na2S04 
and concentrated in vacuo to -5 mL. The ether solution was transferred to a centrifuge 
tube and triturated with hexanes (3 x 30 mL). The resulting precipitate was dissolved in 
20 mL ethyl acetate and concentrated in vacuo to yield 1.3669 g (90%) of a pale yellow 
foam. mp = 85-87° C; TLC (Si02: 5:1 (v:v) CHCl3:MeOH; UV detection) Rr: 0.70; 
HRMS : Calc. for [MH]+ C3gH32N04S [598.2052] ; Obs. [598.2079]; 1H NMR 
(CDCl3) o: 7.90 (d, 2H, J=6.8Hz), 7 .3-7.8 (m, 22H), 5.50 (d, 1H, J=8.5 Hz), 4.55 (d, 
2H, 1=7.0 Hz), 4.45 (m, lH), 4 .38 (m, 1H), 3.01 (m, 1H), 1.12 (d, 3H, 1=6.8 Hz); 
Be NMR (CDCl3) o: 146.3, 130.5, 129.0, 128.9, 128.7, 128.6, 128.0, 127.2, 126.3, 
121.0, 66.4, 61.7, 47.7, 43.1, 17.5; IR (thin film) cm-1 : 3395, 3056, 1708, 1610, 
1500, 1446, 1400, 1328, 1251 , 1077, 1036, 908,733, 697. 
Peptide Synthesis 
All peptides were prepared using standard solid phase peptide synthesis protocols 
as described in Chapter 2. Crude peptides were purified using reversed-phase high 
pressure liquid chromatography (RP-HPLC) on a C18 semi-preparative column (1.0 em 
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x 25 em Beckman Instruments) using water/acetonitrile gradients. Purified peptides were 
lyophilized and stored at -70° C. Free thiol concentrations of the sulfur-containing 
peptides were measured spectrophotometrically after modification with bis(p-
nitrophenyl)-disulfide (DTNB) as described by Ellman.41 
HPLC Methods: 
A : Flow rate 1 ml/min; Analytical C18 column, detection@ 228, 254 nm. 
Gradient: 5 mins. H20 (0.1% TFA), Linear gradient 0-25% CH3CN (0.08 % TFA) over 
25 mins, 5 mins 25% CH3CN (0.08% TFA), 25-0% CH3CN (0.08% TFA) over 2 
mins. 
B : Flow rate 1 ml/min; Analytical C18 column, detection @ 228, 254 nm. 
Gradient: 5 mins. H20 (0.1% TFA), Linear gradient: 0-40% CH3CN (0.08% TFA) over 
25 mins, 5 mins 25% CH3CN (0.08% TFA), 40-0% CH3CN (0.08% TFA) over 5 
mins. 
Spectroscopic Studies 
lH and 13C NMR spectra for synthetic intermediates were collected at 300 MHz 
and 75.5 MHz respectively on a General Electric QE-300 NMR Spectrometer. lH and 
13C NMR data for the petpides were collected at 500.14 MHz and 125.7 MHz 
respectively on a Bruker AMX500 NMR Spectrometer. All2D-NMR spectra (ROESY, 
TOCSY) and variable temperature experiments were recorded as described in Chapter 2. 
In cases where spectral overlap was a concern, the temperature was elevated or lowered 
by 5°C to avoid difficulties in spectral analysis. Circular dichroism spectra were recorded 
at ambient temperature (25-28° C) at 25-50 uM in a 1.0 em quartz cell. All solutions were 
prepared in fully degassed (N2 sparged) Millipore water and the pH was adjusted using 
small amounts (1-lOuL) of 1.0 N NaOH or 1.0 N HCl solutions. 
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Metal-Biruiing Titrations ofThiol-Containing Peptides 
Circular dichroism metal titrations were performed in 1 em path-length quartz 
cuvettes with peptide concentrations ranging from 25-50 J.LM at pH=7.4 in 100 mM 
PIPES (25° C). Spectra were collected after each addition of metal over the wavelength 
range 195-250 nm using a scan speed of 50 nm/min, a time constant of 0.5 s, and a 
bandwith of 1 nm. A minimum of 8 scans were taken for each spectra. The spectra are 
reported in ellipticity/residue. Metal cation solutions (Zn+2, Co+2) were prepared from 
the corresponding anhydrous chloride salt, and the stock solutions were standardized by 
ethylene-diamine tetraacetic acid complexometric titrations (0.5 M standardized EDTA 
solution, Aldrich) using murexide as an indicator.42 Peptide concentrations were 
determined using the Ellman's test for free thiol groups.41 
Calculation of XI Rotamer Populations from 31 af31 H NMR Coupling Constants 
Calculation of the Xt rotamer populations for L-amino acids with two ~-protons H~ 1 
and H~2 in peptide and protein structures can be accomplished using the following 
equations: 
f(g-) = VHa-Hf3J - 1c) I (1-r- 1c) 
f(t) = (1Ha-llf32- 1c) I (1-r- 1c) 




The standard values for 1c and 1T have been found to be dependent upon the side-
chain substituent; Pachler43 has derived the values of 1T= 13.56 Hz and 1c = 2.60 Hz for 
non-aromatic amino acids and Cung and Marraud44 have found that 1T= 13.85 Hz and 1c 
= 3.55 Hz provide accurate estimations of side-chain rotamer populations for aromatic 
amino acids (His, Phe, Trp, etc.). 
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In order to determine all three rotamer populations, the 13-methylene protons must be 
diastereotopically assigned. This can be done most easily through inspection of the relative 
intraresidue NOE intensities between the a- and 13-protons, and the amide and 13-protons. 
For example, if the residue resides in the trans conformer, strong NOEs would be 
expected between the a-proton and the Hl3l proton, whereas a weaker NOE would be 
expected for the H132 proton since this proton is anti to the a-proton (see Figure 3-6a for 
clarification). In addition, equal intensity NOE connectivities would be expected for both 
Hl3l and H132 protons to the amide proton. Similar arguments can be used assign the 
stereochemistry of the 13-methylene protons for the two gauche conformations. Once the 
protons are diasterotopically assigned and the corresponding vicinal coupling constants are 
determined, the rotamer populations of the residue can be calculated using equations 
3-la-c. 
In cases where the amino acid has only one 13-proton (e.g., threonine), only one 
population can be assessed, as the other two rotamer populations are indistinguisable in 
terms of the coupling constant. For example, for L-threonine (2S ,3R) only the f(g-) 
population can be calculated, as the f(g+) and f(t) are indistinguishable (see Figure 3-6b). 
Conversely, when the 13-center is in the S-configuration (e.g., alia-threonine), only the f(t) 
population can be calculated (Figure 3-6c). The calculation of the rotamer population 
follows a similar equation to those above (Equations 3-la-c) for the unsubstituted residues, 
and is shown below (for a residue with R-configuration at the f3-center) : 
f(g-) = (JIJa-11{3- lc) I (lr- lc) = 1 - f(t)- f(g+) (3-2) 
The fractional distributions of rotamer populations were calculated using the equations 
derived by Pachler43 (for aromatic residues) or those derived by Cung and Marraud44 
(for non-aromatic residues) using the observed 3Jaf3 vicinal coupling constants. The 
side-chain rotamer populations were assumed to follow a three-state model where low-
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energy populations were associated with X 1 in gauche-, gauche+, and trans 
conformations. For non-~-branched amino acids, diastereotopic assignment of the ~­
protons was accomplished through evaluation of intra-residue NOE's between the ~­
protons and the amide and a-protons. 
The vicinal coupling constants (3J a~) for selected residues in the tetrapeptide 
sequences were obtained by inspection of the 1 D NMR spectra or through 1 H 
homonuclear decoupling experiments. Diastereotopic assignment of the ~-protons of 
non-~-branched amino acids were performed as described above using NOE 
connectivities derived from 2D-ROESY experiments. 
Histidine Imidazole pKa Titrations 
Histidine imidazole titrations were collected as a series of lD NMR spectra in 90/10 
H20ID20 from pH*=3.5 to pH*=9.0 in increments of 0.2 pH* units. Solution pH* was 
adjusted using 1.0 N NaOH or 1.0 N HCl and determined with a standardized Beckman 
Model $32 pH meter using an NMR-probe microelectrode (MI-412) from Microelectronics, 
Inc. (Londonderry, NH). For the determination of histidine pK3 values in D20, spectra 
were collected in 99.9% D20 in increments of 0.2 pD units at ambient temperature. 
Solution pD was adjusted using freshly prepared 1.0 N NaOD and determined using 
corrected pH readings (pD = pH + 0.40 units).45 
The chemical shift changes of the imidazole ring protons (o and e) were plotted as a 
function of pH which resulted in a series of sigmoidal curves with inflection points 
observed at the pK3 of the hisitidine imidazole ring. A typical titration curve is shown in 
Figure 3-13. While an inspection of the curves can provide an estimate of the pK3 value, a 
more accurate value can be obtained by applying nonlinear least-squares analysis to a 




OH+ = chemical shift of the protonated imidazole ring 
Oobs = chemical shift of the imidazole ring at a given pH 
ow = chemical shift of the neutral imidazole ring 
n = Hill coefficient 
K a =equilibrium constant 
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Figure 3-13. Results from a Typical Histidine Imidazole pH Titration Monitored through 
lH NMR Spectroscopy (Data shown for Ac-His-NHMe) 
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This equation can be further simplified to a linear equation which is a direct function of the 
observed pH: 
log[~ I (1 - ~)] = n pH- n pK3 
Therefore, a linear plot of log[~ I (1 - ~)] vs pH will provide the Hill coefficent n as 
the slope and -npKa as they-intercept. The Hill coefficient provides a convenient indicator 
of the cooperativity of the dissociation. Ideally, if only one species is dissociating under 
the observed conditions, the Hill coefficient will be unity; any deviation from this value 
(beyond experimental error) implies that other dissociating groups are participating in the 
titration. All histidine pK3 values reponed in this study were processed in this manner. 
Measurement of Esterase Activity 
The catalytic rate of p-nitrophenyl-acetate (p-NPA) hydrolysis for each peptide 
was obtained through measurement of the change in absorbance at 410 nm (due top-
nitrophenol release) over time using the conditions described by Katchalski et a/.46 (0.07 
M phosphate buffer, pH=7.60, 5% v/v 1 ,4-dioxane). The reactions were run under 
pseudo-first order conditions with the peptide in large excess over the p- NP A 
concentration ([Pep] = 1-3 mM, [p-NPA] =50 IJ.M). In a typical experiment, a 25 Jl,L 
aliquot of a 1.0 mM p-NPA (recrystallized twice from EtOH) in 1,4-dioxane (HPLC 
grade, Aldrich) was added to a thermostatted (25.5° C) solution of the peptide ( 1-3 mM) 
in buffer solution (350 IJ.L) in a 1.0 em quartz UV cell. The mixture was thoroughly 
mixed and the reaction was monitored continously at 410 nm for at least 10 half-lives on 
a Shimadzu UV160U Spectrometer equipped with a TCC-240A temperature-controlled 
cell holder. All buffer solutions were prepared from either Ultrapure water from a Milli-
Q filtration system or commercially available HPLC grade water (Aldrich). The 
imidawle was recrystallized from ethanol two times prior to use. 
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The observed first order rate constants were calculated using graphical analysis of 
the data collected over the first three half-lives. The first order plots (ln(Aoo-Aobs) vs 
time) followed Equation 3-4, where Aoo corresponds to the absorbance at infinite time 
(> 10 half-lives), Aobs is the absorbance at any time t , and Ao represents the absorbance 
at time r=O min. In all cases the plots were found to be strictly linear for up to 90% of the 
reaction conversion, and the rate constant kt was 
ln(Aoo-Aobs) = -kt (t )+ ln(Aoo- Ao) (3-4) 
obtained from the slope derived from linear regression analyses on the data. Second 
order rate constants kcat were calculated by correction for the background hydrolysis rate 
(kw) and normalization by the effective imidazole concentration ([Imerr]) as shown in 
Equation 3-5. The effective imidazole concentration (the amount of neutral imidazole 
present in solution) was obtained through multiplication of the peptide concentration by 




kcat = (kt - kw) I [IIDerr] 
pH - pK' =log [ a I (1 - a)] 
[IIDerr] =(a) [Pep] 
(3-5) 
(3-6) 
lH NMR (10% D20190% H20, 282K) o: 8.62 (Ser-NH, 1H, d ,J=7.0 Hz), 8.55 (His E, 
lH, s), 8.53 (His-NH, 1H, d, 1=9.0 Hz), 8.41 (Cys-NH, IH, d, 1=6.5 Hz), 7.67 
(Amide Cap, s, lH), 7.25 (His o, Amide Cap, s, 2H), 4.86 (Cys a, m, IH), 4.69 (His 
a, m, IH), 4.46 (Pro a, m, 1H), 4.37 (Sera, m, 1H), 3.80 (Pro o, Ser ~. m, 2H), 3.75 
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(Pro o, Ser ~. m, 2H), 3.33 (His~. m, 1H), 3.15 (His~. m, 1H), 2.82 (Cys ~. m, 2H), 
2.30 (Pro ~. m, 1H), 1.90 (Pro ~. "((2), Acyl Cap, m, 6H). 
13C NMR (10% 020/90% H20, 282K) 8: 175.7, 175.2, 172.9, 171.5, 175.0, 134.7, 
129.9, 118.5, 62.2, 62.1' 56.8, 54.9, 53.6, 48.9, 48.8, 30.4, 27.4, 25.8, 22.6. 
HRMS :Calc. for [MH]+ Ct9H3oN706S [484.1978]; Obs. [484.1984]. 
RP-HPLC RT: (A) 15.98 mins. 
Ac-~-MeCys-Pro-D-Ser-His-NH2 
IH NMR (10% 020/90% H20, 282K) o: 8.83 (Ser-NH, 1H, d, 1=7.2 Hz), 8.65 (His-
NH, 1H, d, 1=8.40 Hz), 8.63 (His E, 1H, s), 8.47 (~-MeCys-NH, 1H, d, 1=7.64 Hz), 
7.74 (Amide Cap, s, 1H), 7 .35 (His o, Amide Cap, s, 2H), 4 .73 (~-MeCys a, His a, m, 
2H), 4.48 (Pro a, m, I H), 4.41 (Ser a, m, I H), 3.88 (Pro &, Ser p, m, 2H), 3.80 (Pro 
o, Ser ~. m, 2H), 3.38 (~-MeCys ~.His~. m, 2H), 3.19 (His~. m, 1H), 2.40 (Pro~. m, 
1H), 2.10 (Pro "((2), Acyl Cap, m, 5H), 2.00 (Pro ~. m, 1H), 1.38 (~-MeCys y, 3H, d, 
1=6.8 Hz). 
13C NMR (10% 020/90% H20, 282K) o: 175.1, 174.5, 173.4, 172.4, 168.5, 133.8, 
129.6, 129.1, I26.5, 117.6, 61.4, 61.3, 56.2, 52.8, 50.5, 29.7, 26.3, 25.1, 21.7, 
11.9. 
HRMS : Calc. for [MH]+ C2oH32N706S [498.2134]; Obs. [498.2156]. 
RP-HPLC RT : (A) 21.20 mins. 
Ac-Thr-Pro-D-Ser-His-NH2 
IH NMR (10% 020/90% H20, 282K) o: 8.72 (Ser-NH, 1H, d, 1=6.2 Hz), 8.63 (His E, 
1H, s), 8.55 (His-NH, 1H, d, 1=7.81 Hz), 8.30 (Thr NH, 1H, d, 1=6.2 Hz), 7 .69 
(Amide Cap, s, IH), 7.28 (His o, Amide Cap, s, 2H), 4.71 (His a, m, 1H), 4.57 (Thr 
a, m, 1H), 4.45 (Pro a, m, 1 H), 4.36 (Sera, m, 1 H), 4 .10 (Thr p, m, lH), 3.90 (Pro 
o, m, 1H), 3.85 (Ser ~. m, 1H), 3.77 (Ser ~. m, 1H), 3.70 (Pro o, m, lH), 3.36 (His~. 
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m, 1H), 3.14 (His~. m, 1H), 2.30 (Pro~. m, 1H), 2.03 (Pro y(2), Acyl Cap, m, 5H), 
1.93 (Pro~. m, 1H), 1.22 (Thr y, 3H, d, J=6.8 Hz). 
13C NMR (10% D20/90% H20, 282K) o: 175.7, 175.1, 175.0, 172.8, 171.4, 134.5, 
129.8, 118.4, 70.6, 68.0, 62.0, 58.2, 56.6, 53.5, 49.4, 30.3, 27.2, 25.8, 22.7, 19.9. 
HRMS Calc. for [MH]+ CzoH32N707 [482.2392]; Obs. [482.2363]. 
RP-HPLC RT: (B) 12.38 mins. 
Ac-(al/o)Tbr-Pre>:D-Ser-His-NHz 
lH NMR (10% Dz0/90% H20, 282K) o: 8.64 (His-NH, 1H, d, J=7.6 Hz), 8.60 (His E, 
1H, s), 8.49 (His-NH, 1H, d, J=6.8 Hz), 8.41 (Thr NH, 1H, d, J=8.4 Hz), 7.73 
(Amide Cap, s, 1H), 7.28 (His o, Amide Cap, s, 2H), 4.72 (His a, m, 1H), 4.65 (Thr 
a, m, 1H), 4.47 (Pro a, m, 1H), 4.37 (Sera, m, 1H), 4.04 (Thr p, m, 1H), 3.90 (Pro 
o, m, 1H), 3.80 (Pro o, Ser ~. m, 2H), 3.74 (Ser ~. m, lH), 3.36 (His p, m, IH), 3.14 
(His p, m, lH), 2.30 (Prop, m, lH), 2.03 (Prop, y(2), Acyl Cap, m, 6H), 1.25 (Thr y, 
3H, d, J=6.4 Hz). 
13C NMR (10% 020/90% H20, 282K) o: 207, 206.5, 206.4, 203.6, 202.9, 156.6, 
150.7, 136.7, 78.0, 75.3, 67.2, 62.5, 60.6, 51.8, 28.4, 24.5, 22.4, 18.9, 15.3. 
HRMS : Calc. for [MH]+ C2oH32N707 [482.2363]; Obs. [482.2392] . 
RP-HPLC RT : (A) 13.41 mins. 
Ac-Ser-Pro-D-Ser-His-NH2 
1H NMR (10% D20/90% H20, 287K) o: 8.66 (Ser(i+2)-NH, lH, d, J=7.0 Hz), 8.60 
(His E, 1H, s), 8.58 (His-NH, 1H, d, J=8.96 Hz), 8.39 (Ser(i) NH, IH, d, J=7.0 Hz), 
7 .69 (Amide Cap, s, 1 H), 7.28 (His o, Amide Cap, s, 2H), 4.74 (Ser(i) a, m, IH), 4.71 
(His a, m, 1H), 4.48 (Pro a, m, 1H), 4.36 (Ser(i+2) a, m, 1H), 3.90 (Pro o(2), 
Ser(i,i+2) ~(2), m, 6H), 3.36 (His~. m, 1H), 3. 14 (His~. m, 1H), 2.30 (Pro~. m, 
lH), 2.03 (Pro y(2), Acyl Cap, m, 5H), 1.93 (Pro~. m, 1H). 
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Be NMR (10% 020/90% H20, 282K) o: 207.2, 206.5, 206.4, 203.7, 201.9, 156.5, 
150.8, 136.8, 78.0, 67.4, 66.7, 60.8, 58.4, 56.7, 51.4, 28.3, 24.5, 22.7, 18.9. 
HRMS : Calc. for [MH]+ Ct9H3oN707 [468.2207]; Obs. [468.2181]. 
RP-HPLC RT : (A) 10.80 mins. 
Ac-Ser-Pro-D-Ser-Phe-NH2 
1H NMR (10% 020190% H20, 282K) o: 8.51 (Ser(i+2)-NH, 1H, d, 1=7.7 Hz), 8.42 
(Ser(i) NH, 1H, d, 1=7.7 Hz), 8.39 (Phe-NH, lH, d, 1=6.71 Hz), 7.69 (Amide Cap, s, 
1H), 7.30 (Phe Ring, m 5H), 7.20 (Amide Cap, s, 2H), 4 .74 (Ser(i) a, m, lH), 4.60 
(Phe a, m, lH), 4.47 (Pro a, m, 1H), 4.35 (Ser(i+2) a, m, 1H), 3.86 (Pro o, Ser(i+2) 
13, m, 2H), 3.75 (Pro o, Ser(i,i +2) 13, m, 5H), 3.23 (Phe 13, m, 1H), 3.00 (Phe 13, m, 
lH), 2.30 (Pro~. m, lH), 2.03 (Pro '((2), Acyl Cap, m, 5H), 1.93 (Pro~. m, lH). 
Be NMR (10% 020/90% H20, 282K) o: 208.4, 207.0, 206.5, 202.0, 203.2, 160.5, 
151.4, 150.7, 148.8, 78.0, 67.3, 66.9, 60.4, 59.8, 58.4, 51.4, 37.8, 28.3, 22.7, 18.9. 
HRMS : Calc. for [MH]+ C22H32Ns07 [478.2302]; Obs. [478.2330]. 
RP-HPLC RT : (A) 28.53 mins. 
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Chapter 4. Synthesis of Unnatural Amino Acids with 2,2'-Bipyridine and 
1,10-Phenanthroline Side Chains 
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Introduction 
Protein-bound metal cations play central roles in almost all aspects of cellular 
function. In fact, it has been estimated that over 30% of all enzymes are dependent upon 
metal cations for efficient activity.1 Metal cations have been implicated in the nucleation 
and stabilization of protein supermolecular structure (e.g., zinc fingers 2•3) and have been 
implicated as templates for macromolecular assembly .4 Metal cations have also been 
shown to play active roles in protein function, from electron transfer processes and 
enzymatic catalysis to genetic and metabolic regulation. 5 The ability of metal ions to serve 
both structural and functional roles in metalloproteins has prompted an intense effort in the 
area of de novo protein design to incorporate metal cation binding sites within polypeptide 
frameworks to create new three-dimensional structures with defined structural and 
potentially functional properties. 
In the design of new protein constructs, it has become apparent that the number and 
diversity of the ribosomally-encoded metal binding amino acids is surprisingly limited, 
particularly when compared to the wide variety of synthetic ligands which are available for 
selective complexation of metal ions in aqueous media.6 The majority of metal-binding 
sites found in proteins are constructed from just four functional groups: imidazole 
(histidine), sulfur (cysteine, methionine), side chain carboxylate (aspartate, and glutamate), 
and the main chain carbonyl oxygen.1 Thus, a current emphasis has been to expand the 
repertoire of protein building blocks through the design and construction of unnatural 
metal-binding amino acids that would enhance metal cation selectivities as well as widen the 
range of metal coordination geometries over that which is currently available.7•9 
Multidentate ligands are especially interesting in terms of de novo design, as they 
generally afford high binding affinities and selectivities of metal cations, while 
simultaneously reducing the total number of residues needed to construct a full metal 
coordination sphere. This economy of residues is especially appealing in de novo protein 
designs reliant upon solid phase peptide synthesis for production of the polypeptide chain, 
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since this technique limits the total number of residues that can be employed in the overall 
design ( < 100 residues). Several synthetic amino acids capable of multi-dentate 
coordination have been reponed which are based on the well-known dicarooxylate ligands, 
ethylenediaminetetraacetic acid (EDTA)8 and iminodiacetic acid (IDA).7•9 In one 
documented case, a de novo designed polypeptide which incorporated the IDA-derived 
amino acid demonstrated enhanced helical structure and structural stability upon metal 
cation binding. 9 
Another series of well-studied bidentate ligands are the heteroaromatic 1,10-
phenanthroline and 2,2'-bipyridine ring systems. These ligands have been used 
extensively in a wide range of chemical applications, including supramolecular chemistry 
for the design of metal-directed self-assemblies.10 Lehn and co-workers11 have recently 
designed the so-called "deoxyribonucleohelicates" from a bipyridyl-ether polymer with 
covalently attached deoxyribonucleoside sidechains. These structures self assemble in the 
presence of various metal cations to form a helical core of bipyridyl-metal cation 
complexes. Similar helicate structures have been reported for substituted phenanthroline 
analogs.10 Most recently, the bipyridine ligand has been used in de novo protein design 
of a-helical bundle motifs by two independent research groups.12•13 In both cases, the 
bipyridine ligands were covalently attached to theN-terminus through an amide linker, and 
the modified peptides self-assembled to form three helical bundles upon metal cation 
binding. While these studies demonstrate the potential power of the bipyridyl amino acids 
in de novo design for the development of novel protein motifs, the fact that the ligands 
have only been covalently attached to the amino terminus (or through a pendant side chain) 
puts a severe limitation on the utility and applications of the incorporated ligand. 
A more general and practical approach would be to incorporate these moieties as a-
amino acid derivatives, as this would allow for placement of the ligand anywhere in the 
primary sequence of a synthetic peptide. Toward this goal, the work presented in this 
chapter describes the stereoselective syntheses of a series bipyridyl and phenanthrolyl-
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substituted a.-amino acids, and the subsequent NO.-FMOC amino protection to make them 
suitable for solid phase peptide synthesis. The amino acids, (S)-2-o.-amino-3-(2,2'-
bipyrid-6-yl)propanoic acid (1, See Figure 4-1), (S)-2-o.-amino-3-(2,2'-bipyrid-4-
yl)propanoic acid (2), (S)-2-o.-amino-3-(2,2'-bipyrid-5-yl)propanoic acid (3), and (S)-2-
a.-amino-3-(1, 10-phenanthrol-2-yl)propanoic acid (4) represent the three sterically 
accessible regioisomers of the 2,2'-bipyridine ring system and the ortho-substituted analog 





Figure 4-1. Heteroaromatic metal-chelating amino acids 
The four amino acids provide a complementary set of metal ligands that allow for 
the design of an almost unlimited number of metal binding site geometries with controlled 
binding affinities. The specific regioisomers of the bipyridine ring are known to have 
widely different metal cation binding affinities and metal coordination geometry 
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preferences. It is well known that substitutions in the 6 or 6' positions (as in the bipyridyl-
amino acid 1) have reduced metal binding affinities due to the steric crowding near the 
metal-ligating nitrogen atoms. 14•15 In addition, the substitutions at these positions tend to 
disfavor those metal coordination geometries where steric interactions can become an issue, 
such as square planar or octahedral geometries. The 1,1 0-phenanthroline analog, also 
substituted at the ortho position, would be expected to have similar metal coordination 
propenies; however, the metal-binding affinities of the phenanthroline series are known be 
higher (approximately 10-100 fold) than the corresponding 6-substituted-bipyridine 
ligands. 16 This has been attributed to the reduced conformational flexibility and the rigid 
amine orientation present in the phenanthroline ring system due to the extended aromatic 
ring system. 15 As a result, the phenanthroline substituted amino acid can serve as a 
convenient alternative to the 6-bipyridyl amino acid, when strong metal cation binding and 
sterically constrained metal geometries are desired. 
In contrast, the 4- and 5-substituted bipyridyl amino acids, which contain an 
unobstructed N-N' chelation moiety, are complementary to the 6-bipyridyl and 2-
phenanthrolyl-substituted amino acids. These amino acids are expected to have metal 
binding properties comparable in both metal-cation binding affinities and coordination 
geometry preferences to 2,2'-bipyridine_l6 However, the subtle difference between these 
two amino acids allows for specific control of the ligand orientation with respect to the 
polypeptide backbone. These attributes could be used to "fine-tune" a programmed metal 
binding site to achieve the desired metal binding orientation and geometry within a given 
designed motif. 
In addition to the varied metal cation binding properties, these ligands have several 
other qualities that make them particularly useful in terms of de novo design and peptide 
incorporation. First, since the nitrogen atoms are a constitutive pan of the aromatic ring 
system, the ligands do not contain any nucleophilic functionalities that would interfere with 
peptide synthesis. As a result, the unnatural amino acids (1-4) can be directly incorporated 
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into peptides using solid phase peptide synthesis protocols without side-chain protecting 
group manipulations. Secondly, the heteroaromatic ring systems of 1, 10-phenanthroline 
and 2,2'-bipyridine are stable to a wide variety of synthetic conditions, including those 
used for the cleavage of peptides from solid resin supports after peptide synthesis 
(trifluoroacetic acid, thiol scavengers, etc.). Finally, since the stereospecific attachment of 
the ligands to the amino acid framework is in the S configuration, the amino acids (1-4) are 
compatible with all of the commonly-occurring residues. As a result, these amino acids can 
be used in conjunction with any of the ribosomally-encoded amino acids in the construction 
of homochiral polypeptide sequences. 
Results and Discussion 
Synthesis of (S)-2-Amino-3-(bipyrid-6-yl)-propanoic Acid (6Bpa, 1) 
The stereoselective synthesis of 1 was accomplished by the asymmetric alkylation 
of commercially available N-(diphenyl-methylene)glycine tert-butyl ester (5) with 6-
(bromomethyl)-2,2'-bipyridine17 (6) using the phase transfer catalyst, (8S,9R)-(-)-N-
benzylchinchonidinium chloride (Scheme 4-1) according to the method of O'Donnell et 
a/.18 The alkylation proceeded with modest asymmetric induction, 53% ee in favor of the 
S enantiomer, and affords an 80% chemical yield of pure product, 7 after purification. 19 
Enantiomerically pure material (>99% ee) was obtained, as reported for several other 
derivatives, 18 after crystallization of the racemate from a hexane solution of 
enantiomerically enriched 7 at 0 °C. Quantitative hydrolysis of 7 was then effected by 
refluxing in 6N hydrochloric acid for 4 hr to provide (S)-1 in 40% overall yield from S. 
The enantiomeric excess of the amino acid was evaluated either by lH NMR or HPLC 
analysis of the (R)-( + )-a-methoxy-a-(trifluoromethyl)phenylacetic acid amide (Mosher's 
Amide)20 prepared from the methyl ester of 1. Of the two methods, HPLC provided a 
more accurate, independent measure of the enantiomeric excess, as the NMR analysis was 







































































































































































It should be noted that while the absolute stereochemical outcome of the asymmetric 
alkylation was not determined rigorously, the alkylation products have been found to be 
quite predictable with a wide variety of electrophiles. 18 In addition, the change in the 
direction of the optical rotation of 1 in going to an acidic aqueous solution ([a]o (-) 18.6° 
(c=l, H20, 25°C); [a]o (-) 12.9° (c=l, 5N HCl, 25°C)] is in keeping with the Clough-
Lutz-Jirgenson rule,21 and the two enantiomers follow the predicted order of elution from a 
chiral CrownPak CR (-) HPLC column. (See Experimental section this chapter.) Since this 
amino acid was designed for incorporation into polypeptide sequences using solid phase 
peptide synthesis methods, the corresponding amino acid was converted to the 
corresponding 9-fluorenylmethoxycarbonyl (FMOC) derivative 8 through treatment with 
FMOC-azide in 50% aqueous dioxane containing 5% sodium carbonate (70% yield). 22 
The overall synthetic route provides a convenient method to obtain large scale 
quantities of the amino acid starting from 6-bromomethyl bipyridine. In fact, the most 
difficult aspect of the synthetic route has involved generation of large quantities of the 
bromomethyl-bipyridine derivative 6. The reported route 17 employs a radical initiated 
bromination of the 6-methyl-2,2 '-bipyridine23 with N-bromo-succinimide and benzoyl 
peroxide. This method provided only low yields ( <30%) of the desired bromomethyl 
derivative as the reaction conditions had to be compromised to avoid the competing reaction 
to form the ro,ro-dibromo compound. Subsequent purification of the reaction mixture also 
proved difficult, as the monobromo- and dibromo-methyl derivatives had very similar 
chromatographic properties to the starting material on both silica gel and alumina 
chromatographic supports. However, the recent report of modifications to these 
procedures, as well as an alternative, high-yielding synthetic route employing CBr4 and 
PPh3 holds promise for the facile generation of large scale quantities of the 6-bromomethyl 
derivative.24 
Unfortunately, the synthetic route employed for the 6-bipyridyl-alanine was not 
found to be general for the other regioisomers of the bipyridine amino acids. In particular, 
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attempts to prepare the 4-bipyridine-substituted amino acid through the asymmetric 
alkylation were hindered with problems similar to those found for the 6-bromomethyl-
bipyridine in the preparation and purification of large scale quantities of the starting 
material, 4-bromomethyl-bipyridine. In addition, difficulties were encountered in the 
resolution of the amino acid imine derivative.25 While the asymmetric alkylation of the 4-
bromomethyl bipyridine proceeded smoothly in moderate ee (60%), all attempts to resolve 
the amino acid through selective crystallization of the racemic mixture of protected imine 
failed, making the subsequent resolution of the amino acid impossible. As a result of these 
problems, a number of enantioselective enzymatic hydrolysis reactions were investigated as 
an alternate route to obtain the optically pure 4-bipyridyl-substituted amino acid. 
Enzymatic Resolution of Heteroaromatic Metal-Chelating Amino Acids 
A number of commercially available enzymes have been shown to effectively 
resolve racemic mixtures of both natural and unnatural amino acid derivatives, several of 
which are specific for large hydrophobic sidechains.26 One example, Acylase I isolated 
from Aspergillus, has been shown to be effective in resolving a wide variety of aromatic 
and ~-branched amino acids to near enantiomeric purity.27 Hydrolyses catalyzed by this 
enzyme generally afford near quantitative hydrolysis of the L-amino acid derivative, while 
leaving the corresponding N-acyl D-amino acid derivative intact. Separation of the two 
enantiomers is then accomplished by an extraction of the remaining N-acyl derivatives from 
the reaction mixture under acidic conditions. Unfortunately, attempts to resolve 
enantiomeric mixtures of N-acylated 4-bipyridyl-amino acid using the conditions of 
Chenault, Dahmer, and Whitesides27 were unsuccessful, and no reaction was observed 
even after incubation for several days. This lack of activity could be attributed to the steric 
bulk of the bipyridine ring system; however, since Acylase I is known to be a zinc 
metalloenzyme, it is likely that the strong metal-binding affinities of the bipyridyl ligand 
effectively inhibited the enzyme through chelation of the essential zinc cation. 
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Another enzyme which has been shown to effectively resolve enantiomeric mixtures 
of hydrophobic/aromatic amino acid derivatives is the alkaline protease Subtilisin 
Carlsberg.28 This protease was expected to be ideal for the bipyridyl-substituted amino 
acids since it is not dependent upon metal cations for activity and inspection of the crystal 
structure coordinates29•30 indicated that the substrate binding pocket was compatible with 
the large aromatic side chains of 1-4. Unlike Acylase I, subtilisin was found to be 
extremely selective in the hydrolysis of the 4-bipyridyl-alanine methyl esters. As shown in 
Scheme 4-2, the L-methyl ester was selectively hydrolyzed from the optically impure 
mixture 9 using Subtilisin Carlsberg, using the conditions outlined by Chen et aL28 The 
hydrolysis proceeded smoothly at room temperature and was generally complete within two 
hours to afford the L-amino acid 2 in high optical purity (93% ee). Separation of the two 
enantiomers was accomplished through a simple extraction of the D-amino acid ester 10 
(98% ee) with CHCl3. 
Finally, as our main goal is to incorporate the bipyridyl within a peptide backbone, 
the amino acids were N-protected as the 9-fluorenylmethyl carbamate (FMOC) in 
preparation for solid phase peptide synthesis. Since the enzymatic resolution reactions and 
the Na-FM0C protection steps are run under similar conditions, the crude amino acid from 
the enzymatic resolution was used without further purification31 and was treated with 
FMOC-succinimidyl carbonate32 in 30% aqueous dioxane containing 10% sodium 
carbonate (85% yield based on L-amino acid methyl ester) to form the 9-fluorenylmethyl 
carbamate derivative 11. 
The protease-catalyzed hydrolysis proved to be not only simple and convenient, but 
also allowed for the quantitative retrieval of both amino acid enantiomers in high optical 
purity on preparative scales (>3g). In addition, the enzymatic hydrolysis was found to be 
quite general, as all of the regioisomers of the bipyridine L-amino acid methyl esters, as 
well as the phenanthroline L-amino acid methyl ester, were found to be selectively 







































































































































remained intact. (See below for details.) Finally, the enzyme was found to be robust and 
very stable to a wide variety of reaction conditions, even in the presence of organic 
solvents. Also, even though the commercially available preparation of the enzyme contains 
a mixture of proteases (Subtilisin Carlsberg is the major component), the enzyme catalyzed 
hydrolyses were found to be consistent with different batches of the enzyme preparation. 
Synthesis of2-Amino-3-(2,2'-bipyrid-4-yl)propanoic Acid (4Bpa, 2) 
The efficiency of the enzymatic resolution, coupled with the difficulties encountered 
in the preparation of 4-bromomethyl-bipyridine, prompted a re-evaluation of the synthetic 
route to the 4-bipyridyl-amino acid. Since the enzymatic resolution provided a means to 
quantitatively retrieve the L-enantiomer, it was no longer necessary to follow a 
stereoselective synthetic route. As a result, the synthesis of the 4-bipyridyl amino acid 
ester 9 was accomplished using a synthetic route originally described by Erlenmeyer for the 
generation of racemic, aromatic amino acids.33•34 As shown in Scheme 4-3, oxidation of 
4-methyl-bipyridine35 (12) with selenium dioxide in dioxane afforded the carboxaldehyde 
13 (36%) which was subsequently condensed with hippuric acid 14 in acetic anhydride 
containing one equivalent of sodium acetate at 90°C to form the bipyridyl-azlactone 15 (75 
%). Reduction of the azlactone with red phosphorous and hydriodic acid in acetic 
anhydride, 34 followed by esterification of the amino acid in methanol saturated with 
anhydrous HCl, afforded the racemic methyl ester 9. Subsequent enzymatic resolution of 
the methyl ester as described above yielded the L-amino acid 2 in >93% ee and the D-amino 
acid methyl ester in >98% ee. Conversion of the L-amino acid to the NC'-FMOC derivative 
11 with FMOC-ONSu proceeded smoothly to afford the protected amino acid in high yield 






























































































































































































- N -...I 
128 
Synthesis o/2-Amino-3-(2,2'-bipyrid-5-yl)propanoic Acid (5Bpa, 3) 
Synthesis of the 5-substituted-2,2' -bipyridyl derivative 3 (Scheme 4-4) followed 
the stereoselective route employed for the 6-bipyridyl-substituted amino acid (1, See 
Scheme 4-1 ), the key step involving an asymmetric alkylation of commercially available N-
(diphenyl-methylene)glycine tert-butyl ester (5) with 5-(bromomethyl)-2,2'-bipyridine 
(17) using the phase transfer catalyst, (8S ,9R)-(- )-N-benzy lcinchonidini urn chloride. 18 
The alkylation proceeded with modest asymmetric induction (40-60% ee) with an 85% 
overall yield of the protected amino acid 18. For reasons that are still not fully understood, 
the asymmetric induction was found to be sensitive to preparative scale-up. Upon 
increasing the scale of the reaction above 1 mM in reactants, the asymmetric induction 
dropped precipitously (40-60% to <20%). As a result, when preparative scales were 
performed, the reaction was run in small batches (with reactants <1mM) which were 
subsequently pooled for purification. Recent work in this laboratory has shown that the 
asymmetric induction is dependent upon efficient mixing of the two phases, and high 
enantiomeric excesses have been achieved on preparative scales for related systems. 36 
Rather than attempt to resolve the amino acid-imine derivatives through selective 
crystallization of the racemic mixture, the protected amino acid derivative 18 was 
subsequently hydrolyzed in 6N HCl, followed by esterification of the amino acid in acidic 
methanol afforded the optically enriched methyl ester 19 which was ready for the protease-
catalyzed enzymatic resolution. Alkaline protease catalyzed hydrolysis of the 
enantiomerically enriched methyl ester was found to extremely stereoselective, resulting in 
quantitative retrieval of the L-amino acid 3 in >96%ee. The amino acid was subsequently 
Na-FMOC protected as described for the 4-bipyridyl-amino acid to afford the protected 
amino acid derivative 20 in high yield (85%). 
Unlike the preparations of 4-bromomethyl-bipyridine and 6-bromomethyl-
bipyridine, generation of the 5-bromomethyl bipyridine was relatively facile and could be 
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(17) was accomplished by reduction of the ester 16 to the corresponding alcohol using 
lithium aluminum hydride and subsequent bromination using triphenylphosphine and N-
bromo-succinimide in CH2C12 to afford 5-(bromomethyl)-2,2'-bipyridine (17) in 75% 
yield (over two steps). Preparation of the ester 16 was accomplished in moderate yield 
(50-70% ), on preparative scales (5-1 Og) as reported. 12 
Synthesis of 2 -Amino-3 -( 1 ,10-phenanthro/-2 -yl)propanoic Acid (2F en, 4) 
Synthesis of the 2-substituted-1,1 0-phenanthrolyl amino acid 4 was accomplished 
using a modified version of the Sorenson method37 to prepare racemic amino acids. The 
key step involved alkylation of the glycine equivalent diethyl acetamidomalonate (22) with 
2-chloro-1,10-phenanthroline38 (21) in sodium ethoxide/ethanol solution (Scheme 4-5). 
The alkylation proceeded in a quantitative yield (yield based on diethyl acetamidomalonate) 
and no subsequent purification of the desired alkylated product 23 was required. 
Exhaustive hydrolysis of the racemic material 23 in refluxing 6N HCl, followed by 
esterification of the amino acid in acidic methanol produced the racemic amino acid methyl 
ester 24 ready for enzyme-catalyzed resolution. 
Alkaline protease catalyzed hydrolysis of the 2-phenanthroline-substituted amino 
acid methyl ester 24 was found to be highly stereoselective, as expected from the positive 
results obtained from the bipyridyl substituted amino acid esters (9, 19). However, unlike 
the bipyridyl-amino acid methyl esters (9, 19), the phenanthroline methyl ester 24 was 
only sparingly soluble in the 10% sodium bicarbonate buffer employed for the enzymatic 
hydrolysis. As a result , a number of mixed organic/aqueous solvent conditions were 
screened for enzyme activity and stereoselectivity. It was found that while 10% (v/v) t-
butanol/10% sodium bicarbonate had no effect on the catalytic efficiency or stereoselectivity 
compared to neat buffer, both methanol and dimethylsulfoxide (10% v/v) not only slowed 
the hydrolysis rate by -2 fold, but the stereoselectivity of the enzyme was compromised as 





































































































































































































reaction conditions, the phenanthroline methyl ester enzymatic resolution hydrolysis 
required more units of enzyme (-2 fold more enzyme required) and a shorter reaction time 
(40 min vs. 2h) than had been employed in the corresponding bipyridy1-amino acid 
enantiomeric resolutions to maintain a sufficiently high ee (>93%) of the L-enantiomer 4. 
Subsequent FMOC protection of the L-amino acid 4 proceeded smoothly (65%) with 
FMOC-ONSu to provide the fully-protected phenanthroline amino acid derivative 25. 
Synthesis of the starting material, 2-chloromethyl-1, 10-phenanthroline (21), was 
accomplished through halogenation of 2-hydroxymethyl-1, 1 0-phenanthroline with thionyl 
chloride as described by Engerbersen and co-workers. 38 This method was found to 
proceed smoothly in high yield (>95%) and could be performed on preparative scales 
(>lOg). In addition, all of the steps of the synthetic route to the 2-substituted-
phenanthroline amino acid were found to be amenable to reaction scale-up. As a result, the 
2-phenanthroline amino acid (2Fen) can be prepared readily on a preparative scale with little 
difficulty. 
Conclusions 
In conclusion, the synthetic routes to the four heteroaromatic, metal chelating amino 
acids allow for the facile generation of gram scale quantities in high optical purity, suitable 
for peptide incorporation using solid phase peptide synthesis protocols. The four amino 
acids provide a powerful array of metal ligands, each of which is capable of creating a 
unique metal coordination environment. The accessibility of these amino acid isomers for 
polypeptide synthesis will aid in the de novo design of metalloproteins where correct 
programming of the metal cation selectivity, coordination geometry of the metal center, and 
orientation of the metal with respect to the polypeptide backbone is paramount to success. 
The unique metal binding properties of these ligands, when incorporated into polypeptide 
sequences, is examined in Chapter 5. 
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Experimental 
All reagents were obtained from Aldrich Chemical Co. and used without further 
purification. The enzymes, Acylase I, (Asperigillus melleus, EC 3.5.1.14, 0.45 
units/mg) and Protease Type VIII (Subtilisin Carlsberg, Bacterial, CA#[9014-0l-1], 
11 .6 units/mg) were purchased from Sigma Chern. Co., and stored at 4°C. All 
synthetic intermediates were stored at 4°C after purification. 
Determination of Enantiomeric Purity of Amino Acids 
2-Amino-3-(2.2'-bipyrid-6-yllpropanoic Acid (1) 
The asymmetric induction in the phase transfer catalyzed reaction was determined by 
derivatizing the unprotected amino acid as the methyl ester (by treatment with excess 
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diazomethane) followed by conversion to the Mosher's amide20 (by reaction with 
excess (R)-a-methoxy-a-trifluoromethylphenyl acetyl chloride). Purification of the 
final product was achieved by preparative thin layer chromatography (eluent, 
chlorofonn:methanol, 10: 1 ). HPLC analysis to evaluate the enantiomeric excess of 
crude and recrystallized products was carried out on a DNBPG covalent column, 5mm 
(4.6 x 250 mm) eluent 3% i-PrOH/hexanes, 1.2 ml/min. 
CrownPak CR Column Analysis 
Characterization was obtained through HPLC analysis using a CrownPak CR (-) or a 
CrownPak CR (+)column (J.T. Baker), on an lsco Model 2350 HPLC equipped with 
an Isco Model y4 Absorbance detector using the following conditions: 
2-Amino-3-(2.2'-bipyrid-6-yl)propanoic acids: <Crownpak CR (-))Flow rate 0.9 
mL/min, 25 °C, 285 nm, eluent 12% MeOH/ 1 M HCl04: Amino Acid: L 11.1 
min; D 17.15 min. 
2-Amino-3-(2.2' -bipyrid-4-yl)propanoic acids:(Crownpak CR (+))Flow rate 0.7 
mL/min, 25 °C, 285 nm, eluent 0 .1 M HCl04: Amino Acids: D 8.15 min; L 9.73 
min. 
2-Amino-3-(2.2'-bipyrid-5-yl)propanoic acids :(Crownpak CR (+))Flow rate 0.7 
mL/min, 25 °C, 285 nm, eluent 0.1 M HCl04: Amino Acids: D 9.55 min; L 11.92 
min. 
2-Amino-3-Cl. 10-phenanthrol-2-yl)propanoic acids and methyl esters:(Crownpak 
CR ( + )) Acids: Flow rate 1.0 mL/min, 25 °C, 278 nm, eluent 10% MeOH I 0.1 M 
HCl04: Methyl esters: D 11.50 min, L 12.25 min; Amino Acids: D 7.75 min, L 
8.25 min. 
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N-CDiphenylmethylene)-2-amjno-3-(2.2' -bipyrid-6-yl)propanoic Acid lert-Butyl Ester 
!.7) N-(Diphenylmethylene) glycine tert-butyl ester (5) (1.3g, 4.4 mmol), N-
benzylcinchonidinum chloride (0.31 g, 0.736 mmol), and 6 (0.95g, 3.68 mmol) were 
added to a suspension of 20 mL CH2Cl2 and 7.04 mL 50% aqueous NaOH, and 
stirred vigorously for I hr at room temperature at which time the reaction was complete 
by TLC. The organic phase was separated and the aqueous phase was extracted with 
CH2Cl2 (20 mL). The combined organic phases were concentrated in vacuo. The 
residue was redissolved in ether (40 mL) and water (20 mL). The organic phase was 
separated and washed with water (2 x 10 mL), dried (Na2S04 ), and concentrated to 
afford the crude product. The product was purified by flash chromatography (eluent 
hexane:ethyl acetate, 8:1.5 containing 0.5% triethylamine- addition of the triethylamine 
was found to be necessary in order to avoid decomposition of the acid labile imine 
product on silica) to yield 1.37 g (80%) of pure 7. At this stage, 65 mg of material was 
removed for stereochemical analysis. The product was crystallized from hexane at 4°C. 
The solid product (0.69g) was removed and the filtrate concentrated to afford an oil 
(0.58g). The chemical yield of optically pure material is approximately 40%, mp (DL 
racemate) 90-91 °C, (L) oil; [a]0 25 = (-) 327° (c = 1, EtOAc); lH NMR (CDC13) o:l.46 
(s, 9H), 3.40(dd, IH, J = 9.2 and 13.4 Hz), 3.52 (dd, 1H, J = 4.3 and 13.4 Hz), 
4.63 (dd, 1H, J = 4.3 and 9.2 Hz), 7 .16 (m, 4H), 7.27 (m, 5H), 7.32 (t, 1H, J = 6.1 
Hz), 7.52 (d, 2H, J = 8.1 Hz), 7.65 (t, 1H, J = 7.9 Hz), 7.69 (dd, 1H, J = 1.5 and 
7.6 Hz), 8.09 (d, 1H, J = 7.9 Hz), 8.18 (d, 1 H, J = 7.9 Hz), 8.64 (dd, 1H, J = 1.5 
and 3.5 Hz); l3C NMR (CDCl3) o: 28.0, 41.8, 66.5, 81.1, 118.4, 121.4, 123.4, 
124.4, 127.8, 128.0, 128. 1, 128.7, 130.0, 136.3, 136.5, 136.9, 139.6, 148.9, 
155.4, 156.2 , 158.0, 170.6, 170.9, 203.3. Anal. Calcd for C3oH29N302: C, 77.72; 
H, 6.30; N, 9.06. Found: C, 78.08; H, 6.15; N, 9 .09. 
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2-Amino-3-(2.2' -bipyrid-6-yl)propanoic Acid (1) A suspension of optically pure 7 
(0.5g) was refluxed in 6N HCl (10 mL) for 4 hr. The hydrolyzed reaction mixture was 
then cooled, extracted with ether (3 x 5 mL) and concentrated to dryness. The residual 
material was 1 yophilized several times from water to afford (0. 3 g, 100%) of the amino 
acid hydrochloride 1. mp 220 °C (decomp); [a]0 25 = (-) 18.6° (c = 1, H20; pH 7.0), 
(-} 12.9° (c = 1, 5N HCl); MS (M+) 244; 1H NMR (020) ~: 3.30 (dd, 1H, J = 6.6 and 
12.5 Hz), 3.35 (dd, 1H, J = 5.0 and 12.5 Hz), 4.09 (dd, 1H, J = 5.0 and 6.6 Hz), 
7.29 (d, 1H, J = 7.4 Hz), 7.49 (t, 1H, J = 6.1 Hz), 7.79 (t, 1H, J = 7.6 Hz), 7.82 (t, 
1H, J = 7 .7 Hz), 7.98 (t, 1H, 7.7 Hz), 8.07 (d, 1H, J = 7.9 Hz), 8.50 (d, 1H, J = 4.1 
Hz); 13C NMR (020) o: 37.8, 54.9, 121.7, 123.9, 126. 1, 140.2, 141.5, 148.2, 
154.0, 154.6, 157 .2, 17 4. 1. 
N-(9-Fluorenylmethoxycarbonyl)-2-amino-3-(2.2'-bipyrid-6-yl)propanoic Acid (8) 
A solution of FMOC-azide (0.2615 g, 0.9862 mmol) in 2.80 mL 1,4-dioxane 
was added dropwise with stirring to a solution of 1 (0.24 g, 0.99 mmol) in 2.80 mL 
10% Na2C03JH20 at 0°C, over 2h. The reaction was then allowed to warm to room 
temperature and stirred for 36h. The mixture was diluted with 50 mL distilled H20 and 
extracted 3 times with 30 mL 2:1 ethyl acetate: hexane. The aqueous phase was cooled 
in an ice bath, brought to pH=2 with cone. HCl, and concentrated to 5 mL. The 
suspension was then centrifuged (3000 rpm) for 20 min. The aqueous phase was 
decanted and the solid washed with H20 (2 x 10 mL), centrifuged, and decanted. The 
solid was taken up in MeOH and concentrated in vacuo to yield 0.32g (70%) of white 
powder; [a]0 25 = (-) 61.3° (c = 1, MeOH); HRMS [MH+]: Calcd for C2sH24N304: 
[466.1767]; Obs. [466.1781]; 1H NMR (C0300) o: 3.34 (m, 1H), 3.62 (m, lH), 
4 .02 (t, 1H, J=7.2Hz), 4 .28 (m, 2H), 5.13 (m, 1H), 7.07 (m, lH), 7.20 (t, 1H, 
1=7.4 Hz), 7.26 (m, 1H), 7.32 (t, lH, 1=7.3 Hz), 7.44 (d, lH, 1=7.4 Hz), 7.46 (d, 
1H, 1=7.4 Hz), 7.59 (t, 1H, 1=7.9 Hz), 7.65 (d, lH, 1=7.4 Hz), 7.69 (d, 1H, 1=7.5 
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Hz), 8.00 (t, 1H, 1=5.2 Hz), 8.05 (t,1H, 1=7.8 Hz), 8.28 (d, 1H, 1=7.8 Hz), 8.65 
(d, 1H, 1=7.5 Hz), 8.69 (d, 1H, 1=8.0 Hz), 8.78 (d, 1H, 1=4.9 Hz); Be NMR 
(CD30D) o: 39.7, 39.8, 48.2, 54.0, 67.8, 120.9, 122.1, 125.4, 126.0, 128.0, 128.1, 
128.3, 128.7, 128.8, 128.9 , 140.7, 142.4, 143.4, 144.8, 145.0, 145.1, 146.8, 
148.3, 148.4, 149.3, 158.8, 158.9, 160.0, 160.1, 173.8, 175.1. 
4-Foonyl-2.2'-bipyridine Cl3) A slurry of 4-methyl-2,2'-bipyridine25 (12, 7.68g, 45.1 
mmol), Se02 (7 .5g, 68 mmol), and water (1.2 mL, 67 mmol) in 285 mL dioxane was 
refluxed for 2 hr. After cooling slightly additional Se02 (7.5g) and water (1.2 mL) were 
added and refluxing was continued overnight. The mixture was filtered while still warm 
and the filtrate was dried onto silica gel ( -lOcc). The resulting solid mixture was purified 
using flash column chromotography (eluent : CC4!Et0Ac 2:1) yielding 3.02 g (36%) of a 
cream colored solid: mp 84.8-86.0 °C; HRMS [MH+], calcd. for CuH9N20 [185.0715], 
obsd. [185.0715] ; lH NMR (CDCl3) o: 7.37 (m, 1H), 7 .73 (m, 1H), 7 .86 (m, 1H), 8.44 
(d, 1H), 8.73 (d, 1H), 8.83 (s, 1H), 8.90 (d, 1H), 10.18 (s, 1H); 13C NMR (CDCl3) o: 
120.8, 121.0, 121.2, 124.4, 137.1, 142.6, 149.3, 150.4, 154.8, 158.0, 191.7; IR (thin 
film) cm-1 : 2860, 1704, 1585, 1560, 1458, 1446, 1410, 1388, 1267, 1251, 1231, 1172, 
1094, 1061, 988, 908, 839, 788, 739, 664, 649; UV (MeOH) Amax = 283 (13,500), 236 
(10,900). 
4-[(2.2'-B ipyridy})-4-methylenel-2-phenyl-5( 4H)-oxazolone( 15) 4-formyl- 2,2' -hi pyridine 
(8, 6.86g, 37.2 mmol), hippuric acid (14, 6.86g, 38.3 mmol), and sodium acetate (3.09g, 
37.7 mmol) were slurried in acetic anhydride (70 mL). Upon heating to 90 °C, the mixture 
thickened and more acetic anhydride (28 mL) was added. After stirring at 90 °C for 1 hr, 
the mixture was cooled to room temperature, and the solid was filtered and washed with 12 
mL acetic anhydride. This solid was dried in vacuo yielding 12.6 g of tan solid 
contaminated with sodium acetate. This solid was stirred in 400 mL chloroform and 
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filtered. The filtrate were concentrated in vacuo to yield 9.1 g (75%) of a pale tan solid: 
mp 179.9-180.5 °C; HRMS [MH+], calcd. for C2oH t4N 302 [328.1086], obsd. 
[328.1077]; lH NMR (CDCl3) B: 7.26 (s, 1H), 7.35 (m, 1H), 7.56 (m, 3H), 7.66 (m, 
IH), 7.85 (m, lH), 8.23 (d, 2H), 8.32 (m, lH), 8.42 (m, 1H), 8.74 (m, IH), 8.82 (m, 
1H), 8.85 (s, lH); 13C NMR (CDCJ3) B: 121.4, 123.4, 124.3, 124.8, 125.3, 128.4, 
129.1, 129.3, 134.3, 137.2, 137.3, 141.3, 149.6, 150.1, 155.8, 157.3, 165.6, 166.8; 
IR (thin film) cm-1 : 1803, 1794, 1654, 1560, 1451, 1397, 1325, 1298, 1230, 1202, 
1158, 1112, 1095, 1068, 984, 921, 878, 846, 781, 730, 695, 681, 621; UV (MeOH, nm) 
Amax = 354 (20,500), 278 (19,300), 238 (26,000). 
2-Amino-3-(2.2'-bipyrid-4-yl)propanoic Acid Methyl Ester (9) 
Reductive cleavage of the oxazolone: The oxazolone 15 (3.0 g, 9.2 mmol) and red 
phosphorous (1.84 g, 59.4 mmol) were stirred in acetic anhydride (15 mL). Hydriodic 
acid (47%, 12.8 mL, 70.5 mmol) was added dropwise with stirring over 40 min. After 
refluxing for 3.5 hr the mixture was allowed to cool to room temperature. Unreacted 
phosphorous was removed by filtration and washed with 8 mL acetic acid. The filtrate was 
concentrated under reduced pressure at -50 °C. Water (10 mL) was added and removed. 
Water (15 mL) and ether (15 mL) were added to the residue and shaken until all was 
dissolved. The aqueous layer was isolated and washed with ether (3 x 10 mL) and 
concentrated in vacuo to yield a syrupy residue. 
Esterification of the amino acid: Residual water in the above residue was removed 
by toluene azeotrope. The resulting residue was dissolved in MeOH (39 mL, dried over 
and distilled from CaH2). The solution was cooled to 0°C and hydrogen chloride was 
bubbled through it for -3 min. After standing overnight, the solution was concentrated in 
vacuo. The residue was rubbed with Et20 to yield a solid. This solid was stirred with 
ether for 2 hr, collected by centrifugation, washed with ether, 2 x 25 mL and dried in vacuo 
over KOH. The solid residue (in 1 g portions) was partitioned between chloroform and 
139 
0.4 M NaHC03 (100 rnU100 mL). The organic phase was isolated and the aqueous phase 
was washed with chloroform, 4 x 100 mL. The combined organic phases were dried over 
Na2S04 and concentrated in vacuo to yield 1.81 g (77%) of a yellow oil; HRMS [MH+], 
calcd. for Ct4Ht6N302 [258.1243], obsd. [258.1250]; lH NMR (CDCl3) o: 1.69 (s, br, 
2H), 2.89 (m, 1H), 3.16 (m, 1H), 3.72 (s, 3H), 3.82 (m, 1H), 7.16 (m, 1H), 7 .28 (m, 
1H), 7.79 (m, 1H), 8.27 (s, 1H), 8.37 (d, 1H, 1=8.0 Hz), 8.58 (d, 1H, 1=5.0 Hz), 8.65 
(m, 1H); 13C NMR (CDC13) o: 40.4, 52.0, 55.0, 121.1, 121.6, 123.6, 124.5, 136.8, 
147.5, 148.9, 149.1, 155.8, 156.1, 174.9; IR (thin film) cm-1: 3372, 3308,3057,3006, 
2950, 1736, 1604, 1585, 1556, 1460, 1438, 1401, 1271, 1201, 1177, 1017,992,793, 
746; UV (MeOH, nm) Amax = 282 (13,300), 238 (10,600). 
2-Amino-3-(2,2'-bipyrid-5-yl)propanoic Acid Methyl Ester (19) Toluene (20 mL) was 
added to the amino acid hydrochloride (1 .0 g, 3.2 mmol, 40% ee) and removed under 
reduced pressure. The residue was slurried in dry MeOH (15 mL) and cooled to 0°C. 
Anhydrous hydrogen chloride was passed through the mixture for -3 min. After standing 
at room temperature overnight, the solvent was removed under reduced pressure. MeOH 
(-10 mL) was added and removed. The oily residue was rubbed with Et20 until the 
residue formed a fine powder. This powder was isolated by centrifugation and washed 
twice with Et20 (20 mL). The residual solid was dried under reduced pressure, transferred 
to a separatory funnel and then partitioned between CHCl3 (100 mL) and 0.2 M NaHC03 
(100 mL). The organic phase was isolated and the aqueous phase was washed with CHCl3 
(3 x 100 mL). The combined organic phases were dried over Na2S04 and concentrated in 
vacuo to yield 591 mg (73 %) of an oil which partially solidified upon cooling overnight; 
HRMS [MH+], calcd. for C 14H t6N 302 [258.1250], obsd. [258.1239]; 1 H NMR 
(CDCl3) o: 1.87 (s, br, 2H), 2.70 (m, 1H), 2.86 (m, 1H), 3.46 (s, 3H), 3.54 (m, 1H), 
7.03 (m, 1H), 7.44 (m, 1H), 7 .54 (m, 1H), 8.14 (m, 2H), 8.31 (m, 1H), 8.43 (m, 1H); 
nc NMR (CDCl3) 8: 37 .3, 51.4, 54.8, 120.1, 120.3, 123.0, 132.5, 136.2, 137.1, 
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148.5, 149.3, 154.1, 155.2, 174.3; IR (thin film) cm-1 : 3368, 3052, 3003, 2949, 1736, 
1588, 1573, 1555, 1460, 1436, 1200, 1025, 850, 796, 751; UV (MeOH) Amax = 286 
(17,000), 240 (12,600). 
N-<9-Fluorenylmethoxycarbonyl)-(S)-a-amino-(2.2'-bipyrid-4 and 5-yn-propanoic acids 
(11. 20) and N-(9-Fluorenylmethoxy)carbonyll-CS)-2-amino-3-Cl. 1 0-phenanthrol-2-yll-
propanoic acidC25) 
General method for resolution of enantiomers and isolation of Bipyridyl-substituted L-
amina acids: A solution of the protease (30 mg, 200- 500 units) in 120 mL of 0.2 M 
NaHC03 was added to the amino acid methyl ester (9 or 19, 8 mmol) in a 250 mL 
Erlenmeyer flask. The mixture was rotated at 120-200 rpm on an orbital shaker and 
monitored by HPLC at 20 min. intervals. When the ratio of the D-amino acid methyl ester 
to the L-amino acid methyl ester was >50: 1 (about 2 hours), the mixture was extracted with 
chloroform, 6 x 110 mL. The aqueous phase was reduced in volume to remove any 
chloroform and then lyophilized yielding a mixture of amino acid and carbonate salts. The 
combined organic layers were dried over Na2S04 and the solvent was evaporated. HPLC 
analysis of the aqueous phase generally shows a 92-94% ee of the L-amino acid (2 or 3), 
while analysis of the organic residue generally showed 98% ee of the D-amino acid methyl 
ester. 
Method for Enzymatic Resolution of 2-Phenanthrolyl-substituted amino acid: A 
solution of the racemic methyl ester (24, 3.6587g, 16.0 mmol) was dissolved in 45 mL t-
butanol and added to 445 mL 10% NaHC03. A sample of alkaline protease (125 mg, 800 
- 2000 units) in 120 mL of 0.2 M NaHC03 was added to the amino acid methyl ester (8 
mmol) in a 1L Erlenmeyer flask . The mixture was rotated at 120-200 rpm and monitored 
by HPLC at 20 minute intervals. When the ratio of the D-amino acid methyl ester to the L-
amino acid methyl ester was >50: 1 (about 40 min.), the mixture was extracted with 
chloroform, 6 x 150 mL. The aqueous phase was reduced in volume to remove any 
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chloroform and then lyophilized yielding a mixture of amino acid and carbonate salts. The 
combined organic layers were dried over Na2S04 and the solvent was evaporated. HPLC 
analysis of the aqueous phase generally shows a 92-94% ee of the L-amino acid, while 
analysis of the organic residue generally showed 87% ee of the D-amino acid methyl ester. 
General method for amine protection of the L-amino acid followin~ enzymatic resolution: 
The amino acid/carbonate salt mixtures from above were dissolved in 25 mL of 10% 
Na2C03. 9-Fluorenylmethyl succinimidyl carbonate (1.2 eq) was dissolved in 15 mL 
dioxane and added dropwise to the amino acid solution. The reaction mixture was shaken 
periodically for 1.5 hours and then transferred to a separatory funnel and diluted with 100 
mL water. This mixture was washed with ether, 4 x 60 mL, and transferred to a 250 mL 
Erlenmeyer flask. After cooling to 0°C and adjusting to pH <2 with cone. HCl, the 
precipitate was isolated (by centrifugation if necessary) and washed with water, 3 x 100 
mL. The residue was transferred to a round bottom flask with methanol (-200 mL). The 
methanol was removed under reduced pressure and replaced with toluene ( -80 mL). The 
resulting toluene/water mixture was azeotroped under reduced pressure. The residue was 
rubbed with ether (if necessary) to yield a solid which was dried in vacuo to yield 
approximately 85% (yield based on the amount of L-amino acid methyl ester) of the 
FMOC-protected amino acid. 
N-C9-Fluorenylmethoxycarbonyl)-CS)-2-amino-3-C2.2'-bipyrid-4-yl) propanoic acid Cll) 
mp -167°C dec. (over broad range); HRMS [MH+], calcd. for C2gH24N304 [466.1779], 
obsd. [466.1783]; lH NMR (DMSO-d6) o: 3.03 (m, 1H), 3.24 (m, 1H), 4.15 (m, 3H), 
4.35 (m, 1 H), 7.17 (m, 2H), 7.33 (m, 2H), 7.47 (m, 2H), 7.55 (m, 2H), 7 .81 (d, 2H), 
7 .88 (m, 1H), 7.97 (m, 1H), 8.39 (d, br, 1H), 8.42 (s, 1H), 8.59 (d, br, 1H), 8.66 (d, 
br, 1 H); 13C NMR (DMSO-d6) o: 25.2, 36.0, 46.5, 54.5, 65.6, 120.1, 121.1, 122.0, 
124.7, 125.1, 125.2, 125.4, 127.0, 127.6, 138.0, 140.6, 140.6, 143.6, 143.7, 148.2, 
148.9, 149.9, 153.7, 156.0, 172.7; IR (thin film) cm-1 : 3315, 3060, 2957, 1731, 1715, 
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1706, 1696, 1540, 1449, 1255, 1219, 1182, 1152, 1104, 1079, 1046, 1018, 994, 792, 
758, 737; [aJ28o -4.7° (c = 1, DMSO); UV (MeOH) Amax = 299 (7300), 265 (19,900). 
N -(9-FluorenylmethoxycarbonyD-(S)-2-amino-3-<2.2' -bipyridin-5-yl)propanoic Acid (20) 
mp 117°C dec.; HRMS [MH+], calcd. for C2sH24N304 [466.1767], obsd. [466.1779]; 
lH NMR (DMSO-d6) o: 3.01 (m, 1H), 3.24 (m, 1H), 4.17 (m, 3H), 4.32 (m, 1H), 7.25 
(m, 4H), 7.58 (m, 2H), 7.65 (m, lH), 7.84 (m, 3H), 8.07 (m, lH), 8.18 (m, lH), 8.44 
(d, 1H), 8.49 (d, 1H), 8.70 (s, 1H), 8.75 (d, br, 1H); 13C NMR (CD30D) o: 35.5, 55.7, 
68.0, 120.9, 123.5, 124.0, 126.1, 127.3, 128.1, 128.7, 138.4, 142.4, 142.7, 143.4, 
145.0, 147.2, 148.8, 149.3, 150.6, 158.3, 174.0; IR (thin film) cm-1: 1711, 1531, 1448, 
1246, 1045, 759, 739; [a]26o -1.4° (c = 0.5, MeOH); UV (MeOH, nm) Amax = 299 
(12,500), 288 (16,900), 265 (22,400), 228 (10,700). 
N-(9-FluorenylmethoxycarbonyD-(S)-2-amino-3-C 1.1 0-phenanthrol-2-yl)propanoic Acid 
(25) mp = 187°C (dec.); HRMS [MH]+, calcd. for C3oH24N304 [490.1767]; Obs. 
[490.1749]; TLC (Si02; 4:1 CHC13:Me0H; UV); Rf = 0.55; 1H NMR (DMSO-d6) o: 3.45 
(m, 1H), 3.65 (m, 1H), 4.10 (m, 3H), 4.40 (m, 1H), 4.80 (d, 2H, 1=5.8 Hz), 7.05 (m, 
2H), 7.35 (m, 2H), 7.50 (m, 2H), 7.68 (d, 1H, 1=7.2Hz), 7.80 (d, 1H, J=7.6 Hz), 7.93 
(m, 2H), 8.10 (m, 2H), 8.64 (d, 1 H, 1=8.3Hz), 9.00 (d, 1 H, 1=4.6 Hz), 9.25 (d, 1H, 
1=4.85 Hz); 13C NMR (DMSO-d6) o: 47.5, 55.1, 66.6, 121.0, 124.3, 125.0, 126.0, 
126.1, 127.2, 127.3, 127.4, 128.0, 128.6, 128.8, 129.6, 137.2, 137.6, 141.6, 144.7, 
144.8, 150.9, 159.4, 174.2; IR (mineral oil mull) cm-1 : 3307, 1690, 1601, 1537, 1454, 
1372, 1337, 1261, 1150, 1102, 1078, 1037, 850, 761, 732; (a]250 -67.9° (c = 0.35, 
DMSO); UV (MeOH, nm) "-max = 299 (11 ,000), 268 (32,000), 224 (38,900). 
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5-CBromomethyD-2.2' -Bipyridine (17) To a solution of 5-(ethoxycarbonyl)-2,2'-
bipyridine12 (16, 2.25 g, 9.9 mmol) in anhydrous THF (50 mL) at -78 °C was added 10 
mL (10 mmol) of a 1M solution of lithium aluminum hydride in THF. The reaction 
mixture was allowed to warm to -20°C at which temperature the solution became 
completely homogenous. The reaction was stirred at this temperature for 0.5 hr and then 
cooled back down to -78 °C and quenched slowly with 30 mL I 0% aqueous THF. After 
warming to room temperature, the reaction mixture was stirred with dry Celite for 15 
minutes and then filtered. The solution was then concentrated under reduced pressure to 
afford 1.8 g of 5-(hydroxymethyl)-2,2'-bipyridine as a thick orange oil which was used in 
the subsequent reaction without purification. 
The product from the preceding reaction was dissolved in dichloromethane (40 mL) 
and cooled to 0 °C. To this was added triphenylphosphine (2.75 g, 10.5 mmol) and N-
bromosuccinimide (1.95 g, 11 mmol). After stirring for 0.5 hr, the reaction mixture was 
concentrated to approximately one quarter of the original volume and applied directly to a 
flash silica gel column (eluent: hexanes/diethylether 1:1 ). Concentration of the pure 
fractions provided 1.85g (75% yield over two step) of 5-(bromomethyl)-2,2'-bipyridine as 
a pale yellow solid. mp: 70.8-71.3°C; HRMS [MH+]: Calcd for C 11H9N2Br: [247.9949]; 
Obs. [247.9952]; lH NMR (CDCl3) o: 4.52 (s, 2H); 7 .29 (dd, IH, J = 4.8, 7.4 Hz); 
7.83 (m, 2H); 8.39 (d, 2H, J = 8.1 Hz); 8.67 (d, 2H, J = 2.3 Hz); 13C NMR (CDCl3) o: 
29.9, 121.2, 121.5, 124.2, 133.9, 137.2, 137.8, 149.4, 149.5, 155.7, 156.2; IR (thin 
film) cm-1 : 610, 650, 750, 798, 834, 858, 992, 1025, 1039, 1061, 1127, 1203, 1253, 
1392, 1434, 1461, 1556, 1574, 1597, 1713, 2967, 3050; UV: (MeOH, nm) Amax = 289 
(26,700), 244 (18,600). 
N-CDiphenylmethylene)-2-amino-3-(2.2 '-bipyrid-5-yl)propanoic Acid cere-Butyl Ester (18) 
A solution of N-(diphenylmethylene)glycine tert-butyl ester (5) (150 mg, 0.5 mmol) and 
(8S,9R)-(-)-N-benzylcinchonidinium chloride (21 mg, 0.05 mmol) was dissolved in 
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dichloromethane (1 0 mL) and cooled to 0 °C. To this was added 0.8 mL 50% aqueous 
sodium hydroxide and 5-(bromomethyl)-2,2'-bipyridine (17, 160 mg, 0.64 mmol) in 
solution in dichloromethane (2 mL). The reaction mixture was then stirred at 0 °C for 24 h. 
At this time the organic phase was separated and the remaining aqueous phase washed with 
an additional aliquot (5 mL) of dichloromethane. The pooled organic phases were then 
concentrated under reduced pressure and purified by flash chromatography (eluent 
hexane/ethylacetate 5:1 containing 0.5% triethylamine) to afford 200 mg (85% yield) of 
pure product. The optical purity of the product was determined to be 55% ee. HRMS 
[MH+] : Calcd for C3oH3oN302N : [464.2338]; Obs. [464.2333]; 1H NMR (CDCl3) o: 
1.45 (s, 9H); 3.26 (m, 2H); 4 .19 (dd, 1H, J = 5.34, 8.09 Hz); 6.78 (d, 2H, J = 6.64 Hz); 
7 .2-7.6 (m, 9H); 7.77 (t, 1H, J = 7.9 Hz); 8.23 (d, 1H, J = 8.1 Hz); 8.31 (d, 1H, J = 8.0 
Hz); 8.42 (d, lH, J = 9.5 Hz); 8.64 (d, 1H, J = 4.1 Hz); 13C NMR (CDCl3) o: 28.3, 
36.9, 67.4, 81.7, 120.7, 121.2, 123.7, 127.7, 128.3, 128.5, 128.7, 129.0, 130.6, 
134.4, 136.4, 137.1, 138.5, 139.4, 149.3, 150.6, 154.4, 170.6, 171.1 ; IR (thin film) em· 
1 : 650, 668, 696, 751, 849, 1029, 1150, 1220, 1253, 1288, 1368, 1392, 1458, 1558, 
1575, 1589, 1622, 1732, 2933, 2977, 3056; UV: (MeOH, nm) Amax = 243 (18,900); 285 
(18,050). 
2 -Amino-3-(2.2'-bipyrid-5-yll -propionic Acid !.19) A suspension of pure N-
(dipheny1methylene)-2-amino-(2,2'-bipyridin-5-yl)propanoic acid tert-butyl ester (18, 
1.2g, 2.6 mmol) was refluxed in 6N hydrochloric acid (30 mL) for 4h. The hydrolyzed 
reaction mixture was then cooled, extracted with ether, (3 x 15 mL), and concentrated to 
dryness. The residual material was lyophilized several times from water to afford 0.72g 
(100%) of the amino acid hydrochloride: mp : 153 °C (dec.); HRMS [MH+] : Calcd for 
C13H13N302 : [244.1086] ; Obs. [244.1098]; lH NMR (D20) o: 3.33 (t, 2H, J =7Hz); 
4.37 (t, 1H, J = 6.8 Hz); 7.86 (t, 1H, J = 6.8 Hz); 7.86 (t, 1H, J = 5.8 Hz); 8.08 (d, 1H, 
J = 7 Hz); 8.15 (d, 1 H, J = 8.15 Hz); 8.3-8.5 (m, 2H); 8.61 (s, 1 H); 8.66 (d, 1 H, J = 5.6 
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Hz); Be NMR (D20) o: 32.9, 53.4, 123.5, 124.5, 127.6, 134.7, 141.6, 143.2, 145.8, 
146.8, 147.2, 149.8, 170.6; UV: (H20, nm) Amax = 238 (8440); 287 (9960). 
2-Acetamido-2-ethoxycarbonyl-3-( 1.1 0-phenanthrol-2-yl)propanoic Acid Ethyl Ester (23) : 
A ponion of diethyl acetamidomalonate (22, 0.6074 g, 2.80 mmol) was added to a 
solution of sodium (0.0641 g, 2.80 mmol) in 3 mL absolute ethanol and stirred for 30 min. 
A solution of 2-chloromethyl-1,10-phenanthroline38 (21, 0.6710g, 2.93 mmol) in 3 mL 
absolute ethanol was added dropwise to the mixture. After 8 hr at reflux, the mixture was 
cooled, concentrated to a thick red oil, and suspended in water (50 mL), and extracted with 
CHCl3 (3 x 50 mL). The organic fractions were washed with 50 mL each of water, 10% 
Na2C03, and brine, dried over NazS04, and concentrated to an oily red solid. The crude 
product was judged to be >95% pure by TLC and NMR and was taken on to the next step 
without funher purification. An analytical sample was purified using a shon neutral Al203 
column (2: 1 CH2Ciz:EtOAc) to yield a pale yellow solid; mp: 112.4-113.2°C; TLC (AlzOJ; 
2 :1 CH2Clz:EtoAc, UV detection) Rr = 0.43; HRMS Calc. for [MH+] C22H24N 305 
[410.1715]; Obs. [410.1694]; lH NMR (CD30D) o: 1.20 (m, 6H), 2.01 (s, 3H), 4.10 (s, 
2H), 4.24 (m, 4H), 7.62 (d, 2H, 1=8.3Hz), 7.92 (m, 2H), 8.01 (d, 2H, 1=1.8 Hz), 8.42 
(d, 2H, 1=8.3 Hz), 8.70 (d, 2H, 1=8.2 Hz), 9.15 (d, 2H, 1=3.1 Hz); Be NMR (CD30D) 
o: 13.4, 21.5, 41.3, 62.9, 124.2, 125.9, 126.3, 127.8, 137.5, 140.1, 148.2, 171.9, 
175.9; IR (thin film) cm-1 : 3377, 3268, 1660, 1507, 1484, 1396, 1366, 1290, 1202, 
1090, 1055, 1014, 855. 
Racemic 2-amino-3-(1,10-phenanthrol-2-yl)propanoic Acid Methyl Ester (24) : A 
solution of 23 (1.1463 g, 2.8 mmol) in 100 mL 6N HCI was heated to 90 °C with 
stirring for 10 hr. The reaction was cooled and concentrated in vacuo to a thick red oil. 
The oil was then resuspended in water (50 mL) and concentrated in vacuo twice to 
remove excess HCI, after which the residue was dissolved in 20 mL water and brought 
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to pH=9.5 with concentrated NaOH solution. The mixture was then washed with 
CHCl3 (3 x 50 mL) and concentrated in vacuo to yield a white solid. The mixture of 
amino acid and sodium salts was dried over P20s under vacuum overnight. The solid 
mixture was then suspended in 50 ml of freshly distilled MeOH, and anhydrous HCl 
was passed through the mixture for 10 min. After stirring overnight the reaction was 
complete by chiral-HPLC analysis, the solid suspension was concentrated in vacuo. 
The solid was resuspended in MeOH (100 mL) and concentrated in vacuo twice to 
remove excess acid. The solid residue was carefully neutralized with saturated Na2C03 
and extracted with CHCl3 (3 x 50mL). The organic fractions were combined, dried 
over Na2S04, and concentrated to yield a yellow oil (0.5337 g, 83%). HRMS :Calc. 
for [MH]+ C1sH14N302 [268. 1086]; Obs. [268.1101]; lH NMR (CDCI3) o: 3.43 (m, 
lH), 3.72 (m, 4H), 4.26 (m, IH), 7.53 (m, 2H), 7.67 (s, 2H), 8.08 (d, lH, 1=8.1 
Hz), 8.15 (d, 1H, 1=8.0 Hz), 9.08 (d, IH, 1=3.8 Hz); 13C NMR (CD30D) o: 43.8, 
52.8, 55.3, 119.5, 123.4, 124.3, 126.6 , 126.9, 127.8, 129.3, 136.5, 137.0, 146.3, 
150.7, 159.1, 175.6; IR (thin film) cm-1 : 855, 1015, 1139, 1206, 1277, 1394, 1454, 
1494, 1506, 1556, 1590, 1732, 2944, 3373. 
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Chapter 5. Characterization of the Metal-Binding Properties of Peptides 




The design of metalloproteins requires a combined knowledge of the factors that 
contribute to the stabilization of protein structure and those that govern effective metal 
ligation and coordination geometry preferences. This is especially pertinent in the 
construction of catalytic metal centers, as the metal binding sites in these proteins are often 
characterized by distorted geometries which are dictated by the overall protein structure.1•2 
Even in the more simple structural metal binding sites, where the metal cation can assume a 
thermodynamically stable coordination geometry, the choice and orientation of the metal 
ligating groups must be carefully controlled to promote effective metal cation binding. 1•3 
Factors such as the size of the metal cation, the polarizabilities of the ligands and metal 
cation, and the relative spatial distribution of the ligating groups all play important roles in 
metal binding and are primarily responsible for the remarkable metal cation selectivities that 
are observed in naturally-occurring metalloproteins.4 The functional groups commonly 
found in the metal-binding sites of native proteins is largely limited to just four classes; 
imidazole, thiol, carboxylate, and main chain carbonyl. Despite this limitation, a wide 
variety of complex structures constructed from these moieties are known and the binding 
properties of each of these functional groups has been studied in detail. 5-8 
In an effort to expand the repertoire of metal binding ligands available for 
metalloprotein design, a series of novel, metal-cation binding amino acids based on the 
well-known bipyridine and phenanthroline ligands were prepared (see Chapter 4). These 
ligands were anticipated to be complementary to the ribosomally encoded metal-binding 
amino acids due to the bidentate N-N' ligating atoms and the electronic 7t-accepting 
properties of the heteroaromatic ring systems.9 In addition to providing enantiomerically 
pure products, the synthetic routes included steps to afford suitable NU-protection for 
incorporation into larger peptide sequences using solid phase peptide synthesis. The focus 
of this chapter. is to examine the overall metal binding properties of these ligands when they 
are incorporated into polypeptide sequences. The studies described herein provide a survey 
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of the overall binding properties of these novel ligands and establish a foundation for the 
assembly of larger, functional metalloprotein constructs. As mentioned in Chapter 4, the 
four amino acids (1-4) are expected to have widely different metal binding affinities and 
coordination geometry preferences. For example, the two amino acids with substitutions 
ortho to the chelating nitrogen atoms, 2Fen and 6Bpa, are expected to have reduced binding 
affinities and more restricted coordination geometries than the 4- and 5-substituted 
bipyridine amino acids which have unobstructed N-N' chelation moieties.9·10 In order to 
delineate these effects, a variety of peptides were synthesized which incorporate these 
amino acids and the relative metal-binding properties were analyzed using UVNis 
absorption and circular dichroism spectroscopies. 
The first set of peptides (1-4) was designed to measure the relative binding 
affinities of each of the respective ligands when incorporated into a polypeptide backbone 
in the absence of any other strong metal binding ligands, as well as provide a means to 
determine the relative propensity for these ligands to undergo intermolecular metal cation 
ligation. 
Ac-Xaa-Thr-Pro-D-Aia- Vai-Phe-NH2 




The primary sequence includes a central Pro-D-amino acid dipeptide core, which is 
known to induce f3-turn formation (see Chapter 2). The central tetrapeptide, Thr-Pro-D-
Ala-Val has been conformationally analyzed in this lab, 11 and it was found to have a limited 
amount of Type II reverse turn character in aqueous solution. This sequence was used to 
induce a moderate amount of steric bulk near the metal binding ligand to more fully mimic a 
larger protein structure. In addition, the same tetrapeptide sequence was used in the design 
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of a peptide predicted to have enhanced intramolecular metal binding capabilities; Ac-6Bpa-
Thr-Pro-D-Ala-Val-6Bpa-NH2 (5). Since the two bipyridyl-amino acids are juxtaposed on 
either side of the turn sequence, it was anticipated that the two ligands would be brought 
into close proximity and therefore provide a chelating effect. These effects were 
investigated further with another set of peptides, Ac-2Fen-Thr-Pro-D-Ala-Val-His-NH2 
(6), Ac-2Fen-Val-Pro-D-Ser-Phe-His-NH2 (7), and Ac-6Bpa-Thr-Pro-D-Ala-Val-His-
NH2 (8) which incorporate either 2Fen or 6Bpa in conjunction with a histidine residue. 
Peptide 6, like the bis(6Bpa)-peptide 5, was designed to investigate the ability of histidine 
to participate in intramolecular coordination of metal cations with the 2-phenanthrolyl-
amino acid. Further, the effect of the central tetrapeptide sequence on the ability to induce 
intramolecular coordination was examined with peptide 7, as the central tetrapeptide 
sequence, Val-Pro-D-Ser-Phe, has been shown to exhibit a significant Type II reverse turn 
character in solution (see Chapter 2). As a result, it was anticipated that peptide 7 would 
have enhanced metal binding properties in comparison with peptide 6. Finally, in order to 
test the relative binding properties of the similarly substituted 6Bpa and 2Fen in a 
multifunctional peptide, Ac-6Bpa-Val-Pro-D-Ser-His-NH2 (8) was also synthesized and 
investigated. 
A wide range of analytical methods have been employed to study the metal binding 
properties of the bipyridine and phenanthroline ligand series. The most popular method is 
based upon differences between the solubility properties of the metal complexes relative to 
that of the free ligand. 12 The technique relies upon partitioning of the ligand and metal-
ligand complexes in a biphasic system and the stepwise formation constants are calculated 
from the relative concentrations of the metal-bound components found in each phase. This 
method was not employed for the peptide models described above, as these systems were 
expected to remain soluble in an aqueous environment regardless of the coordination state 
of the bipyridine or phenanthroline ligand. Alternatively, potentiometry is a popular 
method for the determination metal-cation binding affinities for peptidyl systems.13 
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Unfortunately, this technique has been shown to produce inaccurate results for systems 
containing bipyridine and phenanthroline. 12 This inaccuracy has been attributed to the 
large differential between the ligand pKa and the respective metal cation equilibrium 
constants. Apparently the proton cannot effectively compete for the bipyridyl- or 
phenanthrolyl-nitrogen atoms in the presence of metal cations, even under low pH 
conditions. Finally, UV /Vis absorption spectroscopy has been used to determine the 
binding affinities of both bipyridine and phenanthroline metal cation complexes. 14•15 It is 
well known that the bipyridine ligands undergo a significant red-shift in the 1t-1t* transition 
( == 10-15 nm depending upon the metal cation) upon metal binding, and a similar, but 
smaller, effect is observed in the phenanthroline ligand series. These characteristic shifts 
provide a means to quantify the unbound and bound states of the ligand directly. 12 This 
technique is ideally suited for the peptide systems developed in this chapter, as it provides a 
sensitive, convenient method to determine the metal binding affinities of the peptides under 
physiological conditions. 
In addition to providing a method for determining the binding affinities of the 
complexes, absorption spectra of some metal complexes may provide information about the 
coordination sphere geometry. Complexes with Co+2 can give rise to distinctive 
absorptions in the visible and near IR regions due to transitions in the metal d-d 
orbitals. 16· 17 Since these transitions are highly dependent upon the ligand field 
arrangement about the metal cation, both the wavelengths of the absorptions and the relative 
molar absorbtivities of the transitions can be used to evaluate the metal-coordination 
environment. Indeed, for many Co+2 complexes it is generally possible to tentatively 
assign both the ligand geometries (tetrahedral, penta-coordinate, octahedral) as well as the 
ligand composition (N3S, N2S2, etc.), by inspection of the visible wavelength regions of 
absorption spectra. 16 These transitions have been proved to be invaluable in the 
characterization of a wide variety of metalloprotein metal-binding site environments, 
including carbonic anhydrase, 18 the protein hormone insulin, 19 and the "zinc-fingers. "20 
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Circular dichroism spectroscopy provides an additional measure of the metal 
binding properties of the peptide-metal complexes. Since the process of metal cation 
binding is likely to affect the overall structure of the peptide, measurable changes in the CD 
spectra would be expected for the peptide backbone upon metal cation binding. In 
addition, the relative disposition of ligand moieties around the metal cation center may 
provide a chiral environment with measurable Cotton effects. These effects are often used 
to distinguish A and L\ enantiomers of symmetrical metal-cation complexes.21 As a result, 
CD can be used both as an alternative method for monitoring the progress of a metal cation 
titration, as well as a sensitive probe of the overall peptide-metal complex structure. For 
the peptides studied in this chapter, the CD spectra of the peptide:metal cation complexes 
provide a basis for comparison of the effects of various metal cations on the overall 
complex structure for a given peptide sequence, and within a series of peptides, the effects 
of metal cation binding can be delineated from the structural perturbations arising from 
changes in the peptide sequence. 
Results and Discussion 
Peptide Synthesis 
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The heteroaromatic, metal binding amino acids (1-4, See Figure 4-1) readily 
undergo peptide incorporation using N<X-FMOC protection-based solid phase peptide 
synthesis strategies and BOP/HOBt activated ester mediated couplings (See Experimental 
section of this chapter). While the amino acids were incorporated into a variety of peptides 
using the standard acylation and deprotection protocols, better coupling efficiencies were 
achieved when the amino acid activated ester solutions were prepared and filtered just prior 
to use and injected manually into the column containing the solid-phase resin. In addition, 
a double coupling protocol was used for all four of the amino acids to ensure that high 
coupling efficiencies were realized. In a typical amino acid coupling, 2.5 equivalents of the 
amino acid activated ester were loaded onto the column for a 1hr acylation period, after 
which a fresh sample of activated ester (1.5 equivalents) was applied for another 1hr. 
acylation period. Peptides synthesized using these protocols exhibited near quantitative 
coupling of the amino acids(> 95%, as determined by RP-HPLC and lH-NMR spectra of 
the cleaved peptides) regardless of position of the amino acid in the peptide primary 
sequence. 
The resulting peptides were found to be quite stable to both the TFA cleavage 
conditions and subsequent workup and purification steps. While many of the peptides 
were sufficiently pure for analysis after synthesis, impure peptides were further purified 
using either semi-preparative RP-HPLC or P2 gel filtration chromatography. Due to the 
high metal cation binding affinities of 4Bpa and 5Bpa, peptides containing these amino 
acids were handled with great care to avoid metal contamination; doubly-distilled, de-
ionized water and polypropylene or Teflon labware was used for all peptide manipulations. 
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Metal-Binding Properties of Peptides With the General Sequence: 
Ac-Xaa-Thr-Pro-D-Aia-Vai-Phe-NH2 (Peptides 1-4) 
Metal cation titrations were performed on each of the four peptides, 1-4 with 
ZnCl2, CoCl2, and CuCl2 metal salts. As can be seen in Figure 5-la, the peptides 
containing bipyridyl-amino acids show an absorption at 285 nm due to the 7t-7t* transition 
of the bipyridyl moiety. A similar absorption is observed for the peptide containing the 
phenanthroline amino acid at 268 nm as shown in Figure 5-1 b. Upon addition of metal 
cations, these absorptions decrease intensity with the concomitant appearance of new 
absorptions at ==240 nm and ==31 0 nm for the bipyridyl-containing peptides and ::::280 nm 
and ==300 nm for the phenanthrolyl-containing peptides. The fact that clearly defined 
isosbestic points were observed upon addition of metal cations to the peptide solutions, 
regardless of the metal cation or the particular peptide, suggests that the transformations 
follow a two state equilibrium mode1.22 As a result, the metal binding affinities and 
respective stoichiometry of the metal-cation:peptide complexes can be obtained directly 
from binding isotherms extracted from the absorption spectra. 22 
Binding isotherms were analyzed at those wavelengths that exhibited the largest 
change in absorption upon metal cation addition and data from a typical titration are shown 
in Figure 5-2a-b. The metal-cation binding process follows a square hyperbola relation as 
expected for a two-state binding process.22 Calculation of the binding constants was 
performed through fitting isotherms collected from a series of wavelengths to the y-
reciprocal form of the square hyperbola (Scott equation, see Experimental section of this 
chapter); sample plots are shown in Figure 5-3a-b. The stoichiometries of the metal:peptide 
complexes were determined directly from binding isotherms collected under saturating 
conditions ([Pep] >> K d) by evaluation of the number of equivalents of metal cations 
(based on the concentration of peptide) needed to reach saturation. The overall results from 
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Figure 5-l. (A) Absorption spectra of the titration of 1 (52 J..LM) with ZnCh, (pH=6.8-
7.0, 0.2M NaCI, 25° C; ZnCI2 was added in 10 J..LM increments); (B) 
Absorption spectra of the titration of 4 (14 J..LM) with ZnCI2, (pH=6.8-7 .0, 
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Figure S-2. (A) Binding isotherm from the titration of 1 (52 ~M) with ZnCl2 (data taken 
at 306 nm); (B) Binding isotherm from the titration of 4 (14 J.l.M) with 






















0 50 100 








--a-- 300 nm 
200 250 
[Zn(ll)) I ~M 
o 276 nm 
D 296 nm 
lJ. 244 nm 
1.2 
[Zn(ll))/ mM 
Figure S-3. (A) y-Reciprocal plot of data from titration of 1 (52 11M) with ZnCh; (B) y-
Reciprocal plot of data from the titration of 4 (14 ~M) with ZnCh. 
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Table 5-l. Dissociation Constants and Metal Complex Stoichiometries for Bipyridyl-




Metal 4Bpa (1) 
Cation 
5Bpa (2) 6Bpa (3) 2Fen (4) 
Zn+2 2.2 ± 0.2 X IQ-5 1.9 ± 0.3 X IQ-5 2.7 ± 0.3 X IQ-3 2.6 ± 0.3 X IQ-4 
(1 :1) (1 :1) (1: 1)b (1:1) 
Co+2 3.8 ± 0.4 X IQ-6 4 .0 ± 0.6 X 10-6 1.1 ± 0.1 X IQ-3 1.1 ± 0.4 X IQ-5 
(2:1)G (2:1)G (1 : 1)b (1: 1) 
Cu+2 < 1 x IQ-8c < 1 x IQ-8c 0.8 ± 0.2 X 10-7 < 1 x IQ-8c 
(1 :1) (1: 1) (1 :1) (1 :1) 
a The binding constants were calculated assuming a 1:1 relationship between the metal 
cation and the peptide; these binding constants represent the overall dissociation Kd = 
[M(II)][2L]2 I [M(II)L2] . bMetal complex stoichiometry was assumed to be 1:1.23 c The 
sensitivity of the UV method limited assessment at lower concentrations. 
The dissociation constants for the peptides vary over 5 orders of magnitude, 
depending the particular unnatural amino acid and the nature of the metal cation. In all 
cases, the tightest binding is observed with Cu+2 and the weakest for Zn+2. The relative 
affinities for the metal cations follow that predicted by the Irving-Williams order of 
stabilities as expected from the similar trends observed in the parent 2,2'-bipyridine and 
1,1 0-phenanthroline ligands as shown in Table 5-2.24 However, the absolute magnitudes 
of the binding affinities are smaller than that observed with the parent ligands, particularly 
in the cases where the substitutions are ortho to the chelating nitrogen atoms, 6Bpa (3) and 
2Fen (4). The diminished affinities for 3 and 4 is due in part to the steric hindrance of the 
substitution near the nitrogen atoms;9•10 however, the lower overall affinities observed for 
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the peptides are probably the result of steric interactions arising from the polypeptide chain. 
The higher affinities of the 2Fen peptide (4) relative to the 6Bpa peptide (3) are consistent 
with the parent ligands (see Table 5-2), and these effects have been attributed to the more 
rigid structure of the 1, 10-phenanthroline ring system.9 The selectivity of the metal cations 
by the various peptides complements that reported for the polypeptide constructs containing 
unnatural oxygen-containing bidentate ligands (IDA and EDTA)25·26 or the "zinc-finger" 
proteins (KdZn = 2.8 ± 0.9 X w-9 M).20 
Table 5-2. Dissociation Constants for Several Bipyridine and Phenanthroline Ligands0 
Kd,M 
Metal Cation 2,2'-Bipyridine 1,1 0-Phenanthroline 2-MePhenb 
Zn+2 7.4 X lQ-6 4.0x I0-7 1.1 x w-5 
Co+2 1.6 X lQ-6 8.3 x w-8 7.9 X 10-6 
Cd+2 6.6 X lQ-5 1.6 X lQ-6 7.1 X 1Q-6 
Ni+2 9.1 X lQ-8 2.5 X 10-9 1.1 X 10-6 
Cu+2 4.7 X 10-7 4.0 X 10-8 4.0 X 10-8 
avalues are based on the first dissociation step; Kd = [M(II)][L] I [M(II)L].24 b2-MePhen 
= 2-Methyl-1, 10-phenanthroline 
All of the metal cations, with the exception of Co+2, form 1:1 complexes with the 
peptides 1 and 2. The Co+2 complexes for these peptides have 2: I peptide:metal cation 
stoichiometry; the tendency to undergo intermolecular metal binding for these complexes 
can be attributed to the unobstructed N-N' chelation moieties which can assemble around 
the metal center efficiently. In fact, it is surprising that the intermolecular aggregation did 
not result in a 3:1 peptide: metal complex, as the Co(Bpy)3 species readily forms when 
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excess 2,2'-bipyridine is incubated with Co+2 cations.27 The lower stoichiometries 
observed for these peptides, as well as that exhibited by all of the peptide:metal complexes 
is most likely due to the steric bulk introduced by the polypeptide backbone; evidently the 
peptide chain restricts the metal coordination from forming higher order supermolecular 
structures. While these peptides provide useful information about the relative propensity 
for the peptides to undergo intermolecular metal coordination, it is not possible to evaluate 
the potential for intrapeptide ligation with these systems. These effects were studied with 
peptide 5, which contains two bipyridyl-ligands in the primary sequence. 
Metal-Binding Properties of Ac-6Bpa-Thr-Pro-D-Ala-Val-6Bpa-NH2 (5) 
The metal binding affinities of peptide 5 were measured using UV Nis absorption 
spectroscopy as described above. The calculated metal binding constants, as shown in 
Table 5-3, were found to be at least an order of magnitude higher than the corresponding 
control peptide 3. In addition, the metal-binding stoichiometries of the metal complexes 
were found to be 1:1 peptide/metal-cation for peptide 5; this metal cation complex 
stoichiometry would not be expected if the bipyridine ligands acted independently. These 
observations, coupled with the fact that the peptide exhibited well-defined isosbestic points 
over the entire course of the titrations for all of the metal cations studied, strongly suggests 
that both bipyridyl ligands in the peptide sequence act cooperatively to ligate the metal-
cation. 
These conclusions are supported by metal titrations monitored with circular 
dichroism spectroscopy. Comparison of the circular dichroism titration studies for 3 and 5 
with Cu+2 cations (see Figure 5-4a-b) demonstrates that the two complexes are quite 
distinct. The complex associated with peptide 5 exhibits an intense, positive ellipticity at 
315 nm (Figure 5-4a) which is attributed to the bipyridyl chromophore. In contrast, the 
CD spectra for the control peptide (3, Figure 5-4b) shows only weak and broad ellipticities 
in this wavelength range (310-330nm). These spectra indicate that the Cu+2 cation induces 
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Table 5-3. Dissociation Constants and Metal Complex Stoichiometries for 6Bpa-




Metal Cation 6B_Qa (5) Phe (3) 
zn+2 9.6 ± 0.6 X J0-4 2.7 ± 0.3 X IQ-3 
(1: 1) (1 :1) 
Co+2 1.1 ± 0.2 X J0-4 1.1 ±0.1 X IQ-3 
(1 :1) (1:1) 
cd+2 1.1 ± 0.2 X J0-4 4.3 ± 0.3 X IQ-3 
(1: 1) (1: 1) 
Ni+2 J.} ± 0.2 X IQ-6 5.0 ± 0.5 X I0-5 
(1 :1) (1 :1) 
cu+2 < 1.0 X 10-8 0.8 ± 0.2 X IQ-7 
(1 : 1) (1: I) 
the formation of a chiral complex involving both bipyridyl ligands of peptide 5 . A 
schematic of the peptide complex is shown in Figure 5-5. 
The corresponding Co+2:peptide 5 complex was analyzed by visible absorption 
spectroscopy. As shown in Figure 5-6a, addition of Co+2 to the peptide is accompanied 
by a weak absorption at 450 nm (£max < 100), which is suggestive of a five-coordinate 
complex.18 Interestingly, however, the Co+2:peptide 5 complex did not show any 
evidence for chiral complex in the circular dichroism spectra (see Figure 5-6b); indeed, the 
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Figure S-4. (A) Circular dichroism spectra of the titration of 5 (40 jl.M) with CuCl2, 
(pH=6.6, 0.2M NaCI, 25° C, CuCl2 was added in 7.5 jl.M increments); (B) 
Circular dichroism spectra of the titration of 3 (40 jl.M) with CuCl2 
(pH=6.6, 0.2M NaCl, 25° C, CuCl2 was added in 7.5jl.M increments). 
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Figure 5-5. Schematic of the Cu(II) :peptide 5 complex. (No indication of the 
coordination geometry is intended.) 
However, the other regions of the CD spectra (200-280 nm) for the Co+2 complex show a 
great deal of similarity to the spectra collected for the Cu+2:peptide 5 complex. As a result, 
the data suggests that the peptide undergoes similar conformational changes upon binding 
the two metal cations; however, the respective coordination geometries of the two 
complexes are not identical. 
The results from these clearly indicate that the metal binding properties of peptides 
containing the bipyridyl amino acids can act cooperatively to bind metal cations, provided 
that the primary sequence is carefully selected to promote these interactions. However, in 
all of these cases, the two bipyridine ligands provide four ligation moieties. Many 
metalloenzymes, particularly the catalytically active Zn+2 enzymes,3·28 contain tetrahedral 
coordination geometries where three of the ligands are derived from the protein structure. 
Based on the results from peptide 5, peptides 6-8 were designed to form a tridentate metal 
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Figure 5-6. (A) Visible absorption spectra of the titration of 5 (300 J.LM) with CoCl2 
(pH=7 .0, 0.2 M NaCl, 25° C); (B) Circular dichroism spectra of the 
titration of 5 (300 J.LM) with CoCI2 (pH=7.0, 0.2 M NaCl, 25° C). CoCl2 
concentrations were as follows: 100 J.LM, 200 J.LM, 300 J.LM, 600 J.LM, and 
1.2mM. 
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Metal Binding Properties of Peptides Containing Phenanthrolyl or Bipyridylligands and 
Histidine - Peptides 6-8 
The metal binding affinities of peptides 6-8 were determined for Co+2 and Zn+2 
cations using absorption spectroscopy titrations as described above, and the results of these 
experiments are shown in Table 5-4. All three of the mixed-ligand peptides were found to 
have 1:1 peptide/metal ion stoichiometries for both Co+2 and zn+2 cations and well-defined 
isosbestic points were observed throughout the metal cation titrations. These observations, 
along with the 25-fold enhancement in the Zn+2 binding affinities of peptide 6 over the 
corresponding control peptide 4 clearly suggests that the histidine and phenanthroline 
ligands act cooperatively to bind the metal cation, in a similar fashion to that observed for 
peptide 5. Similar effects are assumed to be in operation for peptides 7 and 8, since these 
peptides also exhibit enhanced binding affinities over the corresponding control peptides 3 
or 4. 
Table 5-4. Dissociation Constants and Metal Complex Stoichiometries for Peptides 
containing 6Bipyridyl- or 2-Phenanthrolyl-Alanine and Histidine 
Kd,M 
(Peptide:Metal Stoichiometry) 
Peptide Zn+2 Co+2 
Ac-2Fen-Thr-Pro-D-Ala-Val-His-NH2 (6) 9.4 ± 0.2 X lQ-6 < 5 X 10-8 
(1: 1) (1: 1) 
Ac-2Fen-Val-Pro-D-Ser-Phe-His-NHz (7) 2.0 ± 0.8 X lQ-6 < 5 X lQ-8 
(1: 1) (1 :1) 
Ac-6Bpa-Thr-Pro-D-Ala-Val-His-NHz (8) 9.3 ± 0.2 X lQ-5 1.0 ± 0.3 X IQ-5 
(1 :1) (1: 1) 
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The circular dichroism spectra for the metal cation titrations of peptide 6 are shown 
in Figure 5-7a-b. It is clear that the peptide undergoes some spectral changes upon metal 
cation addition; however, unlike the spectra observed for Cu+2:peptide 5 complex, the near 
UV absorption region of the spectra for both metal cations shows only broad, weak 
ellipticities. In addition, comparison of the spectral changes for the two metal cation 
titrations indicates that the two metals have complexes that are distinct from one another. 
The two peptides containing the central tetrapeptide sequences known to promote 
turn formation (7 and 8) show large changes in the UV region of the circular dichroism 
spectra upon addition of metal binding cations (see Figures 5-8a-b, 5-9a-b). The results 
from the titrations with both Co+2 and Zn+2 are very similar for both of the peptides, 
indicating that they undergo similar changes upon binding the metal ions. The resulting 
metal-bound peptide complexes exhibit CD spectra which resemble that predicted for Type 
II reverse turns and p-sheets;29 however, the presence of the bipyridyl and phenanthrolyl 
chromophores could lead to effects on the overall spectra which are hard to characterize. 
As a result, it is not possible to deduce unambiguous structural information from the 
spectra based on the polypeptide chromophores. 
The relative contribution of the central tetrapeptide conformation on the overall 
metal binding properties can be determined through comparison of the metal binding 
affinities of peptides 6 and 7 . These peptides differ only in the central tetrapeptide 
sequence; peptide 6 contains the central tetrapeptide used in all the above studies, Thr-Pro-
D-Ala-Val, which is known to have only moderate reverse tum character in solution.11 In 
contrast, the central tetrapeptide incorporated in peptide 7, Val-Pro-D-Ser-Phe, is known to 
have a large population of reverse tum character in aqueous solution (see Chapter 2). The 
5-fold increase in binding affinity observed for peptide 7 over peptide 6 for Zn+2 indicates 
that the reverse turn plays an active role in the metal binding properties of the peptide, 
presumably through pre-organization of the two metal binding ligands. These results are in 













































Figure 5-7. (A) Circular dichroism spectra of the titration of 6 (30 J..LM) with ZnCl2, 
(pH=8.25, 250 J..LM HEPES, 25° C, ZnCl2 was added in 8 J..LM increments); 
(B) Circular dichroism spectra of the titration of 6 (30 J..LM) with CoCl2 




















































Figure 5-8. (A) Circular dichroism spectra of the titration of 7 (30 11M) with ZnCl2, 
(pH=8.25, 250 11M HEPES, 25° C, ZnCl2 was added in 5 11M increments); 
(B) Circular dichroism spectra of the titration of 7 (20 11M) with CoCl2 





















































Figure 5-9. (A) Circular dichroism spectra of the titration of 8 (40 J.lM) with ZnCl2, 
(pH=8.25, 250 J.lM HEPES, 25° C, ZnCl2 was added in 50 J.lM 
increments); (B) Circular dichroism spectra of the titration of 8 (40 J.lM) 
with CoCh (pH=8.25, 250 J.lM HEPES, 25° C, CoCl2 was added in 20 
J.lM increments). 
174 
sequences on the binding affinities of hexapeptides incorporating two bipyridyl groups 
(6Bpa). 11 Similar correlations were observed between the metal-cation binding affinities 
and the turn nucleation potential of the central tetrapeptide sequence; in the extreme case, a 
15-fold differential in binding affinities was observed. Similarly, the tum sequence has 
been shown to be essential for effective metal cation binding with octapeptides containing 
histidine residues.23 In these studies, a series of octapeptides were prepared which 
incorporated a central tetrapeptide sequence flanked by two dipeptide sequences containing 
a total of three histidine residues. Efficient metal cation binding was observed using 
circular dichroism spectroscopy for the peptides which contained sequences that promoted 
reverse tum nucleation, whereas the sequences that were predicted to have poor reverse 
tum character did not have well-defined metal binding characteristics. 
Finally, the fact that peptide 8, which contains a 6Bpa residue, shows a :::50 fold 
reduction in the binding affinity for Zn+2 and a full 200 fold reduction in the Co+2 binding 
affinity relative to the 2Fen peptide (7) illustrates the ability to precisely modulate the metal 
binding properties of peptides containing mixed-ligand systems. These results demonstrate 
the ability to select for various metal cations based on both the choice of the metal binding 
amino acid, in conjunction with the carefully designed primary sequences. 
Conclusions 
The bipyridyl- and phenanthrolyl-based unnatural amino acids provide ideal 
components for the construction of peptides with unique metal binding properties. The 
amino acids can be readily incorporated into peptide sequences with little modification to 
the standard solid phase peptide synthesis protocols and are stable to the conditions needed 
for peptide cleavage from the resin and subsequent purification. Peptides incorporating 
these amino acids bind a wide variety of metal cations with affinities only slightly lower 
than the parent 2,2'-bipyridine and 1, 10-phenanthroline ligands. Interestingly, while 
peptides containing these amino acids did not readily undergo intermolecular metal 
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chelation, the peptides which were designed to promote intramolecular metal cation binding 
had greatly enhanced metal binding affinities and peptide:metal cation stoichiometries 
consistent with cooperative metal binding. In addition, the cooperative metal binding 
properties were found to be dependent on the primary sequence of the peptide. Several 
peptides were designed to provide enhanced chelation abilities through the incorporation of 
reverse tum character in the polypeptide sequence, and the expected correlation between the 
enhanced metal binding affinities and the amount of reverse turn character in the peptide 
sequence was observed. 
The results of the studies discussed in this chapter provide a foundation for the 
construction of novel metalloprotein motifs containing the four bipyridyl- and 
phenanthrolyl amino acids. The ability to modulate the metal binding affinities through 
both the choice of the metal binding amino acid and the careful selection of the primary 
sequence should allow the construction of tailored metal binding sites programmed for 
either structural or functional roles. An example of the use of these amino acids in a 
functional role is discussed in Chapter 6, where 4Bpa and 6Bpa were used to create 
mutants of horse heart cytochrome c which had enhanced electron transfer properties. 
The metal binding studies on the 6Bpa containing peptides 3 and 5 was published 
as a communication in the Journal of the American Chemical Society: 
Imperiali, B.; Fisher, S.L.; "(S)-a.-Amino-2,2'-bipyridine-6-propanoic Acid: A 
Versatile Amino Acid for de Novo Metalloprotein Design," J. Am. 




All peptides were synthesized on a 0.1-0.2 mmol scale using solid-phase FMOC-
amino protection and BOPIHOBT activated-ester chemistry on a Milligen 9050 automated 
peptide synthesizer using the methods described in Chapter 2 with some modifications. 
PAL resin was used to afford amides at the carboxy terminus. For the commercially 
available residues 4.0 equivalents of amino acid were used per coupling. However, for the 
bipyridyl and phenanthrolyl amino acids a double coupling protocol was employed, where 
the first coupling used 2.5 equivalents of amino acid, followed by a similar acylation with 
1.5 equivalents of residue. Activated esters were formed in situ using BOP, HOBt, and 
0.451 M N-methylmorpholine in N, N-dimethylformamide (DMF). Due to the poor 
solubility of the bipyridyl and phenanthrolyl amino acid activated esters, the amino acid 
ester solutions were filtered manually through a 0.45 IJ.m nylon syringe filter (Gelman 
Scientific) prior to manual injection onto the resin column. Acylation times varied from 30-
90 mins depending upon the coupling efficiency of the particular amino acid; however, a 
minimum of 60 min was employed for any of the unnatural amino acid acylation steps. 
Deprotection of FMOC-protected amine groups was performed using a 7-min 20% 
piperidine/DMF wash or a 5-min 2% DBU/DMF wash. All peptides were acetyl capped on 
the resin using 21 equivalents of acetic anhydride and 5 equivalents of triethylamine in 3 
mL DMF. The resin was shaken for 2 h, filtered, washed with CH2Cl2, and dried in 
vacuo overnight. The peptides were cleaved from the resin and lyophilized from water as 
described in Chapter 2. The purity of the peptides was assessed by RP-HPLC and 1 H 
NMR. Impure peptides were purified using P2 gel filtration chromatography with 50 mM 
acetic acid as eluent, or through semi-preparative RP-HPLC using CH3CN!H20 gradients. 
Fractions containing pure peptide were combined and concentrated by lyophilization, then 
stored at -20 °C. 
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Metal Cation Bindjn~ Iitrations: 
Equilibrium binding constants were determined through titrations of aqueous 
solutions of known peptide concentration with additions of standardized metal solutions at 
25 °C. The titrations were followed through monitoring the red-shift of the bipyridyl or 
phenanthrolyl1t-1t* transition upon metal binding using UV spectroscopy. Metal cation 
solutions (Zn+2, Co+2, Cu+2, Cd+2, Ni+2) were prepared from the corresponding 
anhydrous chloride salt and the zn+2, Co+2 and Cu+2 solutions were standardized by 
ethylene-diamine tetraacetic acid complexometric titrations (0.5 M standardized EDTA 
solution, Aldrich) using murexide as an indicator. 3° Concentrations of peptide were 
determined spectrophotometrically using the absorption of the unbound-bipyridylligand 
transition at 285 nm (Emax = 12,800) or the corresponding phenanthrolyl transition at 268 
nm (Emax = 13,950). For peptides containing only phenanthrolyl or bipyridylligands, the 
pH of the solution was monitored by a glass electrode and held within the range pH=7.0-
7 .5 through small additions of 0.1 N N aOH or 0.1 N HCl in the presence of 200 mM 
NaCl. For peptides containing histidine ligands, the titrations were performed in 50 mM 
HEPES buffer, pH=8.25. The peptide concentrations for each titration ranged from 0.5 
llM-0.5 mM and were varied according to the particular metal cation affinity to ensure that 
the titrations were not performed under saturating conditions. Titrations of dilute peptide 
solutions ( < 2 11M) were carried out in a 10 em-path length quartz cuvette, all other 
titrations were performed in a 1 em cuvette. A miminum of three titrations were collected 
for each metal cation-peptide complex. 
Binding constants were determined from the data between 20-80% of the complex 
formation using graphical analysis. Binding isotherms were obtained from those 
wavelengths where maximal changes in the absorptions were observed upon metal binding 
(typical wavelengths: 250, 270, 275, 280, 300, 305 nm; the actual wavelengths used for 
each determination was based on the particular peptide-metal cation pair). The data from 
each binding isotherm was then plotted as a function of metal concentration divided by the 
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change in absorbance (M = observed absorbance - absorbance of unbound ligand) versus 
the metal concentration in accordance with the y-reciprocal form of the rectangular 
hyperbola (Scott equation):3l,32 
b(M(II)] = (M(II)] + 1 
M (Pep]_L\e,. [Pep]...K,.L\e,. 
Where : b = cell pathlength 
L\£11 =change in molar absorbtivities due to complex formation 
The resulting plots were subjected to linear least-squares regression analysis and the 
binding constant was determined from the corresponding slope andy-intercept according 
to the relation: 
Kd = (y-intercept)/(slope) 
In all cases, the data for each of the wavelengths was found to be strictly linear, and 
the correlation constant (R) from least-squares linear regression analysis was always 
greater than 0.99. The reported metal binding constants represent the average value 
resulting from the multiple determinations and the standard deviation was taken to be the 
error in the binding constant value. In all cases, the binding isotherms were assumed to 
follow a two-state equilibrium when several well-defined isosbestic points associated with 
the addition of metal cations were observed. 22 
The stoichiometry of the metal-cation complexes was determined from titrations 
performed under saturating conditions ([Pep] >> Kd). Under these conditions, the 
stoichiometry of the complex was reflected by the number of equivalents of metal needed to 
reach saturation. 
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Circular dichroism metal titrations were performed in 1 em path-length quartz 
cuvettes with peptide concentrations ranging from 25-50 J,LM using the same conditions as 
listed above for the UV /Vis metal titrations for the peptides in unbuffered solutions; 
peptides containing histidine residues were performed at pH=8.25 in 250 J.LM HEPES (25° 
C). Spectra were collected after each addition of metal over the wavelength range 200-350 
nm using a scan speed of 50 nm/min, a time constant of 0.5 s, and a band with of 1 nm. A 
minimum of 8 scans were taken for each spectra. The spectra are reported in 
ellipticity/mole peptide. 
RP-HPLC Gradients Used: 
(A) 100% H20 (0.1% v/v TFA) 5 min., Linear Gradient 0-60% CH3CN (0.08% 
TFA)/ H20 (0.1% v/v TFA) 25 min., 60% CH3CN (0.11% v/v TFA) 5 min., Linear 
Gradient 60-0% CH3CN (0.08% v/v TFA)/ H20 (0.1 % v/v TFA) 2 min. 
(B) Linear Gradient 10-60% CH3CN (0.08% TFA)/ H20 (0.1 % v/v TFA) 30 
min., 60% CH3CN (0.11% v/v TFA) 5 min., Linear Gradient 60-0% CH3CN (0.08% v/v 
TFA)/ H20 (0.1 % v/v TFA) 5 min. 
Ac-2Fen-Thr-Pro-D-Ala-Val-Phe-NH~ IH NMR (90/10 H20ID20) o: 9.12 (d, 1H, 1=11.0 
Hz), 9.08 (d, IH, J= 19Hz), 8.60 (d, 1H, J=l6Hz), 8.44 (d, IH, J=13Hz), 8.27 (m, 
2H), 8.17 (m, IH), 8.09 (m, IH), 8.00 (d, 2H), 7.90 (d, 1H, J=17Hz), 7.80 (d, 1H, 
J=20Hz), 7.20 (m, 4H), 7.10 (m, 2H), 6.94 (s, IH), 5.25 (m, IH), 4.54 (m, IH), 4.41, 
(m, 1H), 4.24 (m, 1H), 3.94 (m, 1H), 3.85 (m, IH), 3.58 (m, 4H), 3.50 (m, 1H), 3.05 
(m, 1H), 2.78 (m, IH), 2.00 (m, 8H), 1.27 (d, 3H, 1=17 Hz), 1.50 (d, 3H,J=l6Hz), 
0.69 (m, 6H); 13C NMR (90/10 H20ID20) o: 175.6, 175.2, 174.4, 173.7, 173.3, 173.0, 
169.6, 159.0, 146.7, 143.0, 138.3, 137.7, 136.6, 136.0, 129.9, 129.7, 129.3, 129.2, 
128.9, 128.8, 128.7, 127.2, 127.1, 125.1, 124.8, 69.8, 67.3, 60.3, 56.8, 54.8, 48.3, 
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39.6, 39.0, 37.0, 36.9, 30.0, 29.5, 24.7, 22.0, 18.9, 18.4, 17.9, 17.2. RP-HPLC (A): 
RT = 25.0 min.; HRMS [MH+]: calcd. for CnH54N90g [824.4095] obsd. [824.4117]. 
Ac-2Fen-Tbr-Pro-D-Ala-Yal-Hjs-NH?: lH and 13c NMR in (90/10 HzO/DzO)- peptide 
exists in two well defined conformations, see reproduced spectra; RP-HPLC (A) : RT = 
18.8 min.; HRMS [MH+], calcd. for C4oHszN110s [814.4000] obsd. [814.3983]. 
Ac-2Fen-Yal-Pro-D-Ser-Phe-His-NH2: lH and 13C NMR in (90/10 HzO/DzO)- peptide 
exists in several distinct conformations, see reproduced spectra. RP-HPLC (A) : RT = 
27.0 min.;HRMS [MH+], calcd. for C4sHs4N nOs [876.4156] obsd. [876.4140]. 
Ac-6Bpa-Yal-Pro-D-Ser-Phe-His-NH?: lH NMR (D20) o: 8.68 (d, lH, 1=5.0 Hz), 8.51 
(s, 1H), 8.29 (m, 2H), 8.04 ( d, 1H, J=7.8 Hz), 7.97 (t, 1H, 1=7.8 Hz), 7.77 (m, 1H), 
7.41 (d, 1H, 1=7.5 Hz), 7.15 (m, 5H), 7.05 (s, lH), 5.0 (m, 1H), 4.46 (m, 1H), 4.38 
(m, 3H), 4.29 (m, 1H), 3.75 (m, 3H), 3.60 (m, 1H), 3.25 (m, 2H), 3.15 (m, 2H), 3.02 
(m, 2H), 2.15 (m, 1H), 2.10 (m, 2H), 1.92 (m, 4H), 0.96 (d, 3H, 1=6.8 Hz), 0.88 (d, 
3H, 1=6.7 Hz); 13C NMR (90/10 H20/D20) o: 175.5, 175.0, 174.3, 173.9, 173.8, 
172.5, 172.2, 145.5, 142.1, 140.6, 136.6, 134.5, 130.0, 129.7, 128.2, 127.5, 127.3, 
124.7, 128.2, 122.0, 118.5, 118.2, 62.2, 61.8, 57.9, 57.0, 56.3, 54.5, 53.0, 49.2, 
30.9, 30.4, 27.2, 25.8, 22.6, 19.4, 18.2, 16.1; RP-HPLC (B) : RT = 21.8 min.; HRMS 
[MH+], calcd. for C43H54N 11 Og [852.4157] obsd. [852.4160]. 
Ac-4Bpa-Thr-Pro-D-Ala-Val-Phe-NH2: lH NMR (DMSO-d6) o: 8.70 (d, lH, 1=5.0 Hz), 
8.57 (d, 1H, 1=6.0 Hz), 8.38 (m, 2H), 8.18 (m, 2H), 8.00 (t, lH, 1=3.0 Hz), 7.80 (m, 
4H), 7.50 (m, 1H), 7.40 (m, 1H), 7.22 (m, 4H), 7 .15 (m, 1H), 7.07 (m, 2H), 4.75 (m, 
1H), 4.54 (m, 1H), 4.34 (m, 2H), 4.28 (m, 2H), 4.00 (m, 2H), 3.90 (m, IH), 3.72 (m, 
1H), 3.66 (m, 1H), 3.10 (m, 2H), 2.85 (m, 2H), 1.80-1.70 (m, 8H), 1.65 (d, 3H, 1=8.0 
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Hz), 1.10 (d, 3H, J=6.0Hz), 0.74 (d, 3H, J=8.9 Hz), 0.66 (d, 3H, J=7.0 Hz); Be NMR 
(90/10 H20/D20) S: 176.5, 176.1, 175.1, 174.8, 174.2, 173.1, 170.6, 155.0, 148.7, 
148.3, 146.8, 144.1, 137.6, 130.2, 129.8, 128.6, 128.3, 125.3, 124.7, 68.1, 61.8, 
61.0, 57.9, 55.7, 54.7, 50.7, 49.4, 38.2, 31.0, 30.4, 25.7, 22.7, 19.7, 18.8; RP-HPLe 
(A) : RT = 20.04 min.; HRMS [MH+], calcd. for e41Hs4N90g [800.4095] obsd. 
[800.4055] . 
Ac-5Bpa-Thr-Pro-D-Ala-Yal-Phe-NH2: (NMR spectra show evidence of aggregation in 
solution) IH NMR (DMS0-d6) S: 8.68 (m, 1H), 8.51 (m, 1H), 8.38 (m, 1H), 8.30 (m, 
1H), 8.17 (m, 1H), 8.13 (m, 1H), 8.0 (m, 1H), 7.80 (m, 4H), 7.47 (m, 1H), 7.22 (m, 
4H), 7.21 (m, 1H), 7.15 (m, 2H), 4.71 (m, 1H), 4.54 (m, lH), 4.35 (m, 2H), 4.28 (m, 
2H), 4.00 (m, 2H), 3.88 (m, lH), 3.73 (m, 2H), 2.84 (m, 2H), 1.80-1.70 (m, 8H), 1.18 
(d, 3H, J=8.0 Hz), 1.08 (d, 3H, J=7.0 Hz), 0.75 (d, 3H, J=9 .0 Hz), 0.66 (d, 3H, J=6.9 
Hz); Be NMR (90/10 H20!D20) S: 175.8, 175.7, 175.3, 175.2, 174.2, 174.0, 173.3, 
170.0, 169.2, 136.7, 129.3, 129.0, 127.3, 67.5, 67.2, 61.0, 60.1, 57.2, 54.9, 49.9, 
48.6, 37.0, 30.1, 29.5, 24.9, 21.9, 18.5, 18.0; RP-HPLe (A): RT = 25.1 min.; HRMS 
[MH+], calcd. for C41Hs4N908 [800.4095], obsd. [800.4057]. 
Ac-6Bpa-Thr-Pro-D-Ala-Yal-Phe-NH2: IH NMR (DMS0-d6) S: 8.75 (d, 1H, J=4.4 Hz), 
8.52 (d, 1H, J=7.9 Hz),8.30 (m, 2H), 8.09 (t, 1H, J=7.1 Hz), 7.91 (m, 5H), 7.58 (t, 
1H, J=6.6 Hz), 7.40 (d, 1H, J=7 .6 Hz), 7.24 (m, 7H), 4.98 (m, lH), 4.58 (t, 1H, J=6.3 
Hz), 4.40 (m, 1H), 4.32 (m, 2H), 4.04 (m, 2H), 3.73 (m, lH), 3.63 (m, 1H), 3.32 (m, 
lH), 3.11 (m, 2H), 2.86 (m, 1H), 2.04 (m, 2H), 1.81 (m, 6H), 1.20 (d, 3H, J=7.0 Hz), 
1.11 (d, 3H, J=6.2 Hz), 0.77 (d, 3H, J= 6.8 Hz), 0.70 (d, 3H, J=6.8 Hz); HRMS [M+], 
calcd for e41Hs4N90g [800.4095], obsd. [800.4135]. 
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Ac-6Bpa-Thr-Pro-D-Ala-Val-6Bpa-NH2: lH NMR (D20) B: 8.29 (s, 2H), 7.63 (m, 8H), 
7.21 (m, 2H), 7.10 (m, 2H), 4 .30 (d, 1H, 1=5.8 Hz), 3.99 (d, 1H, 1=7.14 Hz), 3.86 (t, 
1H, 1=7.52 Hz), 3.77 (t, 1H, 1= 6.1 Hz), 3.66 (d, IH, 1=7.23 Hz), 3.36 (m, 2H), 3.16 
(m, 1H), 2.93 (m, 4H), 1.64 (m, 13H), 0.99 (d, 3H, 1=7.2 Hz), 0 .36 (d, 3H, 1=6.8 Hz); 
HRMS [M+], calcd for C4sHs6NnOs [878.4313], obsd. [878.4285] . 
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Chapter 6. Semisynthesis of Bipyridyi-Aianine Cytochrome c Mutants: 
Novel Proteins with Enhanced Electron Transfer Properties 
193 
Introduction 
Recent advances in protein engineering have allowed the construction of modified 
proteins with novel properties ranging from modified substrate specificities1•3 or metal-
dependent regulated activities4•5 to enhanced structural stabilities resulting from metal 
cation binding at sites engineered on the protein surface.6 Although site-directed 
mutagenesis has allowed specific alteration of protein architecture, it is a technique that 
relies upon the cell's biosynthetic machinery, and is therefore limited to the encoded amino 
acids. It would be advantageous to include unnatural amino acids into protein ensembles to 
augment existing structures, or to introduce new functionalities altogether. Both in vitro 
expression of chemically acylated suppressor eRN A 7· 11 and total chemical synthesis12 
methods have been employed to incorporate unnatural amino acids into protein sequences. 
However, the former technique suffers from low throughput of protein, while the latter is 
limited to sequence lengths that can be built by employing solid phase peptide synthesis 
technology. 
In contrast, the semisynthetic methodology, 13· 15 in which fragments of native 
protein are fused with synthetically prepared peptides to form complete protein sequences, 
can provide a means for facile generation of proteins containing unnatural amino acids in 
large quantities. To date, the semisynthetic technique has been limited to those proteins that 
are naturally amenable to facile cleavage and religation; however, the use of genetic 
engineering should provide a means for more general application of semisynthesis in the 
future. In addition, the recent developments in synthetic methods for production of novel, 
optically pure amino acids 16 and advances in solid phase peptide synthesis 17 now allow 
the assembly of peptides in essentially infinite variety. With these tools in hand, the stage 
is now set for the general manipulation of proteins well beyond the constraints set by 
nature. 
Semisynthetic methods have been employed with great success for the creation of 
novel cytochrome c (cyt. c) mutants in relatively large (milligram) quantities. The 
194 
preparation of these mutants is generally accomplished through the coupling of two protein 
segments representing residues 1-65 and 66-104 of the complete horse heart cyt. c primary 
sequence as shown in Figure 6-1.18·19 TheN-terminal fragment (residues 1-65), which 
contains the covalently bound heme, is generated from the native protein through cyanogen 
bromide cleavage of native horse heart cyt. c at Met65 under denaturing conditions, 
followed by purification using cation-exchange chromatography to afford a homoserine 
(Hse) lactone at the carboxy terminus.20 The corresponding polypeptide consisting of 
residues 66-104 can be prepared by solid phase peptide synthesis, thereby allowing the 
incorporation of both natural and unnatural amino acids anywhere within this region of the 
protein sequence, with the caveat that the protein must be able to correctly fold to the native 
structure in the presence of these mutations. Reconstitution of the protein is accomplished 
through incubation of the two fragments under neutral reducing conditions, which 
promotes the reaction of the 66-104 amino terminus with the Hse65 lactone to form a 
peptide bond. The fully-formed protein can then be purified using standard 
chromatographic techniques. These methods have been used to prepare a wide variety of 
cytochrome c mutants which contain both natural and unnatural amino acids; several 
notable examples include a mutant containing p-fluorophenylalanine at position 6721 ·22 and 
mutants incorporating a variety unnatural metal ligating residues at position 80 to study the 
effects of axial ligation on the protein-bound heme group.23·24 
To date, Gray and co-workers have used cytochrome c mutants modified with 
redox-active metal centers to study the factors that govern intraprotein electron transfer 
(ET). 25·26 These studies have relied on the semisynthetic technique for site-specific 
incorporation of histidine residues on the protein surface, which were subsequently 
modified with Ru(bpy)2C03 to afford Ru(bpy)2(im)(His)-modified proteins. These 
proteins are capable of efficient photoinduced ET from an electronically excited tRu2+) site 
to the heme-bound Fe-center. The rates of intraprotein ET between the two metal sites 
have been measured for these mutants27 and the results from these studies, in conjunction 
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